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ABSTRA CT 
DEGRADATION OF HUMAN ANAPHY LATOXIN C3a BY RAT PERITONEAL MAST CELLS: A ROLE 
FOR THE SECRETORY GRANULE ENZYME CHYMASE AND HEPARIN PROTEOGLY CAN. 
James Edmund Gervasoni, Jr, B.A. 
Major Director: Shuan Ruddy, M.D. 
Purified human C3a was iodinated (12 5I_C3a) and used to study the 
interaction of labeled peptide with rat peritoneal mast cells (RMC). Cellular 
binding of 12 5I_C3a occurred within 30 sec, followed by a rapid dissociation 
from the cell. Both the binding of 12 5I_C3a and the rate of dissociation 
from the cell were temperature dependent. At OOC, the binding of 12 5I_C3a 
was increased and the rate of dissociation reduced, as compared to 370C. 
Once 12 5I_C3a was exposed to RMC, it lost the ability to rebind to a second 
batch of RMC. Analysis of the supernatants by trichloroacetic acid (TCA) 
precipitation and electrophoresis in sodium dodecyl sulfate polyacrylamide 
gels (SDS PAGE) revealed a decrease in the fraction of 12 51 precipitable by 
12 5 TCA and the appearance of I-C3a cleavage fragments. Pretreatment of RMC 
with enzyme inhibitors specific for chymotrypsin, but not trypsin, abrogated 
the degradation of 12 5I_C3a. Treatment of RMC bearing 12 5I_C3a with Bis 
(sulfosuccinimidyl) suberate (BS3) covalently crosslinked the 12 5I_C3a to 
chymase, the predominant enzyme found in the secretory granules. Antiserum 
d" t d " t  h " "t t d 12 5I_C3a from t t f RMC t t d lrec e agalns c ymase preclpl a e ex rac s 0 rea e 
with BS3. Indirect immunofluorescence of RMC using the 19G fraction of goat 
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anti-rat chymase showed that chymase is present on the surface of unstimulated 
cells. Neither purified chymase nor heparin proteoglycan alone had any 
appreciable effect on 12 5I_C3a, but together they resulted in prompt degrad­
ation of the 125I_C3a• Immunoabsorption of RMC sonicates with specific anti-
body for chymase completely abrogated the ability of these sonicates to degrade 
12 5I_C3a• Intact RMC were pretreated with serine esterase inhibitors prior 
to 12 5I_C3a and BS3 exposure. The cells to which 
12 5I_C3a had been 
crosslinked to were solublized and analyzed by SDS PAGE and autoradiography . 
There were three bands visualized, a 35, 000 dalton band which was defined as 
chymase, and two undefined 4 5, 000 and 55, 000 dalton bands. The results 
indicate that 12 5I_C3a binds to RMC and is promptly degraded by chymase in 
the presence of heparin proteoglycan. In addition, this proteolysis of 
12 5I_C3a by chymase must be blocked in order to detect plasma membrane C3a 
binding components on RMC. 
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I NTRODUCTI ON 
The three systems that play an intricate role in the process of 
inflalllllation are the clotting, kinin, and complement systems. Upon 
activation each system generates primary and secondary products that have 
significant biological effects during the acute inflammatory response. 
The primary products continue on into the central pathways of their 
respective systems. The secondary products contain activation molecules 
that are involved in mediation of the inflammatory response. The 
complement system is made up of two distinct pathways, the classical and 
alternative pathways. The differences between the two pathways involves 
the generation of the C3 and C 5  convertase enzymes. The C3 and C 5  
convertase enzymes are responsible for the cleavage of native C 3  and C 5, 
respectively. The fragments that are generated by the proteolytic 
cleavage of C3 and C 5  are C3a and C3b and C 5a and C 5b, respectively. 
Both the C3b and C 5b fragments are involved in the lytic function of the 
complement system. The smaller C3a and C 5a fragments are termed 
"anaphylatoxins " and mediate other biological function involved in the 
acute inflalllllatory process. In the classical pathway, the complement 
components that are involved in generating C3  and C 5  convertases are 
Clqrs, C2b, C4b, and C3b (1). In the corresponding alternative pathway, 
the molecules that are involved in the C3 and C 5  convertase enzymes are 
Factor B, Factor D, C3b, and properdin ( 2 ) . The C3a fragment generated 
by either the alterative or classical C3 convertase are chemically and 
biologically identical. This is also true for the C 5a fragment generated 
by either pathway. Discovering the molecules responsible for 
anaphylatoxin activity took approximately sixty years. 
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Historical Background. In 1910 Friedberger observed that guinea pig 
serum exposed to immune precipitates acquired the ability to induce 
anaphylactic shock in animals injected with the treated serum. 
Friedberger called these hypothetical substances that caused this shock 
syndrome "anaphylatoxins" (3). In 1913 Bordet showed that anaphylatoxins 
could also be generated by treating serum with other agents such as 
polysaccharides (agar) (4). Agents such as immune complexes, agar, 
dextran, starch, and inulin were used to generate anaphylatoxin activity 
in sera from rats, rabbits, and guinea pigs. Novy and de Kru if in 1917 
working with various types of activators of serum such as trypanosomes 
and agar showed that anaphylatoxin activity was thermolabile and could be 
generated in serum without addition of foreign proteins (5). It was 
concluded at this time that the toxic factor found in various animal sera 
might be derived from the complement system, which at this time was 
poorly understood. Friedberger proposed the "humoral anaphylatoxin 
theory" which stated that the shock-induced syndrome of activated serum 
was caused by humoral factors present in blood (complement) (3). The 
"humoral anaphylatoxin theory" was abandoned in the early 1950 s when Hahn 
and Oberdorf showed that there was a correlation between anaphylactic 
shock syndrome and the liberation of histamine (6). The authors 
concluded that anaphylatoxin itself acts as a histamine liberator when 
injected into guinea pigs (8). Friedberger's hypothesis that complement 
may play a role in the generation of anaphylatoxins was not addressed 
until 1957 when Lepow showed a decrease in complement activity when serum 
was incubated with dextran, with a concomitant increase in anaphylatoxin 
activity (7). It was not until 1959 that Osler et al had 
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the first clear evidence that showed that complement was involved in 
anaphy1 atoxin generation ( 9 ). Osl er et a1, demonstrated that serum 
acquired the ability to induce smooth muscle contraction and enhance 
vasuc1ar permeability upon activation of the complement system. These 
investigators also showed that the hemolytic activity of serum decreased 
as the anaphylatoxin activity increased. Compounds such as che1ators or 
hydrazine which prevent complement activation also showed to inhibit the 
production of spasmogeneic activity ( 9 ). Jensen in 1959 was the first 
investigator to assign the anaphylatoxin activity to a specific 
complement component. Jensen isolated guinea pig C5 from serum and 
digested the molecule with trypsin which generated anaphylatoxin activity 
( 10 ) . In addition, human C5 was also isolated and digested with 
trypsin. Two fragments C5b and C5a were identified and separated by gel 
filtration. The latter fragment showed anaphylatoxin activity ( 11 ). A 
new anaphylatoxin activity was reported by Dias da Silva et a1 ( 1967) in 
a reaction mixture that contained purified complement components C1 
esterase ( C1 esterase is activated C1s) , C4 , C2, and C3 but not C5. In 
the presence of Mg++ this reaction mixture resulted in the cleavage of 
C3. These investigators further demonstrated that a smaller fragment was 
generated from 1
25I_C3 that showed anaphylatoxin activity ( 12 ) . 
Cochrane and Muller-Eberhard showed that there were clearly two distinct 
anaphy1atoxins that could be generated from the complement components C3 
and C5 ( 11) . They also showed that the C3a fragment is a polypeptide of 
6,000  to 15, 0 00 da1tons and has all the anaphylatoxin activities as C5a. 
Shortly after the identification of the two anaphy1atoxins C3a and C5a, 
Bokisch demonstrated a serum protein in humans that inhibited C3a 
4 
anaphylatoxin activity (13). In addition, Bokisch showed that if C3a was 
incubated with normal human serum for greater than minute the C3a 
spasmogenic activity was completely abrogated (1 3). Furthermore, Bokisch 
and Muller-Eberhard isolated and identified the molecule responsible for 
the inactivation of C3a as a carboxypeptidase (14). Previous to their 
findings, anaphylatoxin generation in whole human serum could not be 
demonstrated. Failure to produce anaphylatoxin in human serum was a 
direct effect of this carboxypeptidase activity. The identification of 
this serum inactivator made it possible to isolate and characterize the 
C3a and C 5a molecules in active form and compare them physiochemically. 
Although human C3a had previously been characterized by Cochrane (11), 
C 5a had not. With the use of 1 M epsi1on-aminocaproic acid, an inhibitor 
of the carboxypeptidase enzyme, Va110ta and Muller-Eberhard (1972 ) were 
able to characterize C 5a and compare it to C3a (1 5). 
Chemical Nature of C3a. Va110ta and Muller-Eberhard found that the 
electrophoretic mobility for C3a was + 2 . 1  x 10- 5 cm2 V-1 s-l and 
for C 5a it was +1. 7 x 10- 5 cm2 V-1 Sl. In addition, the 
molecular weights of C3a and C 5a were determined by two methods, gel 
fil tration and gel e1 ectrophoresis. By gel fil tration, the mol ecu1 ar 
weights of C3a and C 5a were 8, 700 and 17, 500 da1tons, respectively; by 
gel electrophoresis C3a was 7, 2 00 and C 5a was 16, 500. Detailed chemical 
analysis of C3a was performed using human, rat, and porcine as a source 
of anaphy1atoxins (16, 17, 18, 19). The amino acid sequence of the three 
animal types are very similar, although there are some noticeable 
differences. These differences do not greatly affect the functional 
activities of these three anaphy1atoxins (2 0). The molecular weights of 
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these t hree C3a ana phyl ato x i n mol ecul es are a ppro x imate l y  9, 000  dal tons 
accord i ng to ge l fi l trati on stud i es and d i rect ca l cu l ati ons u s i ng the 
primary ami no ac i d  sequences (16, 17, 18, 19). The number o f  resi d ues i n  
human and  porc i ne C3a are 77 ami no a c i ds , whereas i n  rat there are 78 
ami no ac i d  resi dues . From t he number of res i d ues o f  C3a and from t he 
am i no a c i d  sequence o f  C3 i t  can  c l earl y be demonstrated that the C3a 
mol ecul e comes from the a c ha i n  o f  nat i ve C 3  and that t he a c ha i n  i s  
cl eaved a t  pos i t i on 77 or 78 by a seri ne hydrol ase en zyme ( C3 co n vertase ) 
( 2 1 ) • All three C3a mol ecul es from human , rat , a nd porc i ne ha ve three 
d i s u l f i de bri dges i n  the mo l ec u l e .  The i soel ectri c po i nts o f  human and  
porc i ne C3a  are 9. 7 and 8 . 6, res pec ti vel y .  C3a  is  a hi ghl y  cat i on i c 
mol ecu l e made u p  o f  a s i ng l e  po l ype pti de cha i n  l ac k i ng c arbohydrate 
resi d ues . I t  has been fo und t hat t he i na c ti ve form of C3a i s  t he 
C3ad A form . The C3ad A mo l ec u l e i s  nati ve C3a wh i ch ha s had es rg es rg 
i ts COOH- term i na l  arg i n i ne res i d ue c l eaved off  (17). The C3a des Arg i s  
no ns pa smo geni c and i s  the mol ecul e produced fol l owi n g  cl e a v a ge by t he 
s erum carboxype pti dase i nacti va tor.  I t  has been shown that the 
COOH- termi nal  octa pep ti de of C3a i s  1 to 2 %  as a c ti ve i n  a l l b i o l o g i ca l  
a ssays  as com pared to nati ve C3a (2 2 ) . Furthermore , a s  the l ength  o f  the 
octa pepti de i s  decreased go i ng towards the arg i n i ne COOH- termi nus  there 
i s  a progress i ve decrease i n  acti v i ty .  Bel ow a tri pe pti de there i s  
essenti a l l y  no a c ti v i ty o bserved ( 2 3 ) . From these s t ud i es i t  i s  cl ear 
that the COOH- term i na l  reg i o n  o f  the  C3a mo l ec u l e is  essen t i a l  for 
b i ol o g i cal  a c ti v i ty . S truct ural studi es to determi ne t he terti ary 
con format i o n  o f  human and  a porc i ne C3a u s i n g  c i rc u l ar d i choi sm ( CD ) ha ve 
been performed (18,19). T he CD s pectra i nd i c ates that both human and 
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porc i ne C3a  are 40 to 5 0% a lpha heli cal i n  confo nn a ti on . From t he CD  
s pectra it  can  be  deduced that  C3a has a ti ghtly com pa c t  fold i ng 
arran gement wi th the NH2 and COOH- termi nal reg i o ns i n  an al pha heli cal 
co n format i o n  wi th three small loops  formed by the i nt racha i n  d i s ulfi de 
bonds ( 2 4) . Recently ,  evi dence to conf i nn th i s  model has been 
demons trated by Dei senho fer i n  Germany , who has pur i f i ed ,  c rys talli zed , 
a nd analyzed human C3a by x- ray crys tallo gra phi c methods . C3a  i s  folded 
i nto a co nformat i on that resembles a drum sti c k , w i t h  the COOH- term i nal 
end  e xtend i n g  from a hi ghly com pa c ted reg i o n  where t he d i s ulfi de bri d ges 
a re foun d . In add i t i o n , the NH2 - term i nal reg i o n  i s  also i nc luded i n  
that com pa cted dom a i n ( 2 5 ) .  Add i t i onal exper i ments were performed to 
determi ne t he e ffect o f  vari ous  a gents s uch  a s  6 M guan i d i n i um chlo ri de 
a nd merca p toethanol on the co nformat i on and s pa smo gen i c  act i v i ty of C3a 
( 2 4) . Both treatments s how an a lter a t i o n  i n  conforma t i o n  o f  t he C3a 
molecu le as meas ured by CD s pectra , wi t h  les s than 1 0% of the s pa smogen i c  
act i v i ty reta i ned . T he e ffect of t hese a gents i s  reversi ble . After 
t reatment o f  the C3a molecu le by d i a lys i s  a ga i ns t  bu ffer , full acti v i ty 
i s  restored . I rreversi ble i na c ti v a t i o n  o f  C3a  occ u rs only a fter 
extens i ve expos ure to 1 000C .  For example , C3a co u ld be heated to 
1 000 C for 30 m i nutes wi th more than 50% of the s pasmoge n i c act i v i ty 
reta i ned . C om plete a c ti v i ty i s  los t  a fter 3 ho u rs at 1 000 C ( 2 4) . The 
ef fect o f  pH on  the CD s pectra over the range from 1 to 9. 6 i nd i cate that 
si gn i fi cant confonnat i onal c han ges occur at t he lower pH ran ges between 1 
and 3 . 7  ( 2 4) . 
Structural  and Functi onal Aspects o f  C3a . The relat i ons h i p between 
t he s tructural and functi onal as pects of C3a ha ve recently been 
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a pproached by u s i n g  the syntheti c pe pti des d i s c u s sed earl i er .  T he major 
t hru s t  in  s tructure- functi o n  stud i es is  to el uc i date the reg i o n  o f  the 
C3a mol ecul e that  is res po ns i bl e  for i ts b i ol o g i cal  a c ti v i ty . As 
menti oned earl i er ,  a synthet i c octa pe pti de that has the i dent i ca l  ami no 
ac i d  se quence as n a ti ve C3a  at t he COOH- termi nus has t he s ame b i ol og i cal  
acti ons except  to a l es ser  degree ( 2 3 ) . Experi ments that com pa re nati ve 
C3a  to i ts anal o g  t he octa pepti de C3a ( 70-77 ) i nd i cate t he l atter i s  40 to 
50 fol d l es s  acti ve on a mo l e  bas i s i n  i nduc i ng co ntract i on  o f  gu i nea pi g 
i l eal  and uteri ne smooth muscl e .  W hen C3a{70-77 ) i s  i njected 
i nt racutaneous l y i nto humans there i s  a v i s i bl e  s k i n  react i on  ca u sed by 
- 1 0 -9 l oca l  edema and erythema that  i s  m a x i ma l  between 1 0  M to 1 0  M ;  
us i ng nati ve C3a , a s i m i l ar res po nse i s  observed max ima l l y  over the ran ge 
o f  1 0- 1 2 to 1 0- 1 1  M .  I n  add i t i on ,  i f  C3a{70-77 ) or nati ve C3a  i s  
a pp l i ed to gui nea pi g i l eal  s t ri ps , the muscl e contra c t i o n  i s  a bro gated 
towards the other factor . Th i s  cross ta c hyphyl acti c phenomena ( i  .e . ,  
desens i ti z a ti o n  o f  t i s s ue by a s u bstance ) furt her i nd i c ates t hat the 
C3a (70-77 ) synthet i c  pe pti de i s  ana l o gous  to nati ve C3a . The fact that 
C5a  is  not cross tachy phyl a c ti c  wi th e i t her n a ti ve C 3a or C3a ( 70-77 ) 
sugges ts that C5a  and  C3a med i ate the i r  cel l u l ar effects v i a  d i fferent 
receptors . Hug l i has devi sed a model based on  studi es u s i n g  t he 
synthet i c  pe pti des to expl a i n  the mo l ec u l ar i ntera c t i o n  o f  C3a wi t h  i ts 
putati ve cel l ul ar receptor ( 23 ) .  The COOH- termi nal  sequence o f  n a ti ve 
C3a i s  Al a-Ser-H i s- Leu-Gl y-Leu-Al a- Arg-COOH . I f  one repl aces both  
l e uc i ne resi d ues wi th an a l a n i ne res i d ue , C3a ( 70-77 ) a c ti v i ty i s  l os t . 
A l s o  i f  the a r g i n i ne i s  removed , act i v i ty i s  l os t  and i f  the COOH gro u p  
of arg i n i ne i s  repl a cead b y  gl yc i ne ,  t he a c ti v i ty o f  t he pepti de i s  
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l ost . Based on t hese res u l  ts , Hug l  i has pro posed a model for t he 
putat i ve mas t cel l receptor. The pu ta t i ve rece ptor has a hydro pho b i c 
pocket for t he two l euc i ne resi d u es , a ne gati vel y charged poc ket for t he 
arg i n i ne res i due , and  a pos i t i ve l y  charged poc ket for the COOH - termi nus . 
T he T i ss ue E ffects o f  C3a . T he t i ss ue e ffects o f  C3a  are wel l  
documented for smooth musc l e preparat i ons bu t not for va s cu l ar 
permeab i l i ty .  The most common tes t u sed to determ i n e  t he presence of C3a  
i s  to  meas ure the co ntra cti on  o f  gu i nea p i g i l ea l  stri ps .  Other ti s s ue 
tes ted for smooth muscl e contra c t i l i ty to C3a  i nc l udes gu i nea pi g i l eum , 
uteru s , trachea , l un g , co l on ,  atri um , rat i l eum and rat uteru s . The mos t 
rea c ti ve ti s s ue for smooth musc l e contra c ti o n  i s  t he gu i nea pi g i l eum , 
the l eas t i s  l un g  stri ps (2 0). The smooth muscl e co ntracti ons i nduced by 
C3a can be i nh i b i ted by a n ti h i s tami n es , e xcept for the l un g  stri ps .  
These res u l ts s u gges t that C3a med i at i o n  o f  smooth muscl e co ntra c t i o n  i s  
t hrou gh l i bera t i o n  o f  h i s tami ne i n  a l l t hese ti ss ues e xcept t he l un g . I t  
has been s u gges ted that smooth musc l e co ntra c t i o n  o f  gu i nea p i g l un g  i s  
not i nh i b i ted by a n ti h i s tami ne bec a u se t he s ubstances res po nsi bl e for 
contra ct i o n  are pros tagl andi ns (26). 
I n  order to understand t he e ffects of C3a  i n  w hol e t i ss ue � v i vo ,  
one must  ga i n  a better knowl ed ge o f  the parti c u l ar cel l s  that th i s  
mol ecul e i ntera c ts wi th . Furthermore , the i ntera c ti o n  o f  C3a w i t h  a 
parti c u l ar ce l l , on the mol ec u l ar l evel , and  how C3a effects that cel l 
u pon  i ntera c ti on i s  not wel l understood . C 3a produces a v ari ety o f  
effects o n  cel l s  i nc l ud i ng med i ator rel ease  phenomen a , a g grega t i ona l  
res po nses , and s u ppre s s i o n  o f  t he cel l ul ar i mm une res po nses . As a 
res u l t ,  there i s  a grow i ng l i s t  o f  ce l l  types that C3a has been s hown to 
i nteract wi th . The major cel l target for C3a is t he mast ce l l . The 
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effect o f  C3a  on mast  cel ls i s  we l l  documented i n  e a rl y work of the 
1 95 0 ' s .  Many i nves ti gators ha ve s hown that C3a ca u ses vasoami ne rel ease 
( 27 , 28 , 29 ) and degranul a t i o n  of  mast  cel l s  ( 1 1 , 1 2 ) . There has been no 
data to s upport the fact that C3ades Arg ha s any a c t i v i ty for vasoami ne 
rel ease or  degranua 1 ti on o f  mas t ce l l s .  Experi ments to determi ne bi nd i ng 
s i tes for C3a are few ; one study fo und that  1 25 I _C3a b i nd i ng to rat  
mas t cel l s  ranged from 5 to 1 0  m i l l i o n  mo l ec u l es per cel l ( 29 ) . These 
numbers a re pro babl y not correct s i n ce a l l  cel l s  do not have i denti ca l  
di s tri bu ti on  o f  receptors on the i r  surface . Ter Saan  et  a 1  ( 3 0 )  ha s 
found that onl y 2 0% of the rat mast cel l s  b i nd  C3a by u s i n g  ind i rect 
i ll1l1un o f1 uo rescence techni ques . In  add i t i on , i f  these i nves ti gators use 
i nh i b i to rs of  mast  ce l l  degranul at ion  s uch  as ethy1 ened i ami n etetraa ceti c 
a c i d  ( EDTA ) o r  d i sodi um cromog 1 ycate ( DS CG) dur i n g  the i nc u bat i on per i od 
o f  C3a  and R�lC t here was no f1 uorescence observed , i ndi c a ti n g  t he 
degranu l at i on of RMC i ncreases the amount of C3a bi ndi n g . 
T he other ce l l  types to date that ha ve been s hown to ha ve t he 
capa c i ty to b i nd C3a a r e  eo s i no ph i 1 s ,  neutroph i 1 s ,  ba s o ph i 1 s and 
mo nocytes ( 31 ) .  Bec ker et a 1  a re t he onl y i nves ti gators to s how a 
s pec i f i c  receptor s i te for C3a o n  gu i nea p i g pl atel ets ( 32 ) .  I n  
a dd i t i on , these i n ve s ti gators ha ve s hown that  C3a  i ntera c ts wi th gu i nea  
pi g pl atel ets and  causes these cel l s  to  rel ease seroto n i n ( 3 3 ) . 
Recentl y ,  these i n ves ti gators ha ve s hown that C5a causes s eroto n i n 
rel ease from gu i nea p i g platel ets and that the a ct i va t i on  pat hways for 
the ana phy1 ato x i ns are i ndependent of  each  other ( 3 4) . Other stud i es 
have been performed on neutroph i l  s ,  macro ph a ges , and  l ym phocytes to 
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o bserve t he b i ol o gi cal  e ffect o f  C3a  on these var i ous cel l types . 
S howel l ,  et al has demonstrated that C3a ca n cause  l ysosoma l  en zyme 
rel ease i n  a dose-dependent fas h i o n  (10-100 u g/ml ) from human peri pheral 
neutroph i l s (35 ) . These i nves ti gators o bserved that both pri mary and 
secondary granul es were rel eased from neutro ph i l s  when e x posed to C3a 
pl us cytocha l as i n  B. W hen C3a was expos ed to neutroph i l s a l one , there 
was l i mi ted l ysosomal en zyme rel ease . W hen the formyl pepti de receptor 
antagon i s t , t - boc- ( phe l eu ) Z- phe was added to neutroph i l s ,  t h i s  d i d not 
bl oc k  the l ysosomal enzyme rel ease i nduced by C3a . These res u l ts s u g ge s t  
an i nde pendent receptor f o r  C3a  a n d  t h e  fo rmyl pepti des . I n  t he 
macroph a ge system , Hartun g , et al ha ve s hown that  C3a i nduces the rel ease 
of  thrombo xane AZ from gu i nea pi g peri toneal macro pha ges ( 36 ) . These 
i nves ti gators a l so s howed that the hexa pe pti de C3a ( 7 Z-77 ) a l so caused 
thromobo xane rel ease  from gu i nea pi g macro pha ges , and that both C3a  and 
C3a ( 7 Z-77 ) act i va t i on was bl oc ked by a monocl onal  anti -C3a ant i body . 
C3ades Arg was compl etel y i neffec ti ve i n  a c ti vat i n g  these macro pha ges . 
F i na l l y ,  there ha ve been s tud i es do ne that show the effects  of C3a on the 
ce l l ul ar i mm une res po nse . C ha r ri a ut ,  et a l  s howed that C3a  i nh i b i ts 
n atural  k i l l er cel l cytotox i c i ty i n  both mouse  and human sys tems ( 37 ) . 
C ha rri a nt , et a l  a l so fo und t hat t he i n hi b i tory effect was dose and  t ime 
dependent , the i nh i b i t i on  was at the effector-ce l l  l evel , and  that  
C3ades Arg d i d not a l ter t he i n h i b i tory e ffect d i s pl ayed by C3a . 
Morga n , et al have demonstrated the effect of C3a on s u ppres s i on of both 
s pec i fi c  and pol ycl onal  a n ti body res po nses i n  mouse and huma ns ( 38 ) . I n  
these exper i ments i t  was shown that the COOH - term i na l  ar g i n i ne res i due 
1 1  
was essenti a l  for s u ppressi ve a c ti ve . I n  contrast , C3a had no e ffect on 
anti gen o r  m i togen- i nduced B o r  T cel l prol i ferat i ve res po nse .  I t  was 
a 1 so fo und t h at t he hel per T cel l  was the target cel l for thi s C3a 
su ppres s i ve acti v i ty .  Human C3a and  the syntheti c  octape pti de C3a ( 70-77 ) 
i nhi b i ted t he gener a t i on o f  l eu kocyte i nhi b i tory fa ctor ( L I F ) a c ti v i ty by 
human mo no nucl ea r  l eu kocytes and  T l ym phocytes cu l tured wi th m i toge n  
( 39 ) . W hen l ym phocytes were c hromato gra phed onto a C 3a ( 70-77 ) -Se pharose 
col umn the cel l s  found  i n  the effl uen t  fract i ons l os t  the i r a b i l i ty to 
generate L IF a c ti v i ty .  W hen t he l ym phocytes from t he e ffl uent from C3a  
(7 0-77 ) - Sepharose co l umns were anal yzed by  u s i ng monocl onal  anti bod i es to 
s urface a n ti gens , there was a sel e c ti ve depl et ion  of t he hel per/ i nducer 
po pu l  at i on o f  l ym phocytes . I t  was co ncl  uded from these  res u l  ts that C3a 
may pl ay an i m po rtant rol e i n  t he regu l a t i o n  of human T l ymphocyte 
acti v i ty .  
S i m i l ar stud i es that ha ve been des cr i bed a bove for C3a ha ve a l so 
been performed wi t h  C5a ana phyl ato x i n .  There ha ve been s pec i fi c  
receptors for C5a  demo nstrated o n  both human neutroph i l s and mur i ne 
macro pha ges ( 40 , 41 ) . Furthennore , C5a has been s hown to cause  l ysosomal  
enzyme rel ease from rab b i t  a l veo l ar  macroph a ges ( 42 ) and a l so ha s been 
imp l i c ated i n  regul a ti n g  t he i rrrnune res po nse ( 43 ) . 
I t  i s  c l ear from the ev i dence presented a bove that the 
ana phyl ato x i ns pl ay a n  i m po rtant rol e i n  t he o vera l l  i rrrnu n i ty of an 
orga n i sm ,  and  that these mo l ecu l es are.i nvo l ved i n  med i at i n g  a va r i ety of 
ce l l ul ar functi o ns .  These studi es i ndi cate t he u tmost i m po rtance of 
def i n i ng the s pec i f i c  b i o l og i ca l  rol e o f  C3a i n  the acute i nfl ammatory 
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res po nse . I n  order to accompl i s h th i s  tas k ,  a better understand i n g  o f  
t he mo l ecu l ar events  i nvo l ved i n  med i at i on o f  the funct i o n  o f  C 3 a  i s  
im pera ti ve . These events i n vol ve t he understand i n g  o f  t he s pec i fi c  C3a  
receptor and how these  receptors o perate on  the i r  res pect i ve cel l types . 
The f i rst s te p  i n  ga i n i ng t h i s  knowl ed ge i s  to establ i sh ,  i sol ate and 
characteri ze a C3a receptor. 
Mast Ce l l  Heterogeni ety .  
Mas t cel l s  ha ve l ong been reco g i zed , wi th  ba s o ph i l s ,  a s  be i ng the 
major cel l  i nvol ved i n  i lffiled i ate- type hypersens i ti v i ty rea c t i o ns . The 
rol e  of mas t cel l s  i n  i nfl amm at i on and  i n  ho s t  defence aga i ns t  pa ras i t i c  
i nfecti o ns g i ves credence for a central  i n vol vement of t hese cel l s  i n  the 
overa l l  i mmun i ty of an orga n i sm .  The ti s sue l oc a t i on  and  the types of 
med i ators rel eased d u ri ng a c ti vat ion  of mast cel l s  s u p ports t h i s  not ion . 
Mas t cel l s  are l oc ated around the ven u l es and  i n  the co nnecti ve t i ss ues 
of s erosa l , c utaneous , and mucosa 1 s u rfaces w here rel eased med i ators 
wou l d  have the mos t profound effect . The two types o f  med i ators found i n  
mast cel l s  are preformed and n ewl y- generated . The preformed med i ators 
res i de mos tl y i n  the secretory gra nu l es and  i nc l ude the b i o gen i c ami nes 
( h i s tami ne and s eroto ni n ) , proteo gl ycan ( hepari n  or c hondroi ti n s u l fate ) , 
neutral  proteases (c hymas e , carboxyl pe pti dase A ,  or trypta se ) ,  and  t he 
ac i d  hydrol a s es ( S- hexosami ni dase , S- gl ucuron i dase , S- ga l a ctos i dase , and 
a ryl s u l fata s e ) .  The newl y- ge nerated med i ators are l i p i d - deri ved and  are 
produced fo l l owi n g  a c ti v a t i o n  of t he mast ce l l . Among  t hese 
l i p i d- deri ved med i at ors are the l eu kotri enes and  pros tag l and i n 02 
(PG02), whi c h  are both deri ved from ara c h i doni c a c i d , and 
p l atel et - acti vat i ng factor (PAF). 
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There are several cr i teri a used to c haracteri zed mast cel l s ,  n amel y ,  
h i gh a ff i n i ty receptors for mo nomeri c IgE ,  the ab 1 i 1 i ty to produce 
h i s tami ne or s erotoni n , and t he metachromati c s ta i n i n g  of the cyto pl a smi c 
granul es wi th bas i c  dyes . U s i ng these cri teri a i t  ha s become cl ear that 
there e x i s ts at l east  two d i fferent types o f  mast cel l s .  The two types 
of mas t  cel l s  under i nves ti gat i on are the co nnecti ve t i s s ue mast  ce l l  
( CTMC ) and the m ucosal  mast cel l ( MMC ) . The CTMC resi des i n  s k i n  and are 
i sol ated from sero s a l  ti s sue o f  the l un g  and  peri toneum , whereas C are 
fo und i n  the l ami na pro pri a and e p i t hel i um of t he sma l l  i ntes ti nes . 
Connect i ve T i s sue Mas t Cel l . I t  i s  ev i dent from morpho l o g i c ,  
h i s tol og i c , and u l trastructural  stud i es that t he rat CTMC fo und i n  the 
s k i n  i s  d i fferent from the MMC l oc ated i n  the i ntesti nes (44 ) . W hen CTMC 
are s ta i ned wi th a1 c i an bl ue and sa frani n ,  both c a t i o n i c dyes b i nd , 
i nd i cat i ng the presence o f  a h i gh l y  su l fated gl yc o s ami no g l yc a n  i n  the 
granu l es ( 45 ) . Hepari n proteog1 ycan is h i ghl y s u l fated and i s  
res po ns i bl e  for the type o f  s ta i n i ng pa ttern o bserved wi th CTMC . The 
concentrat ion  of he pari n proteo g1 ycan ran ges between 10- 2 0  �g per 106 
cel l s  wi th a mo l ec u l ar wei ght of 75 0 , 000 ( 46 ) . CTMC i s  a p pro x i matel y 2 0  
� m  i n  d i ameter a nd conta i ns amor phous  gra unl es of u n i fo rm  s i ze ( 47 ) .  
There are two types of b i o ge n i c  ami nes found i n  the granu l es o f  CTMC and 
they are h i s tami ne and s eroto n i n  ( 48 ) .  T he concentrat ion  o f  h i s tami ne i n  
t he ce l l  i s  es tamated to range between 10-30  �g per 1 06 ce l l s .  The 
amount of seroton i n i n  these cel l s  ha s not been determ i ned . Both these 
med i ators are i nvol ved in ca u s i n g  i n creased vasod i l a t i on and i ncreased 
vascu l ar permea b i l i ty ( 49 ) .  The other type o f  med i ators rel eased by CTMC 
are t he n ewl y generated c om po unds  s uch a s  PGD2, S RSc ( p r imar i l y  
1 eu kotri ene C ( LTC ) ) ,  and PAF. The functi on o f  PGD2 i s  not c l ear , 
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a l thou gh i t  has been s hown to cause bronchocons t ri ct i on o f  human ( 50 )  and 
can i ne a i rways ( 5 1 ) when admi ni s tered by aerosol . There are several 
b i ol o g i ca l a c ti v i ti es o f  LTC whi c h  i nc l ude neutro ph i l  c hemota x i s  and 
a ggrega t i on  ( 52 ) , bronchoco ns tri cti on ( 53 ) , and  a edema- erythema reacti on 
fo l l owi n g  i ntrac utaneous  i n jec t i o ns i nto hum a ns ( 5 4) . Fi na l l y ,  PAF has 
many b i o l o g i ca l  a ct i v i t i es such as pl atel et a g grega t i on and  secret i on of 
pl a tel et factor 4,  seroto n i n  and t hrom bo xane B 2 rel ease ( 55 ) , smooth 
muscl e contra c t i o n  of gu i nea pi g i l eum ( 5 6 ) , and edema- erythema  rea c ti on 
when i nj ected i nt racutaneous l y i nto both  human and  a n i ma l s ( 57 ) .  
R MC Hepa ri n Proteoglycan . T he major c r i teri o n  for h i s tol o g i cal  
i dent i f i ca t i o n  o f  mas t cel l s  is  based on  the a b i l i ty o f  these ce l l s  to 
produce meta c hrom a s i a fol l owi n g  sta i n i n g  wi th bas i c dyes s uch a s  Al c i an 
bl ue o r  Safra n i n ( 58 ) . The m a s t  cel l com po nent res po ns i bl e  for the 
product i on  of metac hromas i a  fol l owi n g  a dd i t ion  of bas i c dyes is the 
h i gh l y  s u l fated proteo g l ycan  found  i n  the secretory granul es ( 59 , 60 , 61 ) . 
There are severa l types of proteo gl ycans  fo und i n  d i fferent s ubsets of 
mas t  cel l s  in  va r i ou s  s pe c i es . Hepa r i n i s  the predom i nant proteo gl ycan  
found  i n  human , mouse , and  rat  serosal  mast  cel l s ,  whereas c hondro i ti n  
su l fate E i s  the major proteo g l ycan  o f  mouse  mucos a l  mas t cel l s  ( 5 9 , 60 )  
( Fi g .  1 ) . 
C hem i ca l  Compos i ti on o f  Hepa r i n Proteoglyc a n . The hepa r i n 
proteo gl ycan mol ecul e i s  composed of many carbo hydrate c h a i ns attac hed to 
a protei n co re . The type o f  ca r bohyd rate c ha i n  i s  a g l yc o s am i no gl yc a n  
wh i ch i s  c om posed o f  a d i saccha i de u n i t  w i t h  e i t her gl ucuron i c or 
i d uroni c a c i d  l i n ked to a g l uco sami ne ( 62 ) .  Each d i sacch i de un i t  has one 
carbo xyl gro u p  and one to four s u l fate groups . Both t he carbo xyl and 
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F i gure 1 .  Repe a ti n g  D i sacchari de Subun i ts found i n  Hepar in  and 
C ho ndroi t i n S u l fate E .  
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s u l f ate groups  are repo n s i bl e for  hepar in  proteo gl ycan hav i ng a net  
nega t i ve charge . The protei n co re o f  hepa r i n proteo gl ycan  i s  a 
po l ypep ti de made u p  of a l tern a ti n g  gl yc i ne and seri ne ami no a c i ds . T he 
g l ycosami no g l yc a n  i s  attached to gl ucuron i c a c i d ( Gl cUA)- ga l actose ( Gal )­
Ga l - xyl ose (Xyl ) whi ch  i n  turn i s  O- l i n ked to every second or th i rd seri ne 
res i due ( 63 , 6 4 , 65 ,66 , 67 ) .  The a verage mol ecul ar wei ght ( MW )  of  the 
he par in  proteo gl ycan mol ecul e v a ri es amon g  d i fferent s pec i es .  I n  t he rat 
the MW of  the proteo g l yc a n  i s  750 , 000 and  co nta i ns a prote i n  co re of  
1 2 ,000- 2 0 , 000 MW wi th gl ycosami nogl ycan s i de cha i ns of  5 0 , 000- 1 0 0 , 000 MW 
( 6 1 , 68 ) . The human pu l monary mas t cel l proteo g l yc a n  ha s an average MW of  
6 0 , 000 wi th gl ucosami no gl ycan of  2 0 , 000 MW  ( 69 ) . 
B i osynthes i s  of Hepa r i n proteoglycan . The sequence o f  events 
l ead i ng to t he b i osynthes i s  of he pari n proteo gl ycan i n vol ves several  
enzymat i ca l l y  cata l yzed reacti ons . The i n i t i at i on o f  the ca r bohydrate 
c ha i n  forma t i o n  is  fac i l i t ated by t he s eri ne- gl yc i ne sequence fo und i n  
the protei n co re ( 7 0 , 71 ) . The enzyme xyl osyl transferase reco gn i zes the 
s eri ne-gl yc i ne sequence of  t he prote i n  core and i n i ti ates t he transfer of 
xyl ose from uri d i ne d i pho s phate (U D P)- xyl ose to the hyd roxyl  group o f  
s eri ne ( 72 ) .  T h e  el ongat i on  of  t he rema i ni n g  car bohydrate sequence fo und 
i n  hepa r i n i nvo l ves the enzymes ga l actosyl transferase and 
gl uc uro nosyl transferase y i el d i n g  t he sequen ce ( Gl cUA-N-acetyl 
g l uco s am i ne ( G l cNAc))n-G l cUA-Ga l - Ga l - Xyl - Seri ne ( 73 , 7 4 , 7 5 ) .  Two 
add i t i ona l  enzymes , N- acetyl gl ucosami nyl transferase and  
gl uc uro nosyl transferase a re i n vol ved in  forma ti on of t he repeat i n g  
d i s acchari de un i t  ( 76 ) .  The e l onga t i on  react i o n  occurs  i n  the the Gol g i  
a pparatus or t he endo pl a smi c reti cu l um by  t he a dd i ti on  of  the 
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co rres po ndi ng UDP-mo nosacchari de to the grow i n g  po l ysacchar i de cha i n  ( 77 ) .  
Once t he pol ysaccha ri de c ha i n  i s  synt hei zed , there a re fi ve 
mod i fi cat i ons  of the d i sacchari de un i t wh i ch produce a he pa r i n type of 
gl ycosami nogl ycan ( 77 ) .  T he fi ve s te p  mod i fi cat i on proced ure has been 
s tud i ed i n  the mou se mas tocytoma cel l and has be s hown to oc cur  i n  l es s  
than 30  seconds . They are as  fol l ows : 1 )  t he N- a c etyl gl ucosami ne 
res i d ue i s  deacetyl ated to y i el d N- gl ucos ami ne , 2 ) N- g l ucos ami ne i s  
s u l fated , 3 )  parti cul ar  gl ucuron i c a c i d  moi eti es are e p i meri zed to 
i d uron i c a c i d ,  4) the i duroni c a c i d res i due i s  s u l fated at C- 2 ,  5 )  and  
the N- s u l fated gl ucos ami ne res i d ue undergoes an addi t iona l  s u l fati on at 
C-6 y i e l d i ng the com pl et e  hepa r i n gl ycos ami no g l ycan  cha i n .  
Funct ion  o f  Hepar i n Proteogl ycan . The macromol ecul ar  s i ze and 
negati ve charge of he pa r i n  proteo gl ycan ma kes th i s mol ecul e we l l  s u i ted 
fo r be i ng the mat ri x of  the secretory granu l e i n  mas t ce l l s .  I n  the 
secretory granul e hepa r i n  proteo gl ycan a c ts as a cat i oni c exchan ger 
b i nd i ng t i ghtl y wi th the neutral  proteases chymase and carbo xy pe pti dase  A 
of rat serosal  mast  cel l s  and tryptase of the human mast ce l l  
( 7 8 , 7 9 , 80 ) .  Hepa ri n proteo g l ycan  has been s hown to a l ter the acti v i ty o f  
both chymase  on pa rti cu l ar protei n s u b s trates i n  t he r a t  s erosal  m a s t  
cel l a n d  t rypta s e  i n  the human mas t cel l ( 80 ,81 , 82 ) .  Both these f i nd i ngs  
s u g gest that hepa ri n  proteogl ycan may re gul a te t he a c ti vjty of chymase  
and t ryptas e  in  the secretory granul es and i n  the  i nfl ammatory mi l i eu . 
The other component bo und to he pari n proteogl ycan i n  t he sec retory 
granul es i s  h i s tami ne v i a  the carbo xyl  groups of both hepa r i n and 
protei ns at ac i d i c  pH ( 83 ) . U n l i ke the neutral  protea s es , fol l owi n g  
degranul a t i o n  o f  mas t ce l l s ,  h i s tam i ne and  t h e  a c i d  hydrol ases  a r e  freel y 
sol ubl e at phy s i ol o g i ca l  pH . 
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Hepar in  proteogl ycan h a s  been s h own t o  pos s es s  vari ous a c ti v i ti es 
that effect both cel l u l ar and humoral  res ponses . The mos t  wel l known 
act i v i ty of hepari n i s  i ts a n ti coa gul a t i on effect on s erum . 
Anti coagulat i on by hepa r i n i s  med i ated by i ts potent i at i on of 
ant i throm b i n I I I  i nh i b i t i on of throm b i n  ( 84 , 85 ) , coa gula ti on fa ctors XII 
(86),  Xla ( 87 ) ,  Xa ( 88 ) , and  I Xa ( 89) .  Ant i trom b i n I I I has be shown  to  
b i nd he par i n by i ntera ct i n g  w i th s pec i fi c  carbohydrate moi eti es t hat are 
s u lfated at  C-3  of gl ucos am i ne res i dues ( 90 ) .  I n  add i t i on ,  hepa r i n als o  
has been s h own to a ffect t he other two major s erum protei n  systems , the 
com plement and k i n i n sys tem s . I n  the k i n i n sys tem , hepa r i n potent i ates 
t he i nh i b i ti on of b oth pl a smi n ( 9 1 )  and ka l l i kre i n  ( 92 ) and cas ues 
release of pl asmi noge n acti vat or from rat va s cu l ar endothel i a l cel l s  
( 93).  T here ha ve been several i nh i b i t ory effec ts of he pa ri n des cri bed on 
both the c l as s i ca l  and a l terat i ve com plement pa t hways . These i nclude CIs 
act i vat i on of C4 and C2 ( 94 , 95 ) , C 1q b i nd i n g to i mmune com pl e xes ( 96 ) , 
a ct i va t i on of C3 by cobra- venom ( 97 ) ,  C3bBb  con vertase  a s s em bly ( 98 ) ,  and  
act i vat i on of t he a l terati ve pathway by zymoz an ( 98 ) . Hepar i n 
pr oteog l ycan  has been s hown to  en hance C 1  i nh i b i tor act i v i ty ( 98) .  Both 
the neutral  proteas es , chymase  of t he rat and tryptase of t he human , ha ve 
been s hown to ha ve en ha nced proteol ys i s  of the anaphyl atox i n  C3a i n  the 
presence of he pari n ( 99 ) .  S ome of t he other e ffects of he par i n i ncl ude 
en hanced granul ocyte el a s tase  acti v i ty ( 1 00) , rel ease of li poprotei n  
li pase from human t i s s ue � v i vo ( 1 0 1 )  a nd phos pholi pase  Al from rat 
l i ver pl a sma membran es ( 1 02 ) ,  s t imul a ti on of end ot hel i al cell mi grat i on 
( 1 03 ) , and  i nh i b i t i on of anti body-depentent k i l l i ng of Trypanos oma  cruz i  
by eos i noph i l s  ( 1 04 ) .  
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En z ymes of C onnecti ve T i s s ue Mast  Ce l l s .  
Neutra l  Proteases . 
Chymase .  There ex i s ts i n  the secretory granul es of rat seros a l  mas t 
ce 11 s ( RMC ) severa 1 types of en zymes whi ch i ncl ude t he neutral  protea ses , 
ox i da t i ve enzymes , and  the a c i d hyd r ol ases . C hymase  i s  one of two 
neutral  proteas es found i n  the secretory granul es of RMC as a s s es sed by 
hi s tochemi ca l  techn i ques ( 1 05 ) .  C hymas e  i s  an endopepti dase  wi th 
s ubstrate s pec i fi c i ty s i m i l ar  to n- c hymotryps i n , both cl ea v i n g  the 
pepti de bond on the COOH s i de of aromat i c  ami no a c i ds ( 1 06 ) . The 
i nvol vement of b oth h i s ti d i ne and s e r i n e  res i d ues i n  the a cti ve s i te of 
chymase  has been i nd i cated by the i n h i b i t i on of enzymat i c  act i v i ty by 
d i  i sopropyl fl u orophos phate ( DF P) and by L - l- t osyl ami de-2 - phenyl ethyl 
chl oromethyl ket one ( TPCK ) but not by N- n- p-tosyl - L- l ys i ne chl or omet hyl 
ketone ( TLCK )  ( 107 , 1 08 , 1 09 , 1 1 0 ) . 
C hymase has been s hown t o  be a s s oc i ated noncova l en tl y to  hepa r i n 
proteogl yca n  i n  the secretory granul es of RMC ( Ill) . U nder phys i ol og i cal  
condi t i ons , chymase and hepa r i n proteog l ycan  rem a i n  on the s urface of RMC 
as an i nsol u bl e com pl ex fol l owi n g  Ig E-medi ated degranul a t i on (Ill). The 
chymase-hepari n proteog l yc a n  com pl ex can  be d i s s oc i ated wi th 1M NaC l .  
The i nsol ubl e chymase-he pa ri n proteogl ycan com pl e x  rema i ns on t he s urface 
of RMC and does n ' t  d i ffuse away from the cel l fol l ow i n g  RMC acti vat i on .  
T h i s  phenomenon has been i m pl i c ated as  rel evant  to t he c hroni c nature of 
the hos t res ponse  i nvol v i ng mast  cel l s (Ill). 
There are several s ources u sed for t he pu r i fi c ati on of chymase , 
wh i ch i nc l ude l i ve r  ( 1 l2 ) , c utaneou s  ti s sue ( 1 l3 ) , s ke l eta l  muscl e 
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( 1 12 , 1 1 4 )  and RMC. In RMC, chymase accounts for approximatel y 5 0% of the 
total protein found in the secretory granules and 25%  of the total 
protein in the cell with a concentration of 24 pg per cell (Ill). 
Chymase is composed of a single polypeptide chain with a molecular weight 
range between 2 5 , 000 and 29 , 000 daltons ( 1 07 , 1 1 0 ) . Chymase has a 
isoelectric point of 9 . 3  ( 1 1 0 ) . The amino acid sequence of the 
N-terminal 3 5  residues reveal 1 00% homology between serosal and muscle 
chymase with 40% homology with a-chymotrypsin ( 1 14 ) . 
The enzymology of purified chymase has been studied in terms of 
synthetic and various protein substrates. The most efficient substrate 
for chymase found thus far is the synthetic peptide derivative of 
p-nitroanil ide N-Suc-Phe-Leu-Phe-p-nitroanil ide ( 1 07 ) .  The kcat/� 
value for this synthetic peptide substrate was approximately 1 x 106 
- 1  - 1  M s . There have been several protein substrates shown to be 
susceptible to proteolysis by chymase in vitro. These protein substrates 
are neurotensin ( 1 14 ) , human plasma fibronectin ( 1 16 ) , type IV but not 
type I collagen ( 1 17 ) ,  and glucagon ( 1 15 ) . The presence of heparin 
proteoglycan on chymase activity has been variable. In the presence of 
heparin proteoglycan chymase activity has been reduced with protein 
substrates such as ornithine amino transferase ( 1 18 )  and casein 
( 1 07 , 1 1 0 ) . Cleavage of the low molecular weight substrate 
N-benzoyl-L-tyrosine-ethyl ester (BTEE) by chymase is not affected when 
heparin proteoglycan is present ( 1 18 ) .  
Tryptase. Tryptase is an endopeptidase found in human pulmonary 
mast cells which cleaves peptide and ester bonds on the carboxyl side of 
basic amino acids. Tryptase can be measured by its ablility to hydrolyze 
t osy l - L - arg i n i ne methyl ester ( TAME ) a nd certa i n  synt heti c pepti de 
deri vat i ves of p- n i t roan i l i de ( 1 19 , 1 20 ) . Tryptase has been i s ol ated to 
homogene i ty from human pu l monary mast cel l s .  As is observed for chymase 
in  the  rat , tryptase has a l s o  been s hown to  b i nd very ti ght l y to he pa r i n 
proteogl ycan i n  phys i ol og i ca l  bu ffer ( 1 2 1 ) . T he mol ecul ar compos i ti on i s  
d i fferent from chymase , there be i ng two s ubun i ts of 37 , 000 d a l tons and 
two s u bun i ts of 3 5 , 000 dal tons ma k i n g  a 1 44 , 000 dal ton tetramer . The 
concent rati on of tryptase i n  the mas t cel l is a p prox i matel y 12 pg , 
a ccou n ti n g  for a bout 2 3% of t he t otal mast  cel l protei n ;  th i s i s  
com pa ra b l e t o  that percen tage of chymase found i n  RMC . 
Pur i fi ed tryptase generates C 3 b  and C3a  fol l owi n g  i ncu bati on w i t h  C 3  
� v i tro  ( 99 ) . The generati on of the ana phyl atox i n  C3a has been 
con fi rmed b oth by b i oassay and rad i oi mm unoa s s ay .  In a dd i ti on ,  if hepa ri n 
i s  added to  the i nc u ba t i on m i xture the anaphyl atox i n  C3a i s  not detected 
on S O S  PAGE . W h en pur i fi ed C3a i s  i nc u bated wi th  tryptase i n  the 
presence of hepa r i n ,  the C3a mol ecul e was degraded , whereas i n  the 
a bs en ce of hepar i n tryptase had no e ffect ( 99 ) .  Add i ti onal  act i v i ti es of 
t ryptase i nc l ude the c l eava ge of h i gh mol ecu l ar wei ght k i n i nogen wh i ch 
renders t h i s  mol ecul e unabl e to generate k i n i n a c ti v i ty when i nc u bated 
w i th pur i f i ed human uri nary ka l l i krei n ( 1 22 ) . 
C ar boxypepti dase  A .  T h e  s u bstrate s pec i fi c i ty of mast  cel l 
carboxy pe pti dase A i s  s i m i l ar t o  bov i ne carboxype pti dase  A but  the former 
has two to s i xfol d  h i g her a c ti v i ty ( 1 2 3 ) .  T h i s  en zyme i s  a 
meta l l oexopepti dase that cl eaves COO H - term i na l  aromat i c  ami no ac i ds . I t  
i s  s i m i l a r t o  c hymase and tryptase of t he human i n  terms of b i nd i n g  very 
ti ght l y to  hepa r i n proteog l ycan . Carboxy pe pti dase A has been pu r i f i ed 
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from RMC and anal yzed by el ectrophores i s  i n  s od i um dodecyl s u l fate ( S O S )  
po l ya cryl ami de ge l s  wh i ch reveal one prote i n  ban d  of 3 5 , 000 d a l tons . The 
cel l u l ar content based on a c ti v i ty a ccou n ts for a pprox i matel y 10 pg of 
pr otei n per mas t cel l ( 1 2 4 ) . Both carboxy pe pti dase  and chymase together 
account for about 7 0% of t he total protei n  found in t he secretory 
granu l es .  B i ol og i ca l  s ubstrates for carboxype pti dase  A have not been 
defi ned . 
Ac i d  H yd r ol ases . 
8-Hexos ami n i das e .  The enzyme 8- hexos ami n i dase  i s  an exogl ycos i da s e  
found i n  t he secretory granul es of m a s t  cel l s  ( 1 2 5 ) . 8-Hexos ami ni dase  i s  
meas ured by the cata l yti c cl eava ge of the synthet i c  s ub s trate 
p- n i tropheny l - 8-0-2 - a c etami d o- 2- deoxyglucopyra n osi de ( 1 2 6 ) . Th i s  en zyme 
e x i s ts i n  two form s , the A i s omer and the B i s omer . The A i s omer 
cons i s ts of two a and two 8 s u bun i ts ( a282 ) and t he B i s omer i s  
c omposed of four 8 s u bun i ts ( 84 ) T he a cha i ns ha ve a mol ecul ar  wei ght 
of 2 5 , 000 and  the 8 cha i n  i s  27 ,000 ( 1 27 ) . The predom i nant form of the 
en zyme i n  r at mast cell s i s  t he A i s omer , whereas i n  the human mast cel l 
the B i s omer preva i ls .  The enzyme i s  soluble fol l ow i ng degran u l at i on of 
mast  cel l s  and ser ves as a good mar ker for med i ator rel ease  of t hese 
cel ls . 
8-G l ucuron i dase . Th i s  enzyme , li ke 8- hexos am i n i da s e , i s  an 
e x oglyc osi dase  found i n  t he secretory granul es of mast cel ls .  
8-Gl ucuron i dase  cata l yzes the cleava ge of 8- gl ucuronate from the 
nonred uc i ng termi ni  of polysacchri de cha i ns . 8-Gl ucu roni dase  i s  meas ured 
by c l eava ge of the synthet i c substrate phenol pht ha l ei n-8-0- gluc uron i de 
( 1 28 ) . There are two i s omeri c forms of S- gl ucuroni dase  i s ol ated from rat 
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l i ver , t he lys os omal and the mi cros omal forms . B oth of these forms a re 
tet ramers wi th a mol ecu l ar we i ght of 75 , 000 that d i ffer i n  the i r  
i s oel ectri c poi nts ( 1 29 , 1 30 ) . Apparentl y ,  the onl y  i s omeri c form found 
i n  rat seros a l  mas t  cel l s  i s  the l ysos oma l  form . 
a-D-Ga l actosi dase . Th i s  en zyme i s  a l so  found i n  t he secretory 
g ranu l es of mas t ce l l s .  a-D - ga l actos i da s e  i s  detected by the catal yti c 
cl e a v a ge of p- n i tropheny l -a-D- ga l a ctopyranosi de ( 1 3 1 ) .  T he n ature of i ts 
i someri c  form s are not defi ned . 
Aryl s u l fatases . Th i s  enzyme i s  found i n  the secretory gran u l es of 
mast  cel l s  and c atal yzes t he hydrol y s i s  of aromati c s u l fate esters . 
There are two s ubtypes of aryl s u l fata s e , A and B ,  wh i ch are  both detected 
by t he i r  a b i l i ty to cl ea ve p- n i trocatec hol s u l fate ( 1 32 ) .  Aryl s u l fatase 
A has a mol ecu l ar wei ght of 1 16 , 000 wi th an i s oel ectri c poi nt of 4 . 2 . 
Aryl s u l fatase B has a n  i s oel ectri c poi nt of 6 . 4  wi th a molecul ar  wei ghtof 
5 0 , 000 ( 1 3 3 ) . Both aryl s u l fatase  A and B a re found i n  equ a l  amounts  i n  
rat mast cel l s  ( 1 34 ) . 
Mucos a l  Mas t C el l s .  The d i scovery that MMC are a d i st i nct and d i fferent 
ce l l  type than the CTMC was made i n  1 966 by Enerba c k  ( 44 ) . S i nce t hen 
s tud i es us i ng MMC from i s ol ated ti s s ue ha ve not been performed beca use  of 
t he d i ffi cu l ty i n  pu r i fi cat i on of these cel l s .  Recentl y ,  there ha ve been 
full y es tabl i shed cu l tured ce l l s  from both rat and mouse  hemat opoi et i c  
ti s s ue that a ppear  to be analogous to MMC . These cu l t ured mast  cell s 
di ffer s i gn i f i cantl y from the CTMC . The mos t  promi nant d i fference i s  the 
fact that MMC can be cul t ured , but onl y i n  t he presence of concana val i n  
A- spenocyte-cond i ti oned med i um ,  WEH I -3 -condi t i oned med i um ,  or 
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i nterl euk i n- 3 .  MMC are mor phol ogi ca l l y  sma l l er in  d i ameter and  ha ve 
fewer and more  heterogeneous l y s i zed met achromat i ca l l y  s ta i n i ng gran u l es 
than CTMC . MMC a l so  d i ffer i n  t he i r  n ucl ear a p pe arence , i n  that they 
have more i nden tat i ons and  l obes than do CTMC . W hen MMC are sta i ned wi th 
basi c dyes s uch as a l c i an bl ue and s a frani n ,  MMC onl y  b i nd a l c i an bl ue . 
Cel l s  that onl y  b i nd a l c i an bl ue and not sa fran i n ,  a s  do the MMC , i s  
i ndi c ati ve of cel l s  conta i n i ng granul es wi th a proteogl ycan wi th l es s  
su l fated gl ucos am i nogl yca n  ( 45 ) .  MMC d o  not conta i n  hepa r i n bu t rather 
ha ve chondroi ti n s u l fate ( 1 35 ) .  C hondroi ti n s u l fates are 
gl ycos ami nog l ycan  wi th d i sacchari de un i ts com pos ed of gl ucuron i c  a c i d  
l i n ked t o  gal a ct os ami ne ( 1 2 1 )  ( Fi g  1 . ) .  The protei n  core of c hondroi ti n 
su l fates a p pears  to be al ternat i ng ser i ne and gl yc i ne res i dues , wh i ch i s  
the s ame as he pari n proteogl ycan . The mol ecul ar  wei g ht of c hondroi ti n 
s u l fate i s  ap prox imatel y 60 , 000 ( 47 ) .  The types of b i ogen i c  ami nes that 
MMC conta i n  are h i s tami ne and seroton i n .  There i s  a bout 0 . 4 - 0 . 6  �g of 
h i s tam i ne per 106 ce l l s ,  whereas the amount  of serot on i n i s  un known . 
The n ewl y generated medi ators prod uced fol l owi n g  a c ti vat i on of MMC a re 
LTC and PGD 2 . 
The types of en zymes found  i n  the MMC are not as wel l de fi ned a s  the 
CTMC en zymes . Onl y one en zyme has been defi ned i n  t he MMC and that i s  
the neutral  protease  rat mas t cel l protease I I  ( RMC P I I )  ( 1 36 , 1 37 ) .  RMC P 
I I  i s  a seri ne esterase that  i s  s i m i l ar  to chymase ( RMCP I )  found i n  
CTMC . Li ke CTMC chymas e ,  RMC P I I  can be meas ured by the c l eava ge of the 
s yntheti c s ub s trate BTEE ( 1 38 ) .  The mol ecul ar  wei g ht of RMCP I I  i s  a bout 
2 5 , 000 wh i ch i s  approx imat el y 3 , 000- 4 , 000 d a l tons l es s  than RMC P 
T he ami no ac i d  sequence of t he N- termi na l  5 1  ami no ac i ds s h ow 33% 
( 1 39 ) . 
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homol ogy w i th chymotryp s i n , tryp s i n ,  and el astase  a nd 75% homol ogy wi th 
s ke l eta l  muscl e chymas e  ( 1 3 6 ) . The acti v i ty of RMC P II , a ga i ns t  
p- n i troan i l i de deri v a ti ves i s  genera l l y  l ower than RMCP I ( 14 0 , 1 41 ) . 
Mechan i sm of Mas t Cel l Acti vat i on .  There are several  agents that wi l l  
cause  t he degranu l a t i on of mast  cel l s .  T he most  rel e vent to a l l er g i c 
di seases i s  the I gE dependent acti vat i on .  Agents  whi ch i nduce 
non i mm unol og i c  a c ti v a ti on of mast cel l s  i nc l ude cal c i um i onophores ( 1 42 ) ,  
com poun d  48/80 ( 1 43 ) , concanava l i n  A ( 1 44 ) , hydr ogen perox i de and 
mel l i ti n  found in bee venom ( 145 ) , and the ana phl atoxi ns , C3a  and C5a 
( 2 0 )  • 
Fol l ow i ng s ti mu l at i on of human pu l monary mast  cel l s  wi th ant i -Ig E ,  
there i s  a mor phol ogi c  c ha n ge that occ urs w i t h  i n  the granul es whi ch 
i nvol ves both mat ri x breakd ow n  and swel l i ng as  detected by el ectron 
mi cros copy ( 146 ) . Th i s  type of cytopl a smi c granul ar cha n ge s een i n  human 
mas t  cel l s  i s  a l so  observed i n  rat seros a l  mas t ce l l s  fol l ow i n g  ant i -IgE 
s timul at i on ( 146 ) .  
Mas t cel l s  bear  s pe c i f i c  rece ptors for IgE on thei r s urface wi t h i n  
the pl a sma membrane . Cr os s l i n k i n g  of cel l - bound Ig E by e i t her 
mul ti va l ent anti gen or anti -IgE anti body i n i t i ates the degran u l at i on of 
mast  cel l s  ( 147 , 1 48 ) .  The b i oc hemi ca l  e vents a s s oc i ated w i th 
IgE-dependent degran u l at i on of mas t cel l s  are s ummar i zed i n  F i gu re 2 .  
Fol l owi n g  a n ti geni c cros s l i n k i n g  of receptor- bound Ig E ,  t here a ppea rs to 
be a seri ne es terase acti v i ty requ i red for the conti nua t i on of mas t  cel l 
a c ti vat i on ( 149 ) .  Th i s  en zyme has not been i s ol ated but i s  i nd i cated for 
mas t cel l s  by i nh i b i t i on of IgE-dependent degranu l at i on wi th 
d i i sopropyl fl uoroph os phate ( DFP ) . DFP  does n ot i nh i b i t  degranul ati on of 
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F i gure 2 . S chem a ti c Model for I g E -Dependent Acti vat i on of RMC . 
Ag , I gE s pec i f i c  anti gen ; Fc , I g E  receptor ; S E ,  ser i ne es tera s e ;  
MT I , methyl transferase  I ;  MT I I ,  methyl tran sferase  I I ;  P S ,  
phos ph at i dy l seri ne , PME , phos phat i dyl - N -monomet hyl ethan ol ami ne ; PC , 
phos phati dyl chol i ne ;  P LA2 , phos phol i pa s e  A2 ; PLC , phos phal i pase C ;  
Lys - Pc , l ysophos phati dyl chol i n e ;  P GD2 , pros ta gl and i n D2 ; Cyto, 
cyt os kel eta 1 protei ns ; S G , swo 11 en granul es ; G ,  granul es ; CO , 
cyc l ooxygen ase ; DAG ,  d i a cyl gl ycerol ; I P ,  phos pha t i dyl i nos i tol ; AC , 
adenyl ate cycl ase ; ATP , adenos i ne t ri phos phate ; cAMP , cyc l i c  adenos i ne 
monoph os phate ; R2 C2 , i nacti ve prote i n  k i nase ; 2 C ,  act i ve protei n 
k i nase ; ( R- cAMP ) 2 ' noncatayl i c  protei n  k i nase . 
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mast  cel l  i f  added pr i or to  irrmunol og i c  s t imul ati on .  T he process  has  to 
be i n i ti ated before DFP  has  any i nh i b i t ory effect . These  res u l ts s ugges t 
t hat the act i ve s i te for t he putati ve protease i s  protected and that  
pertur bat i on of  the  I gE rece ptor renders the  enzyme s u s ce pti bl e to  
i nh i b i ti on by DFP  ( 1 2 1 ) .  Acc om panyi n g  t he esterase a c ti v i ty ,  fol lowi n g  
i rrmun ol og i ca l  sti mul at i on of mas t cell s ,  i s  an ea rl y ri s e  i n  the cAMP 
levels ( 1 5 0 ) . C oncentrati ons of theophyl l i ne a ppropri ate for t he 
i n hi b i t i on of adenyl cyclase  abroga te I gE-dependent med i at or release , 
i m pl i ca ti n g  t he i n vol vement of t h i s enzyme i n  t he degranul at i on process 
( 15 1 ) . The u l ti mate rol e of cAMP i s  to  acti vate cAMP-de pendent pr otei n 
k i n a s es whi ch are i n vol ved i n  t he phos phoryla ti on essenti a l  protei ns 
requ i red for the secretory res ponse  ( 1 5 2 , 153 ) . I n  add i t i on to  the 
trans i ent ri se i n  cAMP , t he rate of phos phol i pi d  methyl at i on i n creases 
fol l ow i ng  I gE -dependent act i va t i on of mas t cel l s  ( 1 5 0 ) . C onvers i on of 
phos phati dyl ethanol ami ne to phos phat i dyl c hol i ne by methylati on a ppea rs to 
be cata l yzed by two enzymes methyl transferase and I I  ( 154 ) . Two 
addi ti onal  en zymes whi ch  may a lso  be i n volved i n  mast cel l a cti vat i on are 
phos ph ol i pases  A2 and  C ( 1 2 1 ) . Phos ph ol i pa s e  A2 cl eaves 
phos ph ol i pi ds at C-2 to  ge nerate arach i don i c  a c i d  wh i ch i s  the precurs or 
mol ecule u sed i n  t he l i po xygen a se and cycl ooxygen a se pathways ( 1 55 ) . 
Phos ph oli pas e  C cl eaves  ph os ph ol i pi ds at C- 3 ,  generat i ng ph os pha t i dyl 
i nos i tol and d i acyl gl ycerol wh i ch a re i n vol ved i n  t he a c ti vat i on of a 
calmodul i n/calci um-de pendent protei n k i nase  and  protei n  k i nase  C ,  
res pecti vel y  ( 1 2 1 , 1 56 ) .  F i n a l l y ,  t here i s  an a b s ol ute requ i rement for 
calci um i n  the degranulati on of mas t cel l s  ( 1 5 4 ) . I t  a ppears  that 
bri dg i ng of cel l - bound I g E  on mast  cel ls by anti gen i nduces n ot onl y a 
0 d ++ 0 ++ rapl  Ca l n flux but a l s o i ntra cel l ul ar mob i l i z a ti on of free Ca  
( 15 7 )  • 
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MATE R IALS AND  METHODS 
Bu ffers and  Reagents . Phos phate bu ffered s a l i ne ( PB S )  i s  0 . 1 5  M 
NaCl conta i n i ng 0 . 05 M s odi um phos phate , pH 7 . 4 .  TD/OVA i s  Tyrode ' s  
bu ffer ( 1 5 8 )  pH 6 . 8 ,  conta i n i ng 5 mM N -2 - hyd r oxylet hyl p i pe r a z i ne­
N -2 - ethane s u lfoni c ac i d ( Hepes ) ,  5 mM 2 - ( N-mor phol i no ) - ethanes u l foni c 
a c i d  ( Mes ) ,  and  0 . 1%  ova lbumi n ( OVA) . Bov i ne serum al bumi n ,  5 m g/ml , was 
a dded to  PBS to ma ke PBS /BSA.  The fol lowi n g  rea gents were purchased from 
t he s ources i nd i ca ted : Hepes , Mes , and  bov i ne serum a l bum i n ( BSA) 
( Ca l b i oc hem-Be hri n g  C or p . ,  La J ol l a , C A . ) ;  ova l bumi n ,  Fi col l , 
t ri chloroacet i c a c i d  ( TCA) , porc i ne i ntes ti na l  he pa r i n ,  sucros e , 
ben z oyl-L- tyros i ne ethyl es ter ( BTEE ) , h i  ppuryl -L- phenyl a l  a n i ne , 
N- tosyl- L-lysyl - chloromethyl ket one ( TLCK ) ,  tosyl- L- phenyl a l an i ne 
chl or omethyl ketone ( TPCK ) ,  d i i sopropyl fl uorophos phate ( DFP) ( S i gma  
C hem i ca l  C o . , St . Lou i s , MO . ) ;  soybean  tryps i n  i nh i b i tor ( SBT I ) and  
l actoperoxi dase (W orth i ngton B i oc hemi ca l  Co . ,  Freehol d ,  N . J ) . ;  B i s  
( su lfos ucc i n i m i dyl)  suberate ( BS 3 ) ( Pi erce C hem i ca l  C o. , Roc kford , 
I l l . ) ; Na 125 I ( Amers ham C or p . ,  Arl i ngton H ei ghts , I l l . ) ;  Seph a r ose 
CL-4 B ,  Se phade x  G-2 5 , and pheny l -Sepharose ( Ph a rmac i a  F i ne C hemi ca l s ,  
Pi scataway , N . J . ) ;  Dowex l- X2 chlor i de form 1 00-2 00 mes h , protei n  a s s ay 
k i t ,  a cryl ami de , b i sa crylami de , ammoni um pers u l fate , 
N , N , N '  , N ' - tetramethyl ethylened i am i ne ,  s od i um dodecyl sulfate ( S DS ) , 
s i l  ver s ta i n  k i t ,  bromophenol bl ue , mol ecul ar wei ght standards ( B i o-Rad 
Laboratori es , R i chmond , CA. ) ;  TS K 3000 SW 7 . 5  mm x 600 mm col umn 
( Beckman  I nstruments , I nc . ,  I rv i ne , C A . ) ;  Koda k XAR- 2 x- ray f i l m  
( Eas tm a n  Kod a k  Co . , Roches ter , N . Y . ) ; 1 4 "  x 1 4 "  x- ray cassette (Manos tat 
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La boratory I ns trumen ts and  Sc i en t i fi c  Apparatu s , N . Y . ,  N . Y . ) ;  butyl 
pht h a l ate and  d i no nyl phtha l ate ( Fi s her  Sc i enti f i c  Co . ,  P i tts bu r gh , 
PA . ) ;  fl uoresce i n- co nj u gated I gG fra c t i o n  r a b b i t  ant i - go a t  I gG ( heavy 
cha i n  s pec i f i c )  and  I gG fract i o n go at anti - rat  a l bumi n  ( C a ppel 
La boratori es , Cochranv i l l e ,  P A . ) .  Staph yl ococcus  a ureu s Cowan I stra i n  
was a g i ft from D r .  Gordon Arc her . The o r ga n i sm was grown and 
forma l i n- fi xed i n  our  l a boratory . Anti s erum d i rected a ga i nst chymase  was 
produced i n  go at s . The I gG fract i on of  the go at ant i serum was prepa red 
by sequenti a l  ammo ni um s u l fate prec i p i ta t i o n  and OEAE- cell ul ose 
chromatogra phy ( 1 5 9 ) . 
Puri f i ca t i on  of Rat Mas t Cel l s .  Lew i s Stra i n  rats ( fema l e reti red 
breeder ) were anestheti zed w i t h  ether and s a c r i fi ced by card i a c  
punctur e .  Mas t cel l s  were o bta i ned by l ava g i n g  the per i toneal ca v i ty 
w i t h  T O/OVA bu ffer fo l l owed by sedimentat ion  on 35% F i col l ( 1 60 ) . T he 
number  of RMC per rat and thei r pu r i ty and  v i ab i l i ty i s  s hown i n  Tabl e 
1 .  T he pur i ty of mast  cel l s ,  as a s s es s ed by s ta i n i n g  w i t h  neutral  red , 
was 90 -97% and  the v i ab i l i ty ,  determ i ned by trypan bl ue excl u s i on , was 
85 - 9 5 % .  T he y i el d of mast cell s ran ged between 0 . 9 - 2 . 0  x 1 06 per rat . 
Cul tured Cel l s .  Cu l tured mou se mas t cel l s  (CMMC ) and  W E H I - 3  
monocyte/macro pha ge cell l i nes were don ated b y  D r .  L awrence Schwartz . 
CMMC were cu l tured at 1 06 /ml i n  RPMI 1 640  med i um co nta i n i ng the 
fol l owi n g  s u ppl ements : gl utami ne (2 mM fi nal  concentrati o n ) , pyru vate ( 1  
rnf.l ) ,  nones sen t i a l  am i no a c i ds ( 0 . 1 mM ) ,  pen i c i l l i n ( 1 00 U/ml ) ,  
s treptomyc i n  ( l0011g/ml ) ,  gentami c i n  ( 500 llg/ml ) ,  2 -merca pto ethanol  ( 5  x 
1 0- 5  M ) , 1 0% FCS and 25% W EH I -3 co ndi t i oned med i um .  W E H I - 3  cel l s  were 
c u l tured at  5 x 1 05 /ml i n  the s ame med i a as the CMMC . Cul ture fl as ks 
were i nc u bated at  370 C in a humi d i f i ed atmos phere o f  5% CO2 , 95% a i r .  
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Ta bl e 1 .  Pu r i fi c a ti on of Mast  Cel l s  from the Peri toneal Cav i ty 
Number of cel l ( n=76 )  
Frac ti on s ta i n i n g  w i t h  neutral  red ( n = 7 6 ) a 93 . 5% "4 . 0% 
Fra c ti on e xc l  uded by trypan bl ue ( n = 7 6 )  b 89 . 2% "5 . 2 %  
a pur i ty was as ses s ed by neutral  red s ta i n i ng of cel l prepa rat i on .  
b V i ab i l i ty was determ i ned by trypa n  bl ue exc l u s i on .  
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C3a Pur i fi cati on .  Human C3a  was prov i ded by Dr . Tony Hug l i ,  h a v i n g  
been pu r i f i ed by a mod i f i cat i on of a method prev i ous l y descri bed ( 1 61 ) . 
B ri efl y ,  human s erum was act i vated w i t h  i nu l i n  i n  t he presence of 
2- mercaptomethyl - 5 - gua n i d i nopentanoi c a c i d .  C3a was pu r i f i ed from th i s  
compl ement- a c ti v ated s erum by sequenti a l  c hromatogra phy on Se phadex 
G- 2 oo , carboxymet hyl - Sephadex , Sephadex G- 2 o o ,  and oEAE-Seph adex . The 
C3a pre parati on was l yoph i l i zed , s tored at _70oC ,  and rehydrated wi t h  
PBS . The C 3 a  w a s  homoge neou s ; S OS PAGE showed a s i ng l e band  at 9000 
da l t ons . H i gh performance l i qu i d  chromatogra phy ( HPLC ) anal ys i s  on a TSK 
3000 SW 7 . 5  mm x 600 mm s i ze e xc l us i on col umn , equ i l  i brated i n  PBS ,  
detected a s i ngl e protei n  s p i ke i n  t he mol ecu l ar  wei ght ran ge 
corres pond i ng t o  9000 da l tons . 
I od i nat i on .  Human C3a was  i od i n ated w i t h  Na 12 5 I u s i n g  
l act operox i dase  cova l entl y bound  to  Sepha r ose  CL-4B as  prev i ou sl y 
des cri bed ( 1 62 ) .  I od i nated C3a was separated from free i od i de by gel 
f i l trati on over a 0 . 5  cm x 45 cm col umn of Sephadex G- 2 5 .  The Sephadex 
G- 2 5  had been presoa ked in 0 . 1 % oval bumi n to prevent nons pec i fi c  bi nd i ng 
of i od i nated C3a ( 12 5 I_C3a ) to the G- 2 5  mat ri x .  I n  addi t i on ,  I odogen 
was a l so used to i od i n ate C3a . I odogen ( 1 0 �g/test t u be )  was d i s s ol ved i n  
chl oroform and d i s pensed i nt o  s i l i cated pl as t i c tes t  tubes . The 
chl oroform was removed by vol i t i l i z a ti on w i t h  n i trogen . C3a was a dded to 
t hese I odogenated test tu bes ( 25 - 5 0  �g ) w i t h  Na 12 5 I and i ncu bated for 
2 0 m i n .  The reacti on was term i nated by remov i n g  C3a from the tes t tube . 
T he amou nt of free i od i de was a s s es sed by prec i p i tat i on i n  a fi na l  
concentrati on of  1 0% ( w/ v ) TCA . The  TCA  preci pi tab i l i ty ranged between 
75-95% .  S pec i fi c  a cti v i ti es ran ged between 0 . 5 -5 �C i /�g . 
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El ectrophoreti c Analys i s .  Analy s i s i n  t he presence o f  S OS was 
performed o n  e i ther 1 0% ( w/ v )  polya cryl ami de or 5 - 17 %  ( w/ v )  
pol ya cryl ami de li near grad i ent sl a b  gel s  a s  prev i ous l y descri bed ( 1 6 3 ) . 
Protei ns were detected by s i l ve r  s ta i n i ng . Mol ecu l ar wei ght s tanda rds 
i ncluded myo s i n  ( 2 00 , 000 ) , B- gal a ctosi d a se ( 1 1 6 , 2 5 0 ) , phos phoryl ase B 
( 92 , 500 ) , bov i ne serum albumi n ( 66 ,2 00 ) , ova l bumi n ( 45 , 000 ) , c a r bon i c 
a n hydrase ( 3 1 , 000 ) , soybean  tryp s i n  i nh i b i tor ( 2 1 , 5 00 ) , and l yso zyme 
( 14 ,400 )  • 
B i nd i ng o f  1 25 1_C3a  to RMC . All bi nd i n g  a s s ays were performed i n  
6 1 25  TO/OVA bu ffer . 5 . 0  x 1 0  RMC were i nc u ba t ed wi th  B . O  �g of  1 -C3a 
i n  a vo l ume of  1 ml at OO C or 370 C .  At va ri ous  ti mes , a 100  �l 
porti on was remo ved , l ayered o ver a mi n eral o i l  sol u t i o n  ( d i nonyl 
phtha 1 ate :  butyl phtha  1 ate rat i 0 1 : 7 ) ,  and  cent ri fuged i n a 
mi crocentr i fu ge ( Bec kman Mi crocentr i fu ge 1 2 , Pa l o  Alto , CAl , at B050 x g 
for 3 mi n .  T he enti re cent r i f u ge t u be was counted for 1 2 5 1 i n  order to 
obta i n  the total  counts  removed pe r ali quo t . The cel l pe l l et was cut  
off , and  the number  of  125 1 co unts  bound  to mas t cel l s  determi ned . 
No ns pec i fi c  i ntracel lul ar  tra ppi n g  of 1 25 1 _C3a  i n  t he pel l et was  l es s  
than 0 . 1% a s  determi ned by i ncu bati n g  1 2 5 1 _C3a  w i t h  e i ther buffer , rat  
bas o ph i l  ic  l eu kem i a  cel l s  or rat erythrocytes . 
Analys i s  of 1 25 1_C3a  Fol lowi ng Expo s ure to RMC . 2 . 0  x 1 06 RMC 
were i nc ubated wi th 530  n g  o f  1 25 1 _C3a  i n  a vo lume of 200 �l TO/OVA at  
370 C or OO C .  At  va ri ous  ti mes , two 2 0  �l sampl es were removed . One 
s am pl e was tes ted for sol u b i l i ty i n  T C A ,  and t he second for 
el ectrophoreti c mo b i l i ty by SOS PAGE ana l ys i s .  One of the s am pl es was 
a dded to 1 ml PBS/BSA , cent r i f u ged at 2 00 x g ,  and t he s u pern atant 
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coun ted for 1 25 1 to obta i n  i n i ti al c pms . An equ a l  vol ume of 20% TCA was 
a dded to t he s u pernatant . mi xed . and cent r i f u ged at 1 600 x g for 10 mi n .  
One ha l f  of t he s u pernatant was removed and cou nted for 125 1 .  T he 
pe rcent 1 25 1 i ns ol ubl e i n  T CA was ca l cul ated from the fol l ow i n g  formu l a :  
Net % TCA- I ns ol u bl e 1 25 I _C3a = 
I n i ti al cpms - 2x (TCA tre ated s upernatant) x 1 02 
I n i ti al c pms - Free i od i de c pm s  
1 25  The free i od i de term i n  t he denom i n a t or repres ents t he percent I i n  
the l abel ed C3a prepa r at i on that  cou l d not be prec i p i tated by TCA.  The 
second 20 �l s am pl e was a dded to 1 00 �l of SOS  PAGE s ampl e bu ffer ( 0 . 062 
M T ri s .  2 . 3% ( w/ v )  SOS , 1 0% ( v/ v )  g l ycerol . pH 6 . 8 )  and boi l ed for 90 
sec . Seventy- fi ve mi crol i ters were l oa ded onto a 5 - 1 7 %  ( w/ v )  
po l ya cryl ami de l i near grad i en t  sl a b  ge l a n d  subjected to  el ectrophores i s  
at 1 25  vol ts f or 6 hou rs . The gel was s t a i ned , d ri ed . and exposed to  
Koda k XAR-2 X- ray f i l m  i n  a 1 4 "  x 1 4 "  x- ray cassette . The  expos ure  t i me 
was 1 day and 4 hou rs f or the s am pl es obta i ned at 370C and OOC .  
res pecti ve l y .  The x- ray f i l m  was deve l oped by a Koda k RPX- omat proces s or .  
C ros sl i n k i ng of 1 2 5 I _C3a  t o  RMC . 2 . 6  x 1 06 RMC were t reated 
wi th 5 x 1 0-4  M SBTI in TO/OVA for 5 m i n at 370 C .  E i ghty n anograms 
of 1 25 I _C3a were then added to  make a f i na l  vol ume of 500 �l , i nc u bated 
2 0 m i n at OO C .  and  the tube centri fu ged at 2 00 x g for 5 m i n .  The cel l 
pe l l et was res us pended i n  1 ml T O/OVA/ SBT I  bu ffer conta i n i ng a fi na l  
concentrati on of 1 0  mM  BS3 ( 1 64 )  and i ncu bated for 3 0  mi n at OOC .  
T he cel l s  were was hed and ree xposed to 60 n g  of fres h 12 5 I _C3a  i n  1 ml 
TO/OVA/SB TI . Fol l ow i ng centri fugat i on and  remov a l  of the s u pernatant . a n  
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a dd i t i ona l  10 mM BS3 was added and i nc u bated for 30  m i n at OOC .  The 
cel l pe l l et was was hed once w i t h  T D/OVA/SBTI bu ffer and twi ce wi th 0 . 01 M 
Mes , pH 6 . 0  co nta i n i ng 1 . 0 M NaCl  ( son i ca t i o n  bu ffer ) a n d  d i s ru pted . A 
mi croti p atta chment to a Ce l l  D i s ru ptor Model W- 225R  ( Heat  
sys tem s-U l trason i cs , I nc . ,  Farm i ngton , NY ) was u sed  at out pu t  power 2 ,  
50% pu l se cycl e for 3 0  pu l s es . T he RMC soni cate was t hen i nc u bated wi th 
1 00 �l of  a � a ureus s u s pen s i on ( 1 0% w/v )  ( 1 65 ) for 15 mi n at 370C and 
centri fuged at 1600 x g for 10  m i n .  One hundred �l po rt i ons of  the S .  
a ureus- treated RMC s u pernatant were i ncu bated wi th  a n t i - chymase  s erum for 
1 hour  at 370 C at f i na l  d i l ut i ons of  1 : 2 ,  1 :4 ,  1 :8 ,  and 1 : 2 0 ;  co ntrol s 
wi th  normal go at s erum or son i cat ion  bu ffer were s i m i l arl y i nc u bated . 
F i fty nano grams of a � aureus sus pen s i on were added , and  i nc ubated for 
30  m i n  at 370 C .  The react i o n  was s to pped by centri fuga t i on at 1600 x g 
for 1 0  mi n .  The pel l et was was hed 3 t imes and t he percent 1 25 I _ C 3a 
bound  determ i ned .  
I sol at i on of  C hymase and Hepa r i n Proteoglycan . RMC that were 
greater t han 95% pure were u sed i n  a mod i fi c a t i o n  of  a prev i ous l y 
des c ri bed proced ure ( 1 66 ) .  Between 6 - 9  x 1 06 RMC were son i cated i n  
0 . 01 M Mes , p H  6 . 0 ,  co nta i n i ng 0 . 5  M NaC l , m i xed wi th  Dowex l - X2 
( 2ml / 5 x l06 RMC ) equ i l i brated i n  the son i cat i on  bu ffer , poured i nto a 1 
cm x 1 0  cm col umn , and was hed wi th 4 col umn vol umes of 0 . 01 M Mes , pH 
6 . 0 ,  co nta i n i ng 0 . 6  M NaC I .  The chymase was then el uted by i ncrea s i ng 
t he NaCl concentra t i o n  to 1 . 0  M.  C hyma se a c ti v i ty was a s sayed 
s pect ro ph o tomet ri cal l y  by c l eava ge of BTEE ( on e  un i t  of enzyme cl eaves 
o ne �mo l e o f  substrate/mi n at 220C )  ( 1 6 6 , 1 67 ) . Fract i ons co nta i n i ng 
c hyma se a c ti v i ty were pool ed and concentrated by co a ti n g  t he d i a l ys i s  bag  
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w i t h  s ucrose . T he concentrated chymase  was d i a l yzed overni ght a ga i nst 
Tyrode ' s  bu ffer and s t ored at -700C and reta i ned 95%  of t he i n i ti a l 
acti v i ty a fter thawi ng . The s pe c i f i c  act i v i t i es ranged between 8 . 0 - 16 . 6  
un i ts/mg ( protei n was determi ned by t he B i o-Rad protei n  a s s ay k i t  u s i ng 
h uman y-gl obu l i n  as a s tandard ) .  SDS PAGE ana l ys i s of pu r i f i ed chymas e  
s howed a s i n gl e  band of 2 9 , 000 dal tons a fter el ectrophore s i s  under 
reduc i ng cond i t i ons . Carboxype pti dase  A ( one un i t  hyd rol yzes one �ol e 
h i ppuryl -L- phenyl a l an i ne/mi n at 250C ,  pH 7 . 5 )  ( 1 66 , 1 68 ) or hepari n 
pr oteog l ycan  (metachromas i a  wi th  Azu r e  A ( 16 6 ) ) cou l d not be detected i n  
t he pur i fi ed chymase pre para ti on ( 1 69 ) . 
Hepa r i n proteog l yc a n  from the effl uent fracti ons of the D owex 1 -X2 
col umn were pool ed and a ppl i ed to a phenyl -Sepharose col umn equ i l i brated 
w i th 0. 0 1  M Mes , pH 6 . 0 ,  conta i n i ng 3 . 0  M NaCl ( 16 6 ) . The hepa r i n 
proteogl ycan el uted fr om t he col umn i n  t he e ffl uent fra c ti ons , \�hereas  
c a r boxy pe pti dase A rem a i ned bound . Hepa r i n proteog l ycan  was pool ed , 
concentrated , d i a l yzed overni ght a ga i nst  Tyrode ' s  bu ffer , and s t ored at 
- 7 00 C .  The hepa r i n proteog l ycan  had no detecta bl e chymase or 
car boxype p ti dase  A a c ti v i ty and no detecta bl e protei n  as  a s s es sed by the 
B i o-Rad protei n  a s s ay . 
D iges ti on of 1 25 I_C3a  by C hymas e .  F i fty nanogram porti ons of 
1 25 I_C3a were i nc u bated wi t h  chymase a l one ( 0 . 7  un i ts ) ,  c hymase  pl us  
he pari n proteogl ycan ( 60 �g ) ,  hepa ri n proteogl ycan a l one , Tyrode ' s  
bu ffer , or RMC conta i n i ng equ i va l ent amounts  of chymase  and hepa r i n 
proteogl ycan i n  a vol ume of 680 �l at 370C .  At vari ous ti mes , 2 0 �l 
porti ons were removed and the 1 2 5 I _C3a  sol ubl e i n  1 0% TCA determ i ned . 
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. 125  Degradati on of I -C3ades Arg by C hymase  as the  Rati o of 
C hymase : C3ades Arg Vari es . Vari ou s  concent rati ons of chymase , ran g i n g  
between 0 . 19  �g ( 2  x 1 0-5 un i ts )  to  1 00 �g ( 0 . 5  un i ts ) ,  were i nc u bated 
wi th  65 n g  of 125 I -C3a des Arg i n  the presence of 2 5  �g of pu r i f i ed 
hepa r i n pr oteog l ycan  ( 0 . 1 25  ml reacti on vol ume ) .  Fol l ow i n g  a 30 mi n 
i nc u ba t i on at 370 C 80 �l were removed and  ana l yzed for percent TCA 
i ns ol ubl e 1 25 1 materi a l . 
I ndi rect I m unofl uores cence of RMC . Forty thou s and  RMC were a i r  
dri ed onto mi cros co pe s l i des and i ncu bated wi th 1 3 5  �g o f  the I gG 
fracti on of go at anti - rat chymas e for 30 m i n at ro om tem perature . The 
s l i de was was hed 3 times wi th P8S and i ncu b ated for an add i ti onal  30  mi n 
at room tem pe rature wi th 400 �g of fl uores ce i n- conj ugated I gG fracti on of 
ra bb i t  a n t i - goat  I gG .  T he s l i de was was hed 3 ti mes and mou nted i n  
pol yv i nyl a l cohol . Normal  goat serum ( NGS ) was i nc u bated wi th  RMC at a 
prote i n  concentrati on corres pond i ng to  the pr imary anti body 
concentrati on .  RMC showed no fl uores ce i n  s ta i n i ng fol l ow i n g  expos ure to 
NGS and fl  u ores cei n- conj u gated anti  body . 
Immunoabsorpti on of C hymase from RMC S on i cates us i ng 
Chymas e-Speci f i c  Anti body . Three mi l l i on RMC were was hed and  s oni cated 
i n  Tyrode ' s  bu ffer , pH 6 . 8 , conta i n i ng 1 M NaCl . T he RMC soni cates were 
treated twi ce wi th  a � aureus sus pens i on ( 1 0% w / v )  for 2 0 m i n at 
370 Cand centri fuged at  1600 x g for 10  m i n .  C hymase  acti v i ty was 
meas ured a nd porti ons of t he RMC s oni cate corres pond i n g to 0 . 1  u n i ts of 
chymase were i nc u bated wi t h  1 m g  of ei ther the I gG fracti ons of goat 
a n ti - r at chymase  or goat a n ti - r at a l bumi n or i n  bu ffer for 1 hr at 
370 C .  Fi fty �l of a � aureus sus pens i on ( 1 0% w/ v )  was added , and  
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i nc ubated  for 20 m i n at 370 C and  centri fu ged at 1600 x g for 10 mi n .  A 
porti on of each s u pern atant was sa ved , and t he e xp os ure to anti body and 
� a ureus sus pens i on repe ated . The res i dua l  a b i l  i ty to d i ges t C3a was 
then a s s es sed by i nc u bati on w i t h  f i fty n anograms of 1 2 5 1 _C3a  for 1 hr 
at 37 0C and mea s u red for percent 125 1 i ns ol u bl e i n  TCA .  
E ffect of SBT 1  on C3a - 1 nduced Rel ease of S-Hexos ami n i da s e  from RMC . 
Two hundred thous and RMC were pretreated i n  a vol ume of 0 . 3  ml wi th 
varyi n g  concentrati ons of SBT 1  ( 3 . 0  x 1 0-4M- 1 . 7 x 10 -8M )  at 37 0C 
for 5 mi n .  T hree mi crograms of 125 1 _C 3a ( 0 . 3nM ) were a dded and 
i ncu bated for an add i ti ona l  3 0  mi n at 37 0C .  A 90 )11 porti on was 
removed ,  d i s pensed i n  1 ml of PBS/BSA sol uti on , and  ana l yzed for percent 
TCA i ns ol ubl e 1 25 1 materi a l . An add i t i ona l  200 )11 porti on was  removed 
a nd put i nto 0 . 4  ml of i ce col d Tyrode ' s  bu ffer mi n u s  Ca ++ and Mg ++ 
( Tyr ode ' s - ) and  centri fuged • Both the ce 1 1  pe 1 1  et and s upernatant were 
anal yzed for S- hex os ami ni d a se content . T o  serve as control s ,  both 
1 25 1 _C3a  and  the cal c i um i onoph ore A2 3 187 were  i ncubated w i th 
nontreated RMC . 
S-Hexos am i n i dase  Ana lys i s .  Both the cel l pe l l ets  and  s upernatants 
were anal yzed for S- he x os ami ni d a se as  d es cri bed i n  S c hwartz  et a l  ( 17 0 ) . 
B ri efl y ,  the RMC pe l l et wa s res u s pened i n  Tyrode ' s  sol uti on adj us ted to 1 
M NaCl and s oni cated . A 5 0 )11 porti on was removed and a dded to 0 . 45 ml 
of 0 . 2 M phos ph ate and 0 . 4  M c i t rate bu ffer , pH 4 . 5 ,  conta i ni ng 4mM 
p- n i trophenol -N- a c ety l - S-D-gl ucos ami de ( S- he x- s ubstrate bu ffer ) .  T he 
s u pe rnatant was a l s o  adj us ted t o  1 M NaCl  and  a 50 )11 porti on d i s pensed 
i nto 0 . 45 ml of S- he x- s ubs trate bu ffer . B oth porti ons from t he pel l et 
and  the s upernatant were i nc ubated wi th the S- hex- subs trate bu ffer at 
37 0 C for 1 hr . The reacti on was term i nated by add i ng 1 . 5  ml of 0 . 2  M 
gl yc i ne , pH 1 0 . 7 , and t he opti cal den s i ty at 4 1 0  nanometers determ i n ed . 
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B i nd i ng of 125 I _C3a  to RMC i n  the Presence of  Heea ri n .  Varyi n g  
dos es of RMC were pretreated wi th 1 0  m g/ml SBTI  for  5 mi n at  DoC .  
These cel l s  were t reated wi th  50 un i ts ( 0 . 3  m g ) of he pa r i n ,  50 u n i ts of 
hepa ri n i n  0 . 3 M NaC l  Tyrode ' s  bu ffer , or l eft unt reated . Both  
he pari n and NaCl were t i trated s e paratel y a nd used at o ptimal  
1 25  concentrati o ns . T he cel l s  were t hen i nc u bated w i th 7 0  n g  of I - C 3a 
for 30 m i n at Do C .  The cel l s  were centri fuged and  a n al yzed for pe rcent 
1 25 I_C3a  bound  to RMC . The  v i ab i l i ty o f  the  cel l s  i n  bot h  Tyrode ' s  
( 0 . 15  M NaCl ) and  Tyrode ' s  co nta i n i ng 0 . 3  M NaCl  were 86 . 0% and  88 . 0% ,  
res pect i vel y .  
B i nd i ng of 125 I_C3a  to RMC i n  the Pres ence of Agents wh i ch I nh i b i t  
Degradat i on , Degran u l at i on ,  and  B i nd i ng to Heea r i n Proteoglyc a n .  I n  al l 
t hree anal yses , t he cel l s ,  pr i or to e xpos ure to 125 I _ C 3a , are 
res u s pended i n  Tyrode ' s  bu ffer co nta i n i ng 0 . 3  M N aCl , 1mM TPCK , 4 mM 
SBT I , and 1mM E DTA. For t he dose-de pendent b i nd i n g s t udy , i ncre a s i n g  
concentrati o ns of  125 I _C3a  were i nc u bated w i th 5 x 1 05 RMC i n  a 
vo l ume of 0 . 5  ml for 2 0  m i n at DoC .  A 0 . 4  ml po rti on  was removed , 
l ayered o nto o i l , cent r i fu ged , and t he number of mol ecul es per cel l 
cal cul ated . I n  t he k i neti c anal y s i s  of 125 I _C3a  to RMC , 5 . 5  x 1 05 
RMC were i nc u bated wi th 65 n g  of 125 I _C3a  i n  a vol ume of 0 . 5  ml at 
DoC .  At var i o u s  ti mes , a 0 . 4  ml po rt i o n  wa s removed and l aye red onto 
o i l , centr i fu ged , and t he cel l pel l et used to cal cul ate t he num ber of 
mol ecu l es per RMC .  For t he col d i nh i b i t i o n  s t udy , 6 x 1 0 5 RMC were 
i nc u bated w i th  1 0  n g  of  125 I _C3a i n  the presence o f  varyi ng 
concentra t i o ns o f  C3a ( rang i ng between 0 . 1  �g- 2 0 �g ) i n  a vol ume of 0 . 5  
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m1 for 2 0 m i n at OO C .  A 0 . 4  m1 porti on was removed ,  l ayered onto  oi l ,  
and anal yzed for the number of mol ecul es per RMC . 
Percent TCA I nsol u bl e 125 1 Materi a l  and B i nd i ng of 1 25 I _C3a 
Fol l owi ng E xpos ure to CMMC . CMMC ( 1 . 2 x 1 06 ) were i nc u bated wi th 1 8  n g  
of 1 25 I _C3a i n  a vol ume of 0 . 3  m1 at OOC ,  250C ,  and 37 0C i n  the 
pres ence or absence of 4mM SBTI . At va ri ou s  ti mes , a 20 �1 porti on was 
removed , d i s pensed i nto 1 m1 of PBS/BSA,  and cent r i f u ged . The 
s u pernatant was then anal yzed for percent TCA i ns ol u bl e 125 1 materi al . 
To anal yze t he b i nd i n g  of 125 I _C3a  to CMMC , 1 7 . 4  x 1 06 CMMC were 
i nc u bated wi th 1 �g Of 1 25 I _C3a  i n  a vol ume of 1 m1 at OOC ,  250C ,  
and  37 0C .  At vari ou s  ti mes , a 40 � 1  porti on was removed , des penced 
i nto  0 . 4  m1 of Tyrode ' s bu ffer and 1 aye red onto  oi l .  The number  of 
125 I_C3a  mol ecul es per cel l were ca l cu l at ed from the  cel l pel l et .  
Cros s1 i n k i ng of I ntact RMC wi th C3a . RMC were rad i oi od i nated 
( 1 25 I_RMC ) u s i ng the l actoperox i dase  met hod as descr i bed by Conrad et 
a 1  ( 1 7 1 ) . Bri efl y ,  3 . 75  x 106 RMC were i nc u bated wi th 30 �g of 
1 actoperox i dase  and  200 �C i  of Na 125 I i n  a vol ume of 0 . 2  m1 . Hydrogen 
peroxi de ( 0 . 1  mM) was a dded every mi n over a 3 mi n peri od .  The rea c ti on 
was termi nated by d i l uti n g  the cel l s u s pens i on i n  1 0  m1 of Tyrode ' s  
bu ffer and centri fuged . The cel l s  were was hed 5 ti mes and res u s pended to 
a vol ume of 0 . 2 m1 in Tyrode ' s  conta i n i ng 1mM DFP ( Tyrode ' s=/DFP )  
for 5 m in  at  OO C .  I n  addi t i on ,  3 . 75 x 1 06 non i odi nated RMC were 
i ncu bated se paratel y wi th Tyrode ' s-/ D FP for 5 m i n  at OOC .  Four  
mi crograms of C3a and  4 �g of 1 25 I _C3a were added to  the 1 2 5 I _RMC and 
RMC s u s pensi ons , res pec ti vel y for 30  m i n  at OOC .  Both cel l s u s pens i ons 
were was hed once and res us pended in  30  mM BS3 and i ncu bated for an 
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addi t i onal  30 m i n at OO C .  1 25  1 2 5  The I-RMC - C3a a n d  RMC - I -C3a 
cross l i n ked materi a l  were both was hed and res us pended i n  Tyrode ' s  
conta i n i ng the noni on i c detergent  N on i det-40  ( NP-40)  and  protea s e  
i nh i b i ti ons ( 0 . 01 M ben z ami d i ne ,  0 . 02 M i odoa cetami de , 1 01lg/ml l eu pepti n ,  
400]lg /ml SBTI , 1 3  mM phenanthrol i ne ,  30  U aprot i n i n ,  and  2mM OFP ) then 
s oni cated . B oth cel l l ys ates were centri fu ged at 2 000 x g for 2 0 mi n .  
The s ol ub i l zed porti ons were ei ther anal yzed d i rectl y by SOS PAGE or were 
i ncu bated w i t h  a n ti -C3a  a n ti bod i es a nd 1 0% Staph  A s u s pens i on ( as 
des cr i bed i n  C ros sl i n k i ng of 1 25 I_C3a to  RMC secti on of Materi a l  and 
Methods ) and t hen anal yzed on SOS  PAGE . I n  a dd i ti on ,  t he i ns ol u bl e cel l 
pel l et was a l s o  anal yzed on S OS PAGE . The gel was s t a i ned , d r i ed and  
exposed to  Koda k XAR- 2 x- ray f i l m  i n  a 1 4  x 1 4  i n .  x- ray cas sette for 2 4 
hr . The x- ray fi l m  was proces sed and devel oped by a Kod a k  RPX- omat 
process or .  
Cros sl i n k i ng 12 5I_C3a  to  I ntact RMC i n  the Presence of Var i ou s  
P rotease I nh i bi t ors . Two m i l l i on RMC were pret reated wi th e i ther 4 mM 
SBT I , 0 . 04 mM SBTI, 1 mM TPC K ,  ImM TLCK , or 1 mM OFP for 1 0  m i n  at OOC .  
Two m i cr ograms of 1 2 5 I _C3a were i nc u bated wi th these cel l s  for 2 0 m i n  
a t  OO C .  The cel l s  were centri fu ged and res us pended i n  Tyrode ' s  
bu ffer conta i n i ng 1 mM BS3 and  i ncubated for 30 m i n  at OOC .  The 
cel l s  were cent r i f u ged and was hed 5 t imes and res us pended to a vol ume of 
0 . 2 ml wi th Tyr ode ' s-/N P -40/ protease i nh i bi t i on coc kta i l  and 
s oni cated . T he cel l s  were cen t r i f u ged at 2 000 x g for 2 0 min and the 
s u pernatant anal yzed by SOS PAGE and a utorad i ogra phy . 
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RES U L  TS 
B i ndi ng o f  1 2 5 I_C3a  to RMC . The number of C3a mol ecules bound to 
RMC at 370 C was exam i ned as a funct i o n  of  ti me . E i ght  m i crograms of 
1 25 I_C3a  was i nc u bated wi th  5 . 0  x 1 06 RMC in  a vo l ume of  1 ml at 
370 C .  At va r i ou s  ti mes , 100  �l  a l i quots  were removed , l ayered over a 
mi neral o i l  sol u t i on , a nd centrifu ged . T he s u pernatant was a s p i rated and 
the number  of mo l ecu l es bound  pe r cel l determ i ned . For t he experi ment 
s hown i n  Fi gure 3 ,  t he num ber of mol ecul es offered per cel l was 1 07 
m i l l i o n  and 1 0  m i l l i o n  were bound at 30 sec . After 1 0  m i n ,  the number of 
1 2 5 I _C3a  mo l ecul es bound  per cell had  decreased to 2 . 5  m i l l i o n . 
S i m i l ar rapi d bi nd i n g  and d i s soc i a t ion  of 1 2 5 I _C3a by RMC was o bs er ved 
i n  3 separate e x peri ments u s i ng 2 d i fferent 12 5 I _ C3a pre parat i o ns . 
W hen the i nacti ve form of C3a , C3ades Arg ' was used i n  b i nd i ng stud i es 
wi th  RMC , s i m i l ar res u l ts were o bta i ned (data  not s hown ) . The amount of 
degranul a ti on of  RMC fol l owi n g  e xpos ure to 1 07 m i l l i o n  mol ecul es o f  C3a 
per cel l was :$ 1% as  as ses sed by 8- hexos ami n i das e  acti v i ty i n  the 
s u pern atant ( 1 7 0 ) . 
T here i s  a ten perature dependence of 125 I _C3a b i nd i n g  to RMC .  At 
30  sec , 1 7 . 0  x 106 1 25 I _C3a  mol  ecul  es  were bound per  cel l at OOC ,  
as  compared to 8 . 9  x 1 06 mol ecu l es bound per cel l at 37 0C .  By 60 
m i n , o f  the 1 25 I _C3a  mo l ecul es bound at  30 sec , 7 9 . 8% had d i s so c i ated 
at 370 C ,  whereas only 37 . 6 %  had d i s so c i ated at Do C ( Table 2 ) . These  
d a ta i ndi cate t hat t he k i n e ti c  e qu i l i bri um esta b i l i s hed between 
1 25 I _C3a  and  RI�C does not  foll ow the  Henri -Mi chael i s-Menten model . 
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F i gure 3 .  D i s s oc i a t i on of 1 2 5I_C3a  from RMC at 37°C .  
1 25I_C3a (8 �g ) was i ncu bated w i th 5 . 0  x 1 06 RMC i n  1 ml of 
T O/OVA at 37 °C .  At va r i ou s  ti mes , a 100  �l a l i quot was removed and 
cen t r i f u ged t hrou gh mi neral oi l .  The number of 1 25I_C3a  mol ecul es 
bound pe r cel l was ca l cu l ated by u s i ng the s pec i f i c  acti v i ty of the 
1 25 I_C3a  prepa r at i on and  a mol ecu l ar  wei ght of C3a of 9000 . 
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Tabl e 2 .  B i ndi ng of 1 25 I _C3a  t o  RMC at 37° C and OO C . a 
Temperature 
Mol ecul es bound per RMC x 1 0-6 
8 . 9  1 7 . 0  
1 .8 1 0 . 6  
a 6 1 25  5 . 0  x 1 0  RMC were i ncu bated w i th 8 . 0  �g of I -C3a  in  a vol ume 
of 1 ml at OO C or 37° C .  A 1 00 �l  port i on was removed at  0 . 5  m i n  and 
60 mi n and t he number of molecul es bound per cel l determi ned as  des cri bed 
i n  Materi a l  and Methods . 
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D os e  Dependent B i nd i ng of 1 25 I_C3a to  RMC . S i nce the b i nd i ng of 
1 2 5I_C3a  t o  RMC i s  h i gher at OO C than 370 C ( Tabl e 2 ) the dos e 
res ponse s t ud i es were performed at OO C .  W hen i ncea s i n g  concentrat i ons 
of 1 2 5I_C3a  are i nc u bated wi th 5 . 0  x 10 5 RMC i n  0 . 6  m1 Tyrode ' s /OVA 
at OOC for 5 m i n ,  saturati on cou l d  n ot be obta i ned . The maxi mum number 
of 1 2 5I_C3a  mol ecul es offered pe r cel l was 530 m i l l i on .  At th i s  
concentrati on the number of mol ecul es bound per cel l was 97 m i l l i on and 
s ti l l  i ncreas i ng as  i nd i cated i n  F i gure 4.  It was ev i dent from the data 
of T a bl e 2 ,  Fi gure 3 ,  and  Fi gure 4 that t he b i nd i n g  of 1 2 5I_C 3a to  RMC 
does not reach  equ i 1  i bri um as wou l d  be expected by Hen r i -M i chae1 i s-Menten 
model for a l i gand and i ts s pec i fi c  receptor .  
In order to i nvesti gate whether 125I_ C3a wh i ch had bound to and 
been rel eased from RMC was ca pa bl e  of b i nd i ng to fres h RMC the fol l ow i n g  
e x peri ment w a s  performed . One m i l l i on RMC were i ncu bated wi th 2 80 n g  of 
1 2 5I_C3a  in  a vol ume of 1 m1 T O/OVA for 2 0  mi n at 37 0C .  Two a 1 i quots 
were removed . One was l aye red ove r  m i neral oi l and the b i nd i ng of 
1 25 I_C3a determ i ned . The other a l i qu ot was centri fuged at  2 00 x g for 
5 mi n ,  t he s u pern atant was removed , and a vol ume corres pondi n g  to 60 n g  
of 1 2 5I_C3a  (based  on the cpms a n d  ori g i nal  s pec i f i c  act i v i ty ) was 
e xposed to a fresh pre parati on of RMC for 2 0 min at 37 0C .  Th i s 
pr ocedure was repeated a total  of four ti mes . As s hown i n  F i qu r e  5 , 3 . 2 
m i l l i on mol ecul es were bound per cel l d u ri n g  t he fi rst 2 0 mi n 
i nc u bat i on .  When the s upernatant from the f i rs t  i nc u ba t i on was 
re-exposed to a fresh batch of RMC t he number of mol ecul es bound per cel l 
decreased t o  1 m i l l i on .  After the fourth  t rans fer , the number of 
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F i gure 4 .  D os e  Dependent B i nd i n g  of 1 2 5I_C3a  to  RMC at OOC .  
RMC ( 5  x 1 05 ) were i nc u ba ted wi th  i ncreas i ng concentrati ons of 
1 2 5 I _C3a  for 5 m in  at OO C in  a vol ume of 0 .6  ml . A porti on was 
removed , 1 ayered over oi l , a nd cent r i fu ged . T he pel l et was anal yzed for 
the number  of 1 2 5 I _C3a mol ec u l es bound  per RMC . 
F i  gure 4 .  
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F i gure 5 .  Reb i ndi ng of 1 2 5 I _C3a  Fol l ow i ng Repe ated Ex pos ures to RMC . 
1 25 I _C3a  ( 280 ng )  was i nc u ba ted wi th 1 . 0  x 1 06 RMC in  1 ml of 
T O/OVA for 2 0 m i  n at 370 C .  Two a l i quots were removed . One a l i quot was 
1 ayered over mi neral oi l and cent r i f u ged . The number of 125 I _ C 3a 
mol ecules bound  pe r cell was ca l cul ated from the RMC pe l l et .  The second 
a l i quot was cent r i fu ged and t he s u pernatant was removed and ree xposed to 
a n ew batch of RMC for 2 0 mi n at 37 0C .  T h i s  procedure was repeated 
fou r  t i mes . Equ a l  1 25 I _C3a rad i oacti ve counts  were t rans fered to  each 
RMC mi xture . 
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mol ecul es bound per cel l was onl y  0 . 1 7 m i l l i on .  1 2 5  Thus , I-C3a  was 
a l tered u pon expos ure  to  RMC , s uch  that it  d i d not reb i nd to  these cel l s .  
Degradati on of 1 25 I_C3a  by RMC . To determ i ne i f  1 2 5 I _C3a was 
under goi n g  a confonnati ona l  c han ge or was bei n g  degraded , percent 
i nsol u bl i l i ty i n  TCA was meas ured and t he s i ze of t he 12 5 1 materi a l  i n  
t he s u pern atants fol l owi n g  expos ure 
SDS  PAGE . Fi gure 6 s hows t he % TCA 
125  of I -C3a  t o  RMC was anal yzed by 
prec i p i ta bl i ty of 125 I _C3a at 
var i ous  ti mes fol l owi n g  i ncu bati on w i t h  RMC at 37 0C and OOC .  By 30 
s ec , the % TCA prec i p i t a b i l ty decreased from the i n i t i a l va l ue of 1 00% t o  
3 0% a n d  63% a t  370 C a n d  OO C res pecti ve ly .  A further decrease 
occ urred d u ri n g  t he ens u i ng 10  mi n a fter whi ch t he % TCA prec i pi ta b i l ty 
rema i ned cons tan t . SDS PAGE anal ys i s of the s upernatants  i s  s hown i n  
F i gure 7 .  Fol l owi n g  i nc u b a ti on a t  370C for 3 0  s ec ( l eft panel ) , t here 
was a decrease i n  the amou n t  of rad i oact i v i ty detected on the 
autoradi ogr a ph due to counts l os t  i n  t he bu ffer front and a s h i ft towards 
a l ower mol ecu l ar wei ght s pec i es . W i th conti nued i nc u bat i on ,  the 
detectabl e rad i oa c ti v i ty f u rt her decre as es . At OO C ( ri g ht panel ) , the 
c han ges were l es s  marked s o  that t he 1 25 I _C3a s h i ft to a l ower 
m ol ecul ar wei ght s pe c i es oc curs  at 1 0  m i n  and  rad i oact i v i ty pers i s ts 
t hrou ghout t he i ncu bati on peri od .  Thus  t he mar ked decrease i n  1 25 I _ C 3a 
% TCA prec i p i ta b i l ty fol l ow i n g  expos ure  to  RMC was accom pa n i ed by a 
decrea s e  i n  mol ecul ar  wei g ht fol l owi ng S DS PAGE ana l ys i s . 
I nh i b i t i on of 125 I_C3a  Decrea s e  i n  % TCA Prec ipi tab l i ty by 
Treatment of RNC wi th  Vari  ou s Protease I n h i  b i t ors . The tem perature 
dependent degradati on of 1 2 5 I _C3a s u gges ted that th i s  pe pti de i s  be i ng 
c l ea ved by RMC proteases . The ca pac i ty of a v a ri ety of protease 
i nh i bi t ors  to  bl oc k  th i s  degradati on was tes ted . Three hundred - thousand  
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F i gure  6 .  Sol ub i l i ty i n  TCA of 1 2 5 I _C3a  Fol l ow i n g  Expos ure t o  RMC . 
125 I _C3a  ( 530  n g )  was i nc u bated wi th 2 . 0  x 106 RMC i n  2 00 �l of 
T O/OVA at 370 C or OO C .  At vari ou s  ti mes , a port i on was removed ,  
centr i fu ged , and t he s u pernatants anal zyed f or s ol u b i l i ty i n  l OX TCA . 
54 
Fi  gure 6 .  
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125 0 S DS PAGE Anal ys i s  of 1 -C3a  Expos ed to  RMC at 37 C and 
Cond i ti ons of i ncu bati on were t he s ame a s  F i g .  3 .  Equa l  1 25 1 
counts  from each ti me i nterva l were l oaded onto  a 5 - 17%  ( w/ v )  
pol yacyl ami de grad i ent sl a b  gel . Autorad i ogra phy f or t he s am pl es at 
37 0 C ( l eft pa nel ) and OO C ( r i ght pa nel ) were for 1 day and 4 hours , 
res pecti vel y .  T he t i me , i n  mi nutes , of 1 2 5 1 _C3a  expos ure to  RMC i s  
i nd i cated a bove each l ane . The 0 t i me re presents 12 5 1 _C3a  e xposed to  
TD/OVA a l one . T he a p parent decrease of 125 1 at 37°C i s  d ue to  l os s  
of 1 abe 1 i nto  the anodal  bu ffer . 
Fi gure 7 .  
o 0.5 2.5 1 0  30 o 0.5 2.5 1 0  30 
- 92 Kd -
- 6 6 Kd -
- 45 Kd -
- 3 I Kd -
- 2 I Kd -
- 1 4Kd -
. 
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RMC were treated wi th  i nh i b i tors  for  5 m i n  at 370C .  Then  40  n g  o f  
1 25 I _C3a  was added i n  a tota l  vo l ume of  600 �l and  i nc u ba ted for 2 0 
m i nat 370 C .  Su pernatants were anal yzed for % TCA prec i pi tabl e 
1 2 5 I _ C 3 a  co unts . As s hown i n  Tabl e 3 ,  t h e  mos t  effecti ve i nh i b i tors 
were DFP , SBT I ,  and TPCK , whi c h  a l l  i n h i b i t  s eri ne esterases , t he l atter 
two wi th  c hymot ryps i n- l i ke s pec i f i c i t i es ( 1 72 , 17 3 ) . The l ea s t  effecti ve 
i nh i b i tor was  TL CK , whi c h  i n h i b i ts s eri ne es teras es wi th tryps i n- l i ke 
s pec i fi c i ty ( 45 ) .  T hese data  i nd i cate that t he degra d a t i o n  of 125 I _ C3a  
by RMC was  abrogated by c hymotryps i n  bu t not t ryps i n- l i ke protease 
i nh i  b i tors . 
E ffect o f  SBT I  on t he B i nd i ng o f  125 I _ C3a  to RMC . I t  was  
establ i s hed i n  Fi gures 6 & 7 and Tabl e 2 that 1 2 5 I _C3a  was be i n g 
degraded by RMC and that th i s  degrada t i o n  co u l d be abrogated i f  RMC were  
pretreated wi th c hymotryp s i n- s pec i fi c  i nh i b i to rs . I n  t he fol l owi n g  
expe r i ment , 2 . 0  x 1 05 RMC were pretreated wi th  4 m M  S B T I  for 5 mi n at 
370 C .  I ncreas i ng co ncentrati ons of 1 2 5 I _C3a  were i nc u bated wi th 
t hese pretreated RMC i n  a vol ume of 0 . 5 ml for 2 0 mi n at 370C .  A 
po rti  on was remove d ,  1 ayered o nto oi 1,  centri fuged , and  the number  of  
mol ecu l es bound per  RMC determi ned . As  s hown i n  Fi gure 8 ,  u p  to  28 
m i l l i on mol ecul es were offered per cel l a nd 2 m i l l i on 1 2 5 I _C3a  
mol ec u l es were bound  wi th  SB TI  present . In  co ntras t ,  when 28  m i l l i o n  
125 I _ C 3 a  mo l ec u l es were i nc u bated wi th untreated RMC there were on l y 
5 00 , 000 mol ecul es bound per ce l l . T he b i nd i n g  o f  1 2 5 I _C3a  to RMC i s  
i ncreased i n  the presence o f  SBTI . 
RMC ( 2 . 0  x 1 05 ) were pretreated wi th  4 mM SBn i n  a 0 . 5  ml vo l ume 
for 5 m i n at 370 C .  The cel l s  were than transferred to i ce for 15 m i n .  
I ncreas i ng concentrati ons of 1 2 5 I _C3a  were i nc u bated wi th these cel l s  
for 2 0 m i n at OO C .  As s hown i n  F i gure 9 ,  even at co ncent rati ons of 
I nh i b i tor 
l 2 5 I_C3a  
l 2 5 I_C3a  
DFP  




Ta bl e 3 .  I n h i b i t i on of l25 I _C3a  Degra d a ti on 
by RMC wi th Protease I nh i bi tors 
Percent 125 I - i nsol u ble i n  
Concentrati on E xpt . I a E xpt . I I 
i n  bu ffer b ( - - ) 1 00 100  
pl us RMCc (- - ) 6 . 5  26 . 0  
1 0-3M ND 65 . 0  
1 0-4M 96 . 2  ND 
10-4M 96 . 2 ND 
10-4M 6 . 2 ND 
TCA 
a Expt . I and  I I repres ent the same expe r i mental  protocol ( as descri  bed i n  
res u l ts secti on )  u s i ng d i fferent RMC and 1 25 I _C3a pre parat i ons . 
bW hen l25 I _C3a  i s  i ncu bated wi th bu ffer a l one for 2 5  mi n at 37 oC .  
cW hen RMC are i ncu bated f or 5 mi n at 37 0C i n  bu ffer wi t hout protease  
1 25  0 i nhi b i tors , fol l owed by expos ure to I -C3a  for 2 0 m i n  at 37 C .  
N D=Not Done 
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F igure 8 .  E ffect o f  SBT I  on t he B i nd i ng o f  1 25 I _C3a  to  RMC at 37 °C .  
RMC (2 . 0  x 105 ) were pretreated wi th  bu ffer or 4 mM SBTI  for 5 mi n 
at 37° C .  I ncreas i ng co ncen trati o ns o f  125 I _C3a were i ncuba ted wi th 
these cel l s  for 20 m i n at 370 C in a vo l ume o f  0 . 5  ml . A port i o n  was 
remo ved and ana l yzed for t he number o f  125 I _C3a  mol ecul es bo und per 
ce l l . 
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F i gure 9 .  E ffect o f  SBTI  o n  the b i nd i n g  of  1
25 I _C3a  to RMC at OOC .  
RMC ( 2 x 1 05 ) were pretreated wi th 4 mM SBTI  for 5 mi n at 37°C .  
T he cel l s  were than  tran sferred to OoC for 1 5  mi n .  I ncreasi n g  
co ncentrat i ons  o f  1 25 I _C3a  were added to these ce l l s  and  i nc u bated for 
2 0 m i n at Oo C i n  a vo l ume 0 . 5  ml . A po rt i o n  was removed and ana l yzed 
for the number  of 125 I _C3a  mo l ecul es bou n d  per ce l l . 
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1 25 I_C3a  o f  4 8  mi l l i o n  mo l ec u l es o ffered per  ce l l . saturat i on co u l d  not 
be obta i ned . 1 25 I_C3a  was  s uppl emented wi th non i od i nated C3a  and used 
i n  an e xperiment perfo rmed exactl y  as the a bo ve s t udy . At concentrati o ns 
of 2 1 0 m i l l i o n  mo l ec u l es offered per cel l saturat i o n co u l d not be reached 
( data not s hown ) .  
E ffect o f  Protami ne on  t he B i nd i ng o f  125 I _ C3a to RMC . C3a  i s  a 
h i gh ly  basi c mol ecul e ca pabl e of i ntera c ti n g  el ectrostati ca l l y  wi th  
nega t i ve l y  c h a r ged mo i et i es on  the  s ur face o f  RMC . To  tes t th i s  
hypothes i s  two very basi c proti ens . pol y-L-l y s i ne and protami ne were used 
to pret reat RMC pri o r  to 1 25 I _C3a expos ure . Both  po l y- L - l ys i ne and 
protami ne were t i t r ated to determi ne t he opt ima l  concentrat i o ns wh i ch 
wou l d not cause  degranu l at i o n  o f  RMC . At a l l co ncentrati o ns tes ted . 
pol y- l - l ys i ne cau sed degranul a ti on .  I n  contrast . protami ne cou l d  be used 
a t  a co ncent rat i o n  o f  50 �g per m i l l i o n  cel l s  wi thout ca u s i ng 
degranul a t i o n  or cel l death as  as ses sed by mi c ro s co pi c  exami n a ti on and 
t rypa n bl ue exc l us i o n . repecti ve l y .  To determ i ne the e ffect of protami ne 
o n  125 I _C3a  b i ndi ng to RMC . 2 . 0  x 1 05 SB T I  treated RMC were i nc u bated 
wi th 1 0  �g o f  protami ne for 1 5  m i n  at DoC .  I ncrea s i n g  concentrati o ns 
o f  125 r _C3a were added to these cel l s  and i nc u bated for 2 0 mi n at 
Do C .  The cel l s  were l ayered o nto o i l and  the numbe r  of mol ec u l es per 
ce l l  determi ned . As s hown i n  Fi gure 1 0 .  RMC coul d not be s aturated e ven 
when 25 m i l l i o n  mo l ec u l es o f  125 r _C3a were o f fered per RMC . These data 
i ndi c a te that  s at u r a ti on  i s  not observed i n  the presence of  a cat i o n i c  
com pound  s uc h  as  protam i ne . 
B i nd i ng o f  125 r_C3a  to RMC i n  the P resence o f  Hepa ri n .  The l ar ge 
amo unt o f  b i nd i n g  and t he unsaturabl e n ature o f  t he i ntera c ti on between 
125 r C 3  d RMC b ' b d 125 r C3 ' t " h - a an may e attrl  ute to - a aSSOC l a l n g Wl t 
s ur face bound hepa r i n proteo g l yca n . Prel im i nary experi ments  u s i n g  a 
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F i gure 1 0 .  E ffect o f  P rotami ne o n  t he B i nd i n g  of 
1 2 5 I _C3a to RMC at  
OO C .  
RMC ( 2 x 1 05 ) were pretreated wi th 4 mM SBTI for 5 mi n at OOC .  
T hese cel l s  were i nc u bated wi th 1 0  �g of protami ne  for 1 5  mi n at OOC .  
I ncreas i ng co ncent rati o ns of  1 2 5 I _C3a were i ncubated for an  add i t i on 20 
m i n at OO C i n  a vo l ume of 0 . 5  ml . A prot i on was removed and  ana l yzed 
for the numbe r  of 125 I _C3a mol ecul es bound per RMC . 
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Fi gure 1 0 .  
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col umn of a garose to whi ch hepa ri n had been co val entl y l i n ked s howed that 
125 pas sa ge o f  I -C3a ove r s uc h  a co l umn res u l ts i n  26% b i ndi n g .  These  
mol ecul es cou l d  be  el uted from t he hepa r i n-a garose col umn by u s i n g  0 . 3  M 
N aCl (data  not s hown ) .  The fol l ow i n g  expe r i ment was performed to tes t i f  
t he nega ti vel y c har ged com ponent o f  RMC to whi ch 1 25 I _C3a  was 
i nteracti ng  wi t h  was hepa r i n proteo g l yca n .  Varyi n g  n umbers of  RMC wh i ch 
had been pretreated w i t h  SBTI  were i ncubated w i t h  1 2 5 I _C3a  i n  the 
presence o f  Tyrode ' s  bu ffer , Tyrode ' s  bu ffer co nta i n i ng e xo geneo u s  
commerc i al he pari n ,  o r  Tyrode ' s  bu ffer pl us he pari n co nta i n i n g  0 . 3  M NaCl  
o 1 25  for  2 0 mi n at 0 C .  S hown i n  Fi gure 1 1  i s  the percent I -C3a bound 
to RMC under these three co nd i t i ons . U nt reated RMC bou n d  u p  to 20% o f  
t h e  125 I _C3a  mo l ecu l es offered . W hen  hepa r i n on l y o r  he pa r i n pl us 0 . 3  
M NaCl were present i n  t he rea c t i o n  mi x ture there was 8 %  and 4 %  o f  the 
1 2 5 I _C3a mol ecu l es offered , res pecti ve l y .  Thes e data s how a 60 . 0% and  
125  a 80 . 0% reduct i o n  i n  the percent I -C3a bound  for  bo th  hepa r i n and  
hepari n p l  us  0 . 3  �1 NaCl , r es pecti vel y ,  as  com pa red to  untre ated RMC . 
Th i s  i ndi c ates that t he h i gh amo unt of b i nd i ng of 
125 I _C3a  to RMC cou l d 
parti a l l y  be expl a i ned by the e l ectros tat i c  i nteract i o n  o f  pos i t i ve l y 
c h a r ge d  1 2 5 I _C3a wi t h  the nega t i ve l y  charge d  hepa r i n proteo gl ycan  
deposi ted on t he s u rface of  RMC . 
Cova l en t  C ross l i n k i ng o f  125 I_C3a  to C hymas e .  C hymase i s  the mos t 
a bunda nt protease and prote i n  compo n ent fo und i n  the secretory granul es 
of RMC and has chymo t ryps i n- l i ke s pec i f i c i ty ( 1 74 ) . I n  order to 
demo ns trate the i nteract i o n  o f  125 I _C3a  wi th  chymase , a chemi cal  
crossl i n k i ng a gent , BS3 , was added to RMC so n i cates to  b i nd 125 I _C3a 
125 cova l en tl y to chymas e .  The I -C3a- chymase com pl ex was then 
prec i p i t ated as des c ri bed i n  Materi a l s  and Methods . Fi gure 12 s hows t he 
dose dependent i mm u no prec i p i t a t i o n  of 125 I _C3a by a n ti body to chymase . 
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F i gure 1 1 .  B i nd i ng of  125 I _C3a to RMC i n  the Presence o f  Hepa r i n .  
V aryi n g  num bers of  RMC were pretreated wi th 4 mM SBT !  for 5 mi n at 
DoC .  These cel l s  were than i nc u bated wi th 70 n g  of  1 2 5 I _C3a  i n  
Tyrode ' s  bu ffer , Tyrode ' s  bu ffer co nta i n i ng exogenous commerc i a l he pa r i n ,  
or Tyrode ' s  bu ffer pl us exo genous commerc i a l hepari n conta i n i ng 0 . 3  M 
HaCl i n  a vol ume of 0 . 6  ml for 30 mi n at DoC .  A porti o n  was removed 
and a n a l yzed for pe rcent 1 2 5 I _C3a mo l ecu l es bound  per ce l l . 
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F igure 1 2 . 1 25  I mm u no prec i p i ta t i o n  of I -C3a  Cova l entl y L i n ked to RMC 
C hymase by Anti - C hymas e  Anti body . 
RMC soni cates prepa red a s  des cri bed i n  Mater i a l s and Met hods  were 
i ncu bated fi rst wi th d i l ut i o ns of go at a n t i - c hymase  s erum . go at  s erum . or 
bu ffer and then wi th  a s u s pens i on of � a ureus . The ord i nate s hows the 
percent 125 I _C3a  prec i pi tated . Cal cul ated from the formul a .  percent 
l25 I_C3a  prec i pi tated = c pms  in  prec i pi tate a fter � a ureus 
treatment/cpms in  s u pernatant before � a ureus treatment x 1 0 0 .  
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At  t he h i g hest concentra t i o n  of t he a n t i s erum , 2 3%  of t he i n i ti a l 1 25 1 
co unts wereprec i p i tated . At t he l owest concentrati on , t he percent 125 1 
co unts prec i p i tated decreased to 1 0 . 9% .  Th i s  i nd i cates that 125 I _ C 3a 
was co va l entl y cross l  i n ked to chymas e  fol l ow i ng  i nc u ba t i o n  wi th  i ntact 
RMC and BS3 . 
Degradat i o n o f  1 2 5 I_C3a  by Pur i f i ed C hymase  i n  the P resence of  
Hepa r i n P roteoglyc a n . To s how defi n i t i ve l y  that chymase i s  the enzyme 
d i rectl y res po n s i bl e for t he degra d a t i o n  of 1 2 5 I _ C3a by RMC , pu r i f i ed 
chymase was a s s ayed for proteo l y ti c  cl ea va ge of t he 125 I _ C3a mol ecul e .  
Both  chymase and  hepa r i n proteo g l ycan  were pu r i f i ed from RMC and a s s ayed 
for a c ti v i ty j u st p r i o r  to each  e x per i ment as d es c ri bed i n  Materi a l s and  
Methods . 1 25 I_C3a  was i nc u bated wi th  0 .7  un i ts of  chymas e al one , 0 . 7  
un i ts of  chymase pl us hepa ri n  proteogl ycan ( 60 �g ) o r  hepa ri n  
proteogl ycan a l one ( 60 �g ) a t  37 0C .  125 I _C 3 a  was a l so i ncu bated w i th  
RMC co nta i n i ng e qu i va l ent amounts  of  chymas e  and  hepa r i n proteo g l ycan . 
At v a ri ous  t imes , a porti o n  was remo ved from t he rea c t i o n  mi xture and t he 
1 2 5 I _C3a  was ana l yzed for  % TCA  prec i pi tab l i ty .  As  shown in  F i gure 1 3 , 
chymase  or hepa r i n proteogl ycan  a l one had very l i ttl e e ffect o n  t he % TCA 
prec i p i tab l i ty of  125 I _C3a • In co n t ras t ,  c hymas e  and  hepa r i n 
proteogl yc an  to get her caused a decrease i n  the % TCA prec i p i ta b i l i ty to 
65 . 2% at 30 sec a n d  3 1 . 4% a fter 30 m i n .  C hymase  a l one has  very l ow C3a 
proteol yti c a c ti v i ty and  the a dd i ti o n  of hepa r i n  proteogl ycan gre atl y 
i ncreases the degradati o n . Al tho u gh the com b i nat i on of chymas e and  
he pari n proteogl ycan was not  as effec ti ve a s  RMC conta i n i ng equ i val ent 
amoun ts of  these materi a l s ,  o ve r n i ght i nc u ba t i on at room tem perature 
prod uced 5% TCA prec i p i ta b i l ty ( data  not s hown ) .  S i m i l ar res u l ts were 
o bta i n ed us i ng 1 25 I -C3ades  Arg  (data  not s hown ) .  
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F i gure  1 3 .  Deg r ada t i o n  of  125 I _C3a by Pur i f i ed Rat  C hymase  in  the 
Pres en ce or  Absence of  Rat Hepari n Proteogl ycan . 
1 2 5 I _C3a  ( 50 n g ) was i ncuba ted wi th  chymas e  a l one ( 0 . 7  un i ts ) ( � ) ,  
c hyma se ( 0 . 7  un i ts ) pl us  he pari n proteo gl ycan ( 60 �g ) ( II ) , hepar i n 
proteogl ycan  a l one ( 60 �g ) ( � ) ,  or RMC co nta i n i ng equ i va l ent amounts of  
chymase and  hepa r i n  proteogl ycan ( � ) at 370C .  At  var ious  ti mes , a 
porti on  of t he rea c t i o n  mi xture  was remo ved and ana l yzed for 125 I _ C3a % 
TCA preci p i ta bl i ty .  
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E ffect o f  Hepa ri n  Proteoglycan o n  the Degrad a t i o n  of  
125 I -C3ades Arg by a- C hymot ryps i n .  The rol e o f  hepa r i n proteo g l ycan  
i n  t he syner g i sm o bs er ved i n  t he degra d a ti on of  125 I _ C 3a by chymase i s  
not know n . I n  a n  effort to def i ne the rol e of hepa r i n proteo g l ycan  i n  
t h i s  reacti on , a- chymotryps i n  was a s s es sed for i ts ca pa c i ty to degrade 
125 I -C3ades Arg both  in  the  pres ence and  a bsence of  pur i f i ed rat  
hepa r i n proteo g l yca n . 1 25 I_C3a  was i ncubated wi th  e i ther 
a- chymotryps i n  ( 0 . 5  un i ts )  or chymase ( 0 . 5  u n i ts )  both i n  t he presence 
a n d  a b sence of  25�g o f  he pa r i n proteo g l yc a n  i n  a vo l ume of  0 . 5  ml at 
370 C .  I n  add i t i on ,  2 5  �g o f  hepa r i n  proteo g l ycan  i n  bu ffer and i ntact 
RMC , conta i n i ng e qu i val ent amo u n ts of  chymase and he pa ri n proteog l ycan , 
were a l so i nc u bated wi th  1 2 5 I _C3a  At  va r i o u s  ti mes , a 60 � l  des Arg ' 
po rti o n  was removed and  d i s pensed i nto 1 ml of PBS/BSA , centri fuged , and  
the pe rcent TCA 125 1 i ns o l ubl e 1 25 1 mater i a l  determ i ned . A s  shown i n  
Tabl e 4 ,  the percent TCA 125 1 i nso l  ubl e materi a l  foun d  i n  the 
s uper natan t  fol l ow i ng  1 25 I -C3ades Arg expo s ur e  to a- chymot ryps i n  i n  
the a bsence o f  hepa r i n proteo g l yc a n  was 95% a n d  50% at  30 sec and  3 0  m i n ,  
repecti vel y .  W hen hepa ri n proteog l ycan  i s  present i n  the rea c t i on 
m i xture , the percent TCA 125 1 i nso l ubl e materi a l  was 83% and  45% for 30 
sec and 3 0  mi n ,  res pecti vel y .  T he o vera l l  act i v i ty of  a- chymotryps i n  i n  
the presence , o r  absence o f  hepa r i n  proteo g l ycan  i n  the de grada t i o n  of  
125 I _C3a  t b 0 0 1 I th f des Arg a p pears  0 e ve ry S l m l  ar . n e presence 0 
hepa r i n the acti v i ty o f  a- chymot ryps i n  a p pears  to be genera l l y  l ower than  
chymase  i n  t he degradati on of  125 I - C 3a des Arg ' 
Treabnent of RMC Son i cates w i t h  A n t i - C hymase Anti body . To determi ne  
whether chymase  was t he sol e en zyme or one  of  severa l  en zymes i n vol ved i n  
the degradat i o n  o f  1 2 5 I _C3a  by RMC , i mmun o a bsorpti o n  of  Rr�C so n i cates 
wi th  ant i body s pec i fi c  for chymase  was perfo rmed . RMC son i cates i n  
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Tabl e 4 .  E ffect o f  Hepari n P roteogl ycan o n  t he Degradati o n  
o f  1 25 r _C3a b y  Chymotryps i n  
Percent TCA 1 2 5 r i nsol u bl e  
Materi a l  
Agent 30  sec 30  mi n 
Tyrode ' s  bu ffer 100 100  
RMC 5 9  1 0  
Chymase 97 60 
Chymotryps i n  95 50 
Hepa ri  n proteo g l yc a n  100 75 
C hymase  pl u s  Hepa r i n  proteo gl ycan 60 26 
C hymo t ryps i  n pl us  Hepa r i n proteogl yc a n  83 45 
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Tyrode ' s  buffer co nta i n i ng 1 M NaCl  were abso r bed one o r  two ti mes wi th e i ther 
goat a n ti - r at chymase  or go at a n t i - rat a l bumi n .  I mmune compl exes were remo ved 
by a ddi t i on of a � a ureus sus pens i on .  The s uper natants  were removed and 
1 2 5  0 1 25  i nc u bated wi th  I -C3a for  1 hr at  37  C and a s s ayed for  percent I 
i nsol u bl e i n  TCA.  T he r es u l ts i n  Tabl e 5 s how that  fol l owi n g  a bsorpt ion  of  
RMC soni cates wi th  ant i - al bumi n  anti body there  i s  no  change i n  the  a b i l i ty of  
these son i cates to  d i ge s t  125 I _C3a  as  com pa red to unt reated son i cates . I n  
co ntast , RMC son i c ates treated wi th a n t i - chyma se anti body l ost  the i r  c a pa c i ty 
to d i gest 125 I _C3a . There i s  a 68 . 0% and 1 00% i nh i b i ti o n  of 125 I _ C 3a 
di ges ti on  by t reated RMC soni cates fol l ow i ng the f i rs t  and second a bsorpti ons 
res pecti vel y .  SDS PAGE anal y s i s  of a porti on  of t he i mm u noa bsor bed RMC 
son i cates reve a l ed a l os s  of predom i nantl y one protei n at a mol ecu l ar wei ght 
of  2 9 , 00 0 .  T he res u l ts i nd i cate t hat chymase  i s  t he major , if not t he so l e 
enzyme i nvo l ved i n  the degrada t i o n  of C3a by RMC . 
Degradati o n  o f  1 2 5 I-C3ades Arg by C hymase as the R at i o  of 
C hymase : C3ades  Arg Vari es . Varyi ng amounts  of chymase were i ncubated wi th a 
constant concentra t i o n  of  1 2 5 I - C 3a des Arg for 30 mi n at 37
0C .  S i nce the 
degradat i o n  o f  1 25 I _C3a by c hymas e  was enhanced when hepa r i n proteo g l yc a n  
was pres ent , 25  � g  of pur i fi ed rat he p a ri n proteogl ycan w a s  added t o  t he 
react i o n  m i xtur e .  As s hown i n  F i gu r e  1 4 ,  there i s  a l i near decreas e  as the 
rati o of  chymase to 125 I - C3ad decreases . The mos t effi c i ent rat i o  es  Arg 
o f  chymas e  to 125 I _ C3a r equ i red for com pl et e degrada t i o n  wi t h i n  30  m i n at 
370 C was 769 . At the l owes t rat i o  of C hymas e : 1 2 5 I -C3ades Arg tes ted , 
1 . 5 ,  on l y 2 0% o f  the 1 2 5 I-C3ades Arg mol ecu l es were degraded as  a s sessed 
by the pe rcent TCA i ns o l ubl e mater i a l  found i n  the s u pernatant . 
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Tabl e 5 .  1llvnuno a bsorpti  o n  o f  C hyma se from RMC Soni  cates . 
RMC so n i cate + bu ffer 
RMC son i cate + a n ti - chyma se 
RMC so n i cate + a nt i - al bumi n 
Percent 1 2 5 1 i nsol u bl e i n  TCA 
1 st  Absorption  
61 . 8  
87 . 8 ( 68 ) a 
59 . 4 ( 0 )  
2 nd Absorpti on 
58 . 8  
1 01 . 7 ( 1 0 0 )  
60 . 0 ( 2 . 9 )  
a parentheses represent  the pe rcent i nh i b i t i on o f  125 1 _C3a d i gest i on . 
E a ch val ue represents the mean from tri pl i cate determi n a ti o ns wh i ch had a 
s tanda rd dev i at i o n o f  l es s  than 1% .  
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F igure  1 4 . Degradat i o n  o f  125 r _C3a  - des 
C hymas e : 1 2 5 r-C3ades Arg Vari es . 
Arg by C hymase as  the Rat i o  of 
125 r _C3a  ( 65 ng ) was i nc u bated wi th var i o u s  co ncent rat i ons  of des Arg 
pur i fi ed RMC c hymase ( 0 . 1 9 �g ( 0 . 2x 1 0-4 u n i ts )- 1 00�g ( 0 . 5  un i ts ) ) i n  the 
pres ence o f  pur i fi ed RMC he pari n proteo gl ycan at 37 0C for 3 0  mi n i n  a vol ume 
of 125 �l . An 80 �l po rti o n  was removed a n d  a n a l yzed for percent TCA 
i ns o l ubl e 125 r materi a l . The experi ment was pe rformed i n  dupl i cate . The 
c l osed c i rc l es represent t he a vera ge val ue o btai ned from t he d u pl i cate val ues 
( X )  • 
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T h  R 1 f D 1 ·  f R C '  h D d ' 1 2 5  e 0 e 0 egranu  a t l o n  0 M l n  t e egra a tl on o f  1 -C3a . T he 
i nact i ve fonn o f  C3a , C3a des Arg ' do es not ha ve the ca pac i ty to degranul ate 
RMC ( 2 0 ) . S i nce C3ades Arg does not acti vate  RMC there s ho u l d not be any 
chymas e  expo s ed on the s ur face as a co nsequence o f  the i nc ubat i o n  wi th  
C3ades Arg ' However , when C3ades Arg i s  exposed to RMC t here is a s i m i l ar 
ra p i d degrada t i o n  as  observed wi th  C3a i n  F i gu r e  6 ( da t a  not s hown ) .  I nd i rect 
i mm unofl uorescence was performed u s i n g  a n t i - c hymase ant i body fol l owed by 
fl uo res cei n - co nj u ga ted a n t i - goat  I gG to determ i ne i f  chymas e  i s  expres s ed o n  
t he s urface of  RMC wi t ho ut pri or  treatment . A s  s hown i n  Fi gure 1 5 ,  c hyma s e  i s  
expres sed o n  the s ur face o f  RMC pu r i f i ed from the per i toneal ca v i ty fol l ow i n g  
1 a va g e  and  Fi  c o  1 1  s e d  i menta ti on . I n  add i ti on , chymase  was a l so detected on 
the s ur face o f  RMC d i rectl y removed from the pe r i toneal ca v i ty pri or  to F i co l l 
sedi menta t i o n  ( data not s hown ) .  
E ffect of  SBT1  on C3a - I nduced Rel ease o f  B-Hexo s ami n i da s e  from RMC . To 
tes t i f  the i nh i bi t i o n  of 125 I _C3a degrada t i o n  by RMC wou l d  enhance 
C3a- i nduced degranul ati o n  o f  RMC , a dose r es po n se e xperi ment u s i n g  SBTI was  
performed . Vary i ng  concentrat i ons of  SBT1  were  i nc u bated wi th  RMC pri o r  to 
e xpos ure to 1 2 5 1 _C3a • 1 2 5 1_C3a  was i nc u bated wi th  SBT1  treated RMC for 30 
m i n at 370 C .  Two po rti o ns were removed , one  was ana l yzed for percent TCA 
i ns o l ubl e 1 25 1 materi a l  and the other a s s ayed for B- hexosam i n i da s e  
act i v i ty .  A s  s hown i n  Fi gure 1 6 ,  t he degra d a t i o n  of  125 1 _C3a by RMC i s  
i nh i bi ted by SBT1  i n  a dose-dependent fas h i o n  as i nd i cated by the i ncrease i n  
the percent TCA i ns o l ubl e 1 25 1 materi a l . Max i mum i nh i b i ti o n o f  1 2 5 1 _C3a 
degradati on by RMC for SBT 1  is  between 0 . 7  mM and 2 . 8  mM . T he percent 
B- hexosami n i dase  rel ease  from RMC i nd uced by 125 I _C3a  i n  the presence of 
SBTI i s  not s i gn i f i ca ntl y d i fferent from that o bserved i n  the a bsence of SBTI . 
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F igure  1 5 . loolun o fl uo rescence of RMC u s i ng Goat I gG Ant i -Rat C hymase  Anti body . 
Fo rty t housand  RMC were a i r  d ri ed on a mi cros co pe s l i de and i ncu bated 
wi th  1 3 5  �g of go at  anti - rat  chymas e  for 30 m i n  and was hed 3 ti mes wi th  PBS .  
T he s l i des were t hen e x posed to 400 �g o f  fl uorescei n- conj u gated ra bbi t 
anti - go at I gG for 30 m i n  and was hed 3 ti mes wi th PBS .  Al l i nc u bat i ons were 
perfo rmed at room tem perature . T he p u r i ty of  th i s RMC prepa r a ti on  was 9 7 % .  
T h e  v i ab i l i ty of  t h e  RMC were 9 5 %  a s  as sessed by t rypa n  bl ue excl u s i o n . 
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F igu re 1 5 .  
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F i gure  16 . E ffect of SBTl  on C3a - l nduced Rel ease of 8-Hexosami n i dase  from RMC . 
2 . 0  x 1 05 RMC were pret reated wi th  i ncreas i ng concentrati ons of SBTl  
pri o r  to i nc u ba t i o n  wi th  3 nM 125 1 _C3a  for 3 0  m i n  at 37 0C in  a vo l ume of  
0 . 3  ml . A 90 � l  porti on  was  remo ved , centr i fu ged , and  anal yzed for  % TCA 
i nso l ubl e 1 2 5 1 materi a l  as des cri bed i n  Materi a l  and Met hods . A seco nd 0 . 2 
ml porti on  was remo ved and des penced i n  0 . 4  ml of i ce col d Tyrode ' s  bu ffer 
and as s ayed for 8- hexosam i n i da s e . RMC i nc u bated wi th  A2 3 187 a l one , wi th C3a 
a l one ,  and wi th buffer a re s hown . T he experiment was performed i n  
d u pu l i cate . The error ba rs represent the range o f  the two va l ues per tes t 
t u be .  
Fi gure 1 6 .  
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B i nd i ng of 125 I _C3a  to RMC i n  the Presence o f  Agents  W h i ch I nh i b i t  
Degradat i o n ,  Degranu l ati on , and  B i nd i ng to Hepa r i n Proteoglycan . The 
prel i mi n ary e xperiments a l l  i nd i cate that  125 I _C3a u pon expos ure to RMC i s  
be i ng degraded by the gran u l ar enzyme chymas e and i s  i nteracti ng wi th  hepa r i n 
proteo gl ycan . The fo l l owi n g  s et of b i nd i n g  stud i es was perfo rmed to test 
whether 1 25 I _C3a  wou l d s how saturab l e b i nd i n g  to RMC i n  the presence of 
rea gents that woul d bl ock  chymase act i v i ty ,  i ntera c t i o ns w i t h  hepari n 
pr oteo g l ycan , and  C3a- i nduced degranu l at i o n . RMC were treated wi th  
Tyrode ' s  bu ffer co nta i n i ng 1 mM  E DTA , 1mM TP CK , 4 mM  SBTI , and  0 . 3  M N aCl . 
125 I_C3a  was  i nc u bated wi th  these  RMC at  OO C .  Three types of  bi ndi ng 
anal yses were performed , dose- res po nse , k i neti c , and i nh i bi ti o n  of  b i nd i ng by 
unl a bel l ed C3a . As s hown i n  Fi gures 17 , when 3 . 6  x 1 06 mol ecul es are 
of fered pe r RMC , saturat i on  i s  not ach i eved even a fter a 60 m i n i ncubat i on .  
As s hown i n  F i gure 18 , even when 5 90 m i l l i on mol ecul es o f  1 2 5 I _C3a  were 
offered per cel l saturat i o n  was no t observed . F i na l l y ,  Fi gu re 19  s hows that 
45 0 m i l l i on mol ecul es of unl a bel l ed C3a per RMC coul d not bl o c k  t he b i nd i n g  of  
1 . 2 m i l l i o n  mol ecu l es of  1 25 I _C3a  per cel l . These data i nd i cate that when 
125 I _C3a  i s  i nc u bated wi th  RMC under co nd i ti ons wh i ch i nh i b i t  degrada t i on , 
degranul at i on , a nd b i nd i n g  to he pari n proteo gl ycan s aturat ion  was not o bs erved . 
Cross l i n k i ng of I ntact RMC wi th 125 I _C 3a • T he cel l ul ar com ponents on  
the s ur face of  RMC to  wh i ch 1 2 5 I _C3a  co u l d be  co va l entl y cros s l i n ked to  was 
determi ned . Two k i nds of e x periments were used to defi ne t he cel l ul a r 
components on RMC w i th whi ch  C3a  i nteracts : 1 ) 125 I _C3a  was i ncu bated wi th 
and co v a l entl y cross l  i n ked to RMC , 2 ) u n l abel l ed C3a  was i nc u bated wi th and 
cro s sl i n ked to l a bel l ed RMC . RMC were vectori a l l y  i od i nated by t he 
l acto peroxi dase  met hod ( 4 . 0  c pm/ cel l ) . Both 125 I _RMC and RMC were 
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F i gure  17 . T ime  Course  of 1 25 I _C3a B i n d i ng to RMC i n  the  Presence o f  Agents 
Wh i c h  I nh i b i t Degradati on , Degranul at ion , and B i nd i n g  to Hepari n Proteogl ycan . 
RMC ( 5 . 5  x 105 ) were pretreated wi th  Tyrode ' s  bu ffer co nta i n i ng 1 mM 
TPC K ,  4 mM SBT I , 1 mM E DTA , and 0 . 3  M NaCl for 5 m i n  at OOC .  125 I _C3a ( 3 0  
n g )  was i ncu bated wi th these cel l s  a t  OOC i n  a vol ume o f  0 . 5 ml . At vari ous  
t imes , a port ion  was  remo ved and  anal yzed for  the number o f  125 I _C3a 
mol ecu l es bound  pe r RMC . 
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F i gu re 1 8 .  Dose  Dependent B i nd i n g  of 125 I _C3a  to RMC i n  the Pres ence 
of  Agents  W h i ch I nh i bi t Degradat i on , Degranu l at i on , and  B i ndi ng to 
Hepa ri n  Proteogl ycan . 
RMC ( 5 x 1 05 ) were pretreated wi th Tyrode ' s  bu ffer conta i ni ng 1 
mM TPCK , 4 mM SB TI , 1 mM E DTA , and 0 . 3  M NaCl  for 5 mi n at OOC .  
I ncreas i ng co ncen t rati ons  of  1 2 5 I _C3a were i nc u bated wi th these cel l s  
for 20  m i n at OOC i n  a vo l ume o f  0. 5 ml . A po rti on  was removed and 
125 a n a l yzed for the number of  I -C3a mo l ecu l es bound per RMC . 
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F i gure 19 . B i nd i ng of  1 25 1 _C3a  to RMC in  the Presence o f  Exc e s s  C3a . 
RMC ( 6  x 1 05 ) were pretreated wi th  Tyrode ' s  bu ffer co nta i n i ng 1 
mM TPCK ,  4 mM SBT 1 , 1 mM E OTA , and 0 . 3  M N aCl for 5 mi n at OOC .  
1 25 1 _C3a  ( 1 1 . 5 n g ) was  i nc u bated wi th  these  ce l l s  i n  the  presence o f  
e xcess  C 3 a  rang i ng between 1 00 n g  and 2 0 � g  for 2 0 mi n at OOC i n  a 
vol ume o f  0 . 5  ml . A po rt i on  was removed and ana l yzed for the number of 
1 25 1_C3a  mo l ec u l es bound  pe r RMC . 
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pret re ated wi th 1 mM OFP for 5 mi n at DoC .  1 2 5  C3a  a n d  I -C3a  were 
i nc u bated w i t h  1 25 I _RMC and RMC , res pec ti vel y for 3 0  mi n at DoC .  
T hese cel l s  were cent r i f u ged and res us pended i n  Tyrode ' s  bu ffer 
conta i n i ng 3 0  mM BS3 and i nc u bated for 3 0  mi n at DoC .  Both cel l 
s us pen s i o ns were centr i fu ged , was hed 5 ti mes , r es u s pended i n  Tyrode ' s  
bu ffer/N P-40 ,  and  son i cated . These l ysates were centri fuged and  both  the 
s u pern ata nts a nd pel l et were anal yzed d i rectl y by S OS PAGE or 
i mmuno pr ec i pi tated wi th  ant i -C3a  ant i body and Staph  A and then ana l yzed 
by SOS PAGE fol l owed by a utorad i o gra phy .  T he res u l ts obta i ned by both 
methods were i denti ca l . The i ntens i ty of the autorad i ography wi th the 
i mm unoprec i p i tated m ateri a l  was very l ow ,  t herefore is not s hown . Fi gure 
2 0 s hows the a utorad i o gra phy of  an S OS PAGE a n a l y s i s .  Shown i n  l anes 1 
a nd 3 are t he i nsol u bl e pel l et and sol u bl e s u pern atant from the 
125 I _C3a_RMC cros s l i n ked materi a l , res pecti ve l y .  There are  three 
d i s ti nct bands v i s ua l i zed at 3 5 , 000 ,  45 , 000 , and 5 5 , 000 mol ecul a r  wei ght , 
a s  detenn i ned by the s tandard curve generated by rad i o i od i nated s tandards 
s hown i n  F i gure 2 1  and Tabl e 6.  W hen 125 I _C3a _RMC l ys ates a re treated 
wi th ant i - chymase anti body and prec i p i tated wi th  S taph  A ,  the onl y band 
detected i s  t he 3 5 , 000 mol ecul ar wei ght  s pec i es ( data not s hown ) . L anes 
2 and 4 are the i ns o l ubl e pe l l et and so l ubl e s upernatant from the 
C3a_ 1 25 I _RMC cros s l i n ked materi a l , repecti ve l y .  None of  the ba nds 
co rres po nd to the 125 I _C3a_RMC ba nds v i s ua l i zed i n  l anes 1 and 3,  wi th 
t he po s s i bl e  e xcep t ion  of  t he 3 5 , 000 mol ecul a r  wei ght band . These data 
i nd i cate that cross l i n k i n g  1 25 I _C3a  to RMC i n  the presence o f  OFP 
enabl es t he detect ion  of  3 bands of 3 5 , 00 0 ,  45 , 000 , and 55 , 000 da l tons 
fo l l ow i n g  S OS PAGE an a l ys i s .  I n  add i t i o n , the onl y ba nd that i s  s i m i l ar 
fol l owi n g  SOS  PAGE anal y s i s  of unl a bel l ed C3a  cross l i n ked to l a bel l ed RMC 
i s  the 35 ,000  d a l ton ba nd . 
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F i gure 2 0 .  C rossl i n k i n g  1 25 I _C3a  to  I ntact RMC and C3a  to  125 I _RMC 
RMC ( 3 . 75 x 106 ) or rad i o l abel l ed RMC ( 3 . 7 5 x 1 06 ) were 
pretre ated wi th 1 mM OFP for 5 mi n at OOC .  Both RMC and 125 I _RMC 
were i nc u bated wi th 4 �g of 1 25 I _C3a  and  C3a , res pect i ve l y ,  for 30 mi n 
at OOc i n  a vo l ume of 0 . 2 ml . The cel l s  were was hed and  res u s pended i n  
Tyrode ' s  bu ffer co nta i n i ng 3 0  mM BS3 and  i nc u bated for 3 0  m i n at 
OO C .  The cel l s  were centri fuged , was hed 3 t i mes , and  res us pended i n  
Tyrode ' s  bu ffer co nta i n i ng 1 %  NP-40 and  soni cated . The cel l l ysate 
was cent r i fu ged and both t he i nsol u bl e pel l et and sol u bl e  fra c t i o n  was 
ana l yzed by SOS PAGE and  a utorad i ogr a phy . Lanes 1 and  2 are  the 
i ns o l ubl e pe l l et from 1 2 5 I _C3a _RMC and C3a_ 1 2 5 I _RMC crossl i n ked 
m ateri a l , res pec ti vel y .  Lanes 3 and 4 are t he sol u bl e fra c t i o n  from 
125 I _C3a _RMC and C3a_ 1 25 I _RMC crossl  i n ked materi a l , res pec t i  vel y .  
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Fi gure 20. 
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F i gure 2 1 . Standard C u r ve for t he Determi n a t i o n  of Mol ecul a r  Wei ghts . 
The s tandard c urve for the determ i nat i on o f  mol ecu l ar wei ghts was 
gen erated by meas ur i n g  the d i stance ( cm ) from t he cathode each protei n of 
known mol ecul ar wei ght m i grated . Th i s  va l ue was d i v i ded by the d i s tance 
t he trac k i n g  dye ( brom phenol bl ue ) mi grated and is  represented on  t he 
ordi nate ( R f ) . On the a bc i ssa  are the l og va l ues of S- ga l actos i da s e  
( 1 16 , 2 5 0 )  ( . ) ,  phos phoryl ase B ( 92 , 5 00 )  ( .. ) ,  B S A  ( 6 6 , 2 00)  ( 0) ,  OVA 
( 45 ,000 )  ( 0 ) ,  c a r bon i c a n hyd rase ( 3 1 , 000 ) ( 6 ) ,  SB TI  ( 2 1 , 50 0 )  ( e ) .  
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Fi gure 2 1 .  
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U nknown 
U n known 
U n known 
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Tabl e 6. Appro x i mate Mol ecul a r  Wei ghts of La bel l ed 
Prote i ns Observed i n  F i gu r e  22 . 
Rf  
A 0 . 6  
B 0 . 47 
C 0 . 38 
MW 
35 , 000 
45 , 000 
55 , 000 
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C 1 ·  k '  1 25  I ros s  l n  l ng -C3a  to I ntact RMC i n  the P resence of Var i ous  
P rotease I nh i bi tors . RMC were e i t her i nc u bated wi th  4 mM SBTI , 0 . 04 mM 
SBT I , 1 mM TPC K ,  1 mM TPCK ,  1 mM DFP , or bu ffer pr i or to expos ure to 
125 I_C3a . As s hown i n  F i gure 22 , when RMC were pret reated wi th  4 mM 
SBT I  ( l ane 2 ) , 1mM TPCK ( l ane 5 ) , and 1 mM DFP ( l ane 6 )  there were t hree 
bands of  3 5 , 000 , 45 , 000 , and 5 5 , 000 d a l tons v i s ua l i zed . These three 
bands of 3 5 , 00 0 ,  4 5 , 000 , and 5 5 , 000 dal tons were a l so v i s ua l i zed i n  
F i  gure 20 .  W hen RMC are pret reated wi th 0 . 04 mM  SB  TI ( 1  ane 3 )  o r  1 mM 
TLC K  ( l ane 4 )  pr i or to e xposure to 125 I _C3a  t here were no bands 
v i s u a l i zed . W hen RMC were not i nc u bated wi th  proteas e  i nh i bi tors pri or 
to expos ure to 125 I _C3a  there were no bands v i s ua l i zed ( l ane 1 ) . There 
are no bands v i s ua l i zed when the i nh i b i tors 1 mM TPCK ( l ane 7 )  or 1 mM 
TL CK ( l ane 8 )  are added to the RMC at t he same t ime a s  t he 125 I _ C 3a . 
Thes e data i ndi cate that the 3 35 ,000 , 45 ,000 ,  and  55 , 000 da l ton bands 
a re onl y d etected on  SDS  PAGE fol l owi n g  prei ncuba ti on  o f  RMC wi th 
125 c hymotryp s i n - l i ke i n h i b i tors p ri o r  to e xpos ure to I - C3a . 
Percent TCA I nsol u bl e  1 2 5 I _ C3a  Materi al and B i nd i ng o f  1 2 5 I _C3a  
Fol l ow i ng Expos ure to CMMC . 1 25 I_C3a  was tes ted for i ts a b i l i ty to  
b i nd t o  CMMC at OO C ,  250 C ,  and  370 C .  CMMC ( 5 . 0  x 1 06 ) were 
i nc u ba ted wi th  1 �g of 125 I _C3a  at  OO C ,  250 C ,  and 370 C .  At 
v a ri ous t imes , a porti on  was remo ved and anal yzed for t he num ber of  
125 I _C3a  mo l ec u l es bound  pe r CMMC . As  shown i n  F i gure 23 , t he  h i ghes t 
b i ndi n g  o f  1 2 5 I _C3a  to CMMC i s  at 370 C wi th  a p prox imatel y 29 ,000 
mol ecul es bound per cel l a fter 30 mi n whi c h  a ppea rs to be s i m i l ar at 60 
o 125  mi n .  At  25 C ,  t here a re 1 2 , 000 and  2 2 , 000 I -C3a  mol ecu l es per 
cel l at  3 0  mi n and 60 mi n ,  res pec ti vel y .  At OOC ,  t he b i nd i n g  i s  the 
l owes t wi th  9 ,000 mo l ec u l es of  125 I _C3a  bound per CMMC at 30 m i n wh i ch 
a l so a ppea rs to rema i n  unchan ged at 60 mi n .  I n  a se parate e x peri ment the 
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b i nd i ng o f  125 I _C3a  to CMMC wa s as sessed at 30° C (data not s hown ) .  
The m a x imum num be r  o f  1 25 I _C3a  mol ecul es bound per cel l were a bout 
2 5 , 00 0 .  At  a l l  temperatures tested , wi th poss i bl y  the e xcept ion  of 
25° C ,  i t  a p pears  equ i l i bri um was obta i ned . 
To determi ne i f  C3a  was bei ng degraded by CMMC as a ssessed by 
percent TCA 1 2 5 1 i nsol u bl e materi a l , 1 2 5 I _C3a  was  i nc u bated wi th  CMMC 
at OO C ,  250C ,  and  37° C i n  the presence or absence of SBTI . As 
s hown i n  Fi gure 2 4 ,  when t he cel l s  were e x posed to 1 25 I _C3a  at 37 0C 
for 60 mi n t here was a red u c t i o n  i n  t he percent TCA 125 1 i nsol u bl e 
m ateri a l  by a bout 4 0 . 0% .  When SBTI i s  present w i t h  CMMC at 37 0C t he 
degra d a t i o n  o f  125 I _C3a  i s  i n h i b i ted . At 25°C ,  there was a 1 0% 
reduct i o n  i n  the percent TCA 125 1 i ns o l ubl e materi a l  that co u l d  be 
i nh i b i ted wi th  SBT I . The degradat i o n  of 1 2 5 I _C 3a by CMMC was  
compl etel y i nh i b i ted by perfo rmi n g  t he e x per iment at OOC .  
D I S CU SS I ON 
W hen rad i o acti ve 125 I _C3a  i s  i nc u bated wi th  RMC for 30 sec at 
37° C ,  there were as many as 1 0  m i l l i o n  mo l ec u l es bound per RMC ( F i g .  
3 ) .  T hese num bers a re i n  a g reement w i t h  those of a prev i ous report for 
RMC ( 15 ) , but co ns i derabl y h i gher than tho s e  for ot her cel l s  us i ng 
1 25 I _C3a  o r  1 2 5 I _C5 a .  G ·  . 1 t 1 t f d t h 4 8 U l nea p l g p a e e s were oun 0 a ve • x 
3 - 1 2  1 0  C 3 a  b i ndi ng s i tes per cel l wi th a Kd of 6 . 6  x 1 0  M ( 32 ) .  
Human neutro ph i l s  o r  m u ri ne macro pha ges had a ppro x i matel y 2 . 0  x 1 05 and 
1 - 3  x 1 05 b i nd i ng s i tes for C5a res pecti ve l y  ( 1 7 5 ,41 ) .  I t  i s  ev i dent 
from Ta bl e 2 that t he b i nd i n g of 1 2 5 I _C3a  to RMC is tem perature 
dependent . T here were 17 m i l l i on 125 I _ C3a  mol ecul es bo und per RMC at  
1 00 
F ·  22 C l '  k '  1 25  C . 1 9ure  . ross ln  l ng of  I -C3a  to I ntact RM ln  the  P resence of 
V a r i o u s  Protease I nh i bi tors . 
RMC ( 2 . 0  x 1 06 ) were i nc u bated w i t h  Tyrode ' s  buffer ( l ane 1 ) , 4 
mM SB TI  ( l ane 2 ) , 0 . 04 mM SBTI ( l ane 3 ) , 1 mM TLCK ( l ane 4 ) , 1 mM TPCK 
( l ane 5 ) , or 1 mM DFP ( l ane 6)  for 10 min at OO C .  1 25 I _ C 3a ( 2 �g ) 
were i nc u bated wi th  t hese cel l s  for 2 0 mi n at DoC .  Both 1 mM TPCK 
( l anes 7) and 1 mM TLCK ( l ane 8) were added to RMC at the same t i me as 
the 1 2 5 I _ C3a  and  i nc u bated for 2 0 m i n  at Do C .  Al l the cel l s  were 
was hed and  resus pended i n  Tyrode ' s  buffer conta i n i ng 1 0  mM BS3 and 
i nc ubated for 30 m i n  at DoC .  The cel l s  were was hed 3 t i mes and 
resus pended i n  Tyro de ' s/  1% NP-40 and soni cated . The cel l s  were 
centri fuged and the s u pernatants anal yzed by SDS PAGE and a utorad i o gr a phy . 
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Fi gure 22. 
1 02 
F i gure 2 3 .  K i n e ti c  Equ i l i bri um Anal y s i s  o f  1 2 5 I _ C 3a B i nd i n g  to CMMC . 
CMMC ( 1 7 . 4  x 1 06 ) were i ncu bated wi th 1 �g o f  125 I _C3a at OOC ,  
250 C ,  o r  37 0 C i n  a vo l ume of 1 ml . At va ri ous  ti mes , a 40 �l  po rt i on 
was remo ved , d i s penced i nto 0 . 4  ml o f  Tyrode ' s  bu ffer , l ayered o nto a 
m i  neral  o i l sol  uti  o n , and  centri fuged . The CMMC pe l l  et was used to 
c a l  cu l  ate the number of 1 2 5 I _C3a mo l ecu l  es bound per ce l l . 
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F i gure  24 .  Percent TCA I nsol ubl e 1 25 I _C3a Materi a l  Fol l ow i n g  Expos ure 
to CMMC . 
CMMC ( 1 . 2  x 1 06 ) were pretreated wi th  Tyrode ' s  bu ffer or 
Tyrode ' s  bu ffer co nta i n i ng 4mM SBTI at Oo C ,  25° C or 37° C for 5 
m i n .  1 2 5 I_C3a  ( 1 8  n g ) was i nc u bated wi th  cel l s  at Oo C pl us or m i nus 
SBT! , 25° C pl us or  m i nus SBT! , and  37° C pl us or mi nus SBT!  in a 
vol ume of 0 . 3  ml . At v a ri ous  times , a 2 0 �l porti on  was remo ved and 
des penced i nto 1 ml of PBS/BSA and centri fuged . The s u pernatants were 
t han anal yzed for percent i nsol u bl e  1 25 ! materi a l . 
1 05 
F i gure 2 4 .  
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1 06 
3 0  sec , as c om pa red to 8 . 9  m i l l i on at 370C .  Fi gure 4 s hows that the 
b i nd i ng of  1 2 5 I _C3a  to RMC at OOC i s  not saturabl e .  An  equ l i br i um 
was not es taba l i shed between 1 2 5 I _C3a and  RMC even when i ncreas i ng the 
numbe r  o f  125 I _C3a  mo l ec u l es to 530  m i l l i o n  o ffered per RMC 
Add i t i o n a l  b i nd i n g  studi es were t herefore perfo rmed i n  order to 
i nves ti gat e  the reas o ns for the h i gh amount of b i ndi ng and  unsat urabl e 
n at u re o f  t he C 3 a -RMC i ntera c t i on . I n  an effort to o bta i n  cond i t i o ns i n  
w h i c h  b i ndi ng o f  C3a to RMC was saturabl e and the numbe r  o f  mol ecul es 
bound per cel l more real i s ti c , a s eri es b i nd i n g  studi es were perfo rmed i n  
w h i c h  the experi mental co nd i t i ons  were vari ed . W hen 25  m i l l i on mol ecul es 
1 2 5  o f  I -C3a  were o ffered per cel l i n  t h e  a bsence o f  S B T I  there was 
4 5 0 , 000 mol ecul es bound per ce l l ; i n  t he presence of SBTI  th i s i ncreased 
t o  1 . 7 m i l l i o n . At OO C ,  i n  the presence o f  SBTI  ( Fi g .  9 ) , the number 
o f  1 2 5 I _C3a  mo l ec u l es bound  pe r RMC is  even h i gher at 4 . 5  m i l l i on .  I n  
t he presence o f  a h i gh ly  ba s i c  protei n ,  s uc h  a s  protami ne , saturat i o n  
coul d n o t  b e  a c h i eved . There w a s  a reduct i on i n  t he num ber o f  125 I _C3a 
mol ecu l es bound per ce l l , from 4 . 5  m i l l i o n  to  3 m i l l i on in  the presence 
o f  protami ne ( Fi gs . 9& 10 ) . Th i s  i n h i b i ti on by the h i ghl y po s i ti vel y 
charge d  protam i ne s u g ges ts an i nteracti o n  o f  C3a wi th  a nega t i ve l y  
char ged com ponent o n  t he s u rfa ce o f  RMC .  T he very l ar ge amo unt of 
1 2 5 I _C3a  bound to  RMC shown i n  F i gu res 3 , 4 , 8 , 9 ,  and  10  may refl ect the 
i ntera c t i o n  o f  th i s  pos i ti vel y char ged pol y pepti de wi th he pa ri n 
1 2 5  proteogl ycan pres ent o n  the s u rface of the RMC .  P a s s a ge o f  I - C3a 
o ve r  a co l umn of a ga rose  to wh i ch hepa r i n has been co va l entl y l i n ked and  
e qu i l i brated i n  PBS ,  res u l ts i n  the b i nd i n g  o f  u p  to  2 6% o f  t he 
1 2 5 I _C3a  mol ecu l es . These mol ecu l es ca n be  el uted from the 
1 07 
hepari n- a garose col umn u s i ng 0 . 3  M NaCl  ( data not s hown ) .  Add i  t ion  of 
commerc i a l i ntes t i na l  mucosa l  he pa r i n to the i nc u ba t i o n  of  RMC and 
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I -C3a , decreases the number  of mo l ecul es bound per cel l in a 
dose- dependent f as h i on .  T he number of mol ecul es bound per cel l furt her 
decreases i f  the i nc u ba t i on i s  performed i n  bu ffer co nta i n i ng 0 . 3  M NaCl  
in  t he presence of  commerc i a l he pari n ,  as com pared to the effect of  
ei ther a l one ( F i g .  1 1 ) . The  res u l ts of F i gures 8 ,  1 1 ,  and  Tabl e 2 a l l  
i nd i c ated t h at the b i nd i n g s t ud i es coul d best be perfo rmed i n  t he 
presence of 1 mM TPC K ,  4 mM SB TI , 1 mM E OTA , and 0 . 3  M N aCl at OOC .  As 
s hown i n  F i gures 17 , 18 , and  19 , saturat i on was s t i l l  not be o bta i ned . 
T he i na b i l i ty to s how s aturat ion  o f  1 25 I _C3a b i nd i n g  to RMC i n  e i t her a 
dose-dependent , k i neti c ,  o r  C3a i n h i b i ti on  s tudy i nd i cates that there are 
l ar ge amou n ts of  non-s pec i fi c  bi nd i ng of  C3a , po s s i bl y  to c hymase and 
hepa r i n proteo gl yc a n  on  the s urface of  RMC . Thes e com pounds on the 
s u rface of  R MC ma ke i t  imposs i bl e  to determi ne e i t her t he num ber of C3a 
receptors per cel l or the i r  affi n i ty u s i ng c l as s i c met hods for s tud i ng 
l i gand- receptor i ntera cti o ns . 
Fo l l owi n g  the i n i ti a l bi nd i n g  of 125 I _C3a by RMC , t here i s  a rapi d 
d i s soc i at i on of the l abel from the ce l l s  ( Fi g .  3 ) . Thi s l abe l ed materi a l  
i s  i n  an a l tered form that  i s  no l on ger ca pa bl e of  b i nd i n g  to  fres h RMC 
( F i g .  5 ) . Ana l ys i s  of the rel eased materi a l  demonstrates l ac k  o f  
prec i p i ta b i l i ty b y  T C A  ( Fi g .  6 )  a n d  sma l l er pepti des by S O S  PAGE ( Fi g .  
7 ) , pres umabl y the products of en zymat i c c l eava ge . Approx i matel y 50% o f  
1 2 5 I i s  d i s so c i ated wi t h i n  3 0  sec and  the rema i nder appears  more s l ow l y  
o ver the next 30  mi n .  One e xpl anat i on  for th i s  phenomenon may b e  t he 
sel ecti ve c l eava ge between two 1 2 5 I l abe l ed tyros i ne res i dues wh i ch are 
l oc ated 43 ami no a c i d res i dues a pa rt ( 16 ) . W hen mast  cel l s  degranul ate , 
much o f  the rel eased hepa r i n proteo g l ycan  and chymase rema i n  as an 
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i nsol u bl e c ompl e x  i n  an extra cel l u l ar posi ti on at the cel l s u rface wi t h i n  
l acunae ( 1 1 1 ) . Conce i va bl y ,  C 3 a  i s  i on i ca l l y  bound t o  hepa r i n 
proteo gl ycan wi t h i n  t hese l ac unae and en zym a ti c  cl ea va ge occurs rel ea s i n g  
o n e  fragment rap i d l y ,  wh i l e  the rema i n i ng po rt i on i s  bound t o  the he pa r i n 
proteogl ycan . T he gradual  decrease i n  t he percent 1 2 5 I _C3a i nsol u bl e  
i n  TCA a fter the 30  sec i nc u ba t i on t i me may be due to  the rel ease o f  th i s  
rema i n i ng fragment i nto t he fl u i d  phase . 
Cl eava ge o f  12 5 I _C3a  by RMC was abrogated wi th i nh i bi tors that 
bl o c k  t he a c ti v i ty o f  c hymotryps i n- l i ke en zymes ( Ta bl e 3 ) .  The 
i n h i b i t i o n  by DFP and TPCK i nd i cate that both  seri ne and h i s ti d i ne 
resi d ues a re i n  t he a c ti ve s i te ( 1 74 ) . Chymase , bei n g  t he most a bundant 
protease i n  rat seros a l  mas t cel l s  and  a l so bea r i n g  c hymot ryps i n- l i ke 
s pec i fi c i ty ( 17 4 )  was t he most l i kel y en zyme i n vo l ved . T he 
i mmun o prec i pi tat i o n  o f  1 25 I _C3a  by ant i body to chymase fol l owi n g  
co val ent cross l i n k i n g  i s  d i rect evi dence for t he i ntera c t i o n  of  t hese two 
mol ecu l es ( F i g .  1 2 ) . Al tho u gh the prec i se mode o f  i nteracti on i s  
un known , the 1 2 5 I _C3a  and  c hymase mo l ec u l es mus t be i n  cl os e pro x im i ty 
so as to a l l ow co va l entl y l i n ka ge of adjacent ami no groups ( e p s i l on ami no 
grou p o f  l ys i ne o r  term i na l  a l pha ami no groups ) o f  thes e two protei ns 
( 1 64 ) .  S i nce c hymase cl ea ves C3a , i t  i s  l i kel y that s ome o f  t he 
1 2 5 I_C3a  mol ecu l e are  bound  to  the acti ve s i te o n  chymase and that the 
pep ti de is cross l i n ked to the en zyme adj a c ent to i ts a c ti ve s i te .  
The effect of  immun o a bso r pti o n  o f  chymas e  from RMC soni cates o n  the 
degrada t i o n  of 1 2 5 I _C3a i s  shown i n  Tabl e 5 . The degradat i o n  o f  
1 2 5 I_C3a  by  RMC so n i cates i s  compl etel y abroga ted by  preabso r pti o n  wi th  
a n t i - c hymase anti body , whereas anti - a l bumi n anti body had  no  effect . I t  
a ppe ars  that chymas e i s  the maj o r  en zyme res po ns i bl e  for the d i ge s t i o n  o f  
C3a by RMC . 
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In order for C3a  to b i nd to chymase and be degraded by i t ,  the 
enzyme mus t be acces s i bl e  for s uch a n  i nteracti on . The co ncentrat i o n  of 
C 3a u sed i n  t hese e x periments ( 8 . 8  x 1 0-7M ) i nd uced no detecta bl e 
degranul at i o n  of RMC ( �1% a bove ba ckground as as ses sed by rel ease of  
S- hexosami n i dase a c ti v i ty ) . Johnson et  a l . fo und that concentrati o ns of 
C3a  l es s  than 9 x 1 0-6M d i d not i nduce h i s tami ne rel ease from pu ri f i ed 
RMC . W hen i nc re a s i n g  concentrati o ns of C3a  rangi n g  u p  to 1 0-5M were 
i ncuba t ed wi th RMC , the max imum total h i s tami ne rel eased was 25 -30% 
( 29 ) . I n  a s i m i l a r  study , Gl ovs ky et al . ,  u s i ng pu r i fi ed h uman 
l eu kocytes , s howed that C 3a co ncentra t i o ns of  1 0-6M i nd uced 30%  rel ease  
of tota l  h i s tam i ne ( 3 1 ) . S i nce no degran u l at i on was detectabl e in  our  
e xperi ments , it  s eems l i kel y that chymase- he pa ri n proteo gl ycan compl exes 
o n  the s ur face o f  the RMC are  res po ns i bl e  for the des truct i on o f  C3a . 
The o b s er v a t i o n  that chymase can be v i s ua l i zed by i mm u no fl uoroes cence 
mi crosco py o n  the s ur face of  uns ti mu l ated RMC ( F i g .  15 ) and that these 
cel l s can d i  gest C 3a d A ' an i nacti ve from of C3a  that does not es rg 
i nd u ce degranul at i on , s u pports th i s  noti on . 
The co ntri bu t i o n  o f  hepa r i n proteo g l ycan  to the degrada t i o n  of  
1 2 5 I _C3a  by puri f i ed chymase i s  demons trated i n  F i gu r e  1 3 .  Nei ther 
chymase  nor he par i n proteog l ycan a l one had t he ca pac i ty to cl ea ve 
1 2 5 I _C3a  to any  a ppreci a bl e exten t , but together 68 .6%  was  cl eaved i n  
3 0  mi n .  T he enhanc i n g  effect of he par in  proteogl ycan on chymase act i v i ty 
i s  i n  co nt ras t to other reports . D im i n i s hed chymas e  proteo l yti c acti v i ty 
i n  t he pres ence of hepar i n proteogl ycan was fo und wi th prote i n  s u bs trates 
such  as orni th i ne am i no transferase apoenzyme (81 ) and  ca se i n (2 3 , 1 1 0 ) . 
C hymase  a c ti v i ty a ga i nst t he es ter s u bs trate BTEE , i n  t he pres ence of  
hepa r i n proteog l yca n , has been va r i a b l y  a ffected ( 2 3 , 1 1 0 ) . 
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An ana l o gous effect on  t he degradati on of  C3a by chymase has a l so 
been s hown to occur wi th t ryptase , the major neut ral proteas e  of human 
mast cel l s  ( 99 ) .  Tryptase pu ri fi ed from human pu l monary mast cel l s  
c l eaves the th i rd com po nent of  com pl ement i nto f i ve fra gments . One of  
these fragments , w i t h  a mol ecul ar wei ght of 9000 , was s hown to be 
authenti c C3a that expres sed ant i ge n i c determ i nents on radi o i mmuno a s s ay 
and ana phyl atox i c a c ti v i ty on b i o a s s ay . W hen hepa ri n to gether wi th 
t rypta s e  was i nc u bated wi th C3 th i s  C3a - l i ke fra gment was not detectab l e 
by SDS  PAGE anal ys i s .  W hen pur i fi ed C3a was  i ncu bated wi th  tryptase i n  
the pres ence o f  hepa r i n ,  the C3a mo l ecu l e was rapi d l y  degraded , whereas 
i n  t he a b s ence of he pa ri n tryptase had no a pprec i a bl e  effect ( 99 ) . These 
observa t i ons  prec i se l y  pa ra l l el tho se  for chymase i n  the present s tudy . 
The rate o f  125 I _C3a degrada t i o n  ( F i g .  1 3 )  by RMC was fas ter than 
that catal yzed by i denti cal  amo unts of chymase and he pa ri n proteogl ycan . 
D i fferences between the res u l ts wi th pur i f i ed materi a l s and i ntact RMC 
may re fi ect t he h i gher l o cal  concentrati o ns of chymase and he pa r i n 
proteo g l yc a n  i n  the l acunae , promoti ng mo re effi c i ent i nteracti on wi th 
1 25 I_C3a • I n  add i t i o n , c a r bo xy pe pti dase  A ,  the second mos t a bu ndant 
protease  that resi des i n  rat  mast cel l secretory granul es and is  bo und to 
hepa r i n proteog l yca n , c l eaves  a romat i c  ami no a c i d  res i dues from the 
carbo xy- termi nal  end of pepti des . Carbo xy pe pti dase  A may a c t  i n  concert 
wi th c hymase  to rel ease  125 I _ tyro s i ne res i d ues from 125 I _ C 3a • 
The rol e o f  hepa r i n proteo gl ycan  i n  the enhancement of chymase  
proteo l ys i s of 125 I _ C3a i s  not  defi ned . I n  order  to  better un der s tand 
t he re qu i rement for  he pari n proteogl ycan , chymotryps i n  was a s s es sed for 
i ts capa c i ty to degrade 125 I _C3a i n  the presence and a bsence of  hepa r i n 
proteog l ycan . As s hown i n  Tabl e 4 ,  when chymotryps i n  i s  i nc u bated wi th 
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1 25 I _C3a  i n  the  pres ence of  hepa r i n proteo g l ycan  there a ppears  to  be  a 
s l i ght a u gmentat ion  of a bout 2 0% i n  the a b i l i ty of t h i s  en zyme to degrade 
1 25 I _C3a , as com pa red to chymo t ryps i n  a l one at 30 sec . At 60 m i n the 
a u gmentati on  i s  not as  o bv i ous . W hen 1 25 I _C3a  was i ncu bated wi th 
c hymase  a l one , there was 97%  and 6 0% TCA i nsol u bl e 12
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s ec a n d  60 mi n ,  res pecti vel y .  W hen chymase was i nc u bated wi th 125 I _C3a  
in  the presence o f  hepa r i n proteo g l yc a n  there was 60% and  26% TCA 
i ns o l ubl e 1 2
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1 materi a l  at 30 and  60 m i n ,  res pect i ve l y .  These data 
s u g ge s ts t h at he pari n proteogl ycan may functi on by ma k i n g  C3a more 
s u s ce pti bl e to proteol ys i s by c hymase  o r  chymot ryps i n .  W hether the 
he pa ri n proteogl ycan confo rm a ti ona l l y  chan ges t he C3a mol ecul e so that 
the pe pti de c l eava ge s i te i s  more acces s i bl e  to the en zyme needs to be 
pro ven e xperimenta l l y .  The a l tern a ti ve , that he pa ri n  s ta b i l i z es chymase 
a ct i v i ty ,  as  it  does for human t rypta s e , a l so requ i res i nves ti ga t i on . 
T he rate at whi ch c hymase degrades for C3a  i s  greater t han 
chymot ryps i n  ( Tabl e 4 ) . C hymase  d i ffers s tructura l l y  from chymot ryps i n  
i n  the num ber o f  d i s u l fi de b ri d ges . T he chymase  mol ecul e has one l ess  
di s u l fi de bond than does  chymot ryps i n .  It  i s  tho u ght that  th i s  
s tructura l  d i fference may be rel e va nt to t he unusual  a b i l i ty o f  chymase  
to  c l eave s ub s trates wi th prol i ne res i dues 3 am i no ac i ds away from the 
c l ea va ge s i te on  t he NH 3- te rmi nal  s i de ( 1 2 1 ) . Such a prol i ne res i d ue 
e x i s ts i n  the pri mary s tructure of C3a  at ami no ac i d  numbe r  31 and  may 
account for the more rapi d rate of C3a c l eavage by chymase . 
T he act i v i ty of pur i fi ed chymase  on t he proteol ys i s  of 125 I _C3a  i n  
the presence o f  hepa r i n  proteog l ycan  ( F i g .  1 4 ) a ppears  to be l ower than 
woul d ha ve been i n i ti a l l y pred i cted by t he rate of  degradat ion  observed 
i n  Fi gures 6 a nd 7 .  As t he r a t i o  of chymase  to 12
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decreases t he amo unt of  proteol y s i s  decreases  i n  a l i near  fas h i on .  T here 
a re several  pos s i b i l i ti es for the reduced act i v i ty .  There may be a l ow 
percenta ge co ntami n a nt that i s  repo n s i bl e for the degradat ion o f  C3a . A 
s eco nd pos s i b i l  i ty i s  that the experi mental  co nd i ti ons were not o pti mi zed 
for m a x imum chyma se a c ti v i ty .  T he data that a rgue a ga i  nst t he former 
ex p l anati o n  are 2 fol d .  The reacti o n  i s  a b rogated by i nh i b i tors  s pec i f i c  
for c hymo tryp s i n- l i ke enzymes . I n  a dd i t i on , when t h i s chymase 
prepa r at i o n  i s  ana l yzed on  S OS PAGE there i s  onl y one protei n ba nd 
detected at 2 9 , 000 mol ecul a r  wei ght  fo l l owi n g  s i l ver s ta i ni n g . Chymase 
i s  a neutral  protease  and  i s  optimal l y  acti ve at a pH  range between 7 . 4 
and 7 . 8 .  Th i s  e x peri ment was perfo rmed at pH 6 . 8 .  T he act i v i ty of 
chymase at pH 6 . 8  does not a p pe a r  to be a ffected when u s i n g  the syn t het i c  
s ub strate BTEE , t he act i v i ty o f  chym a se a t  pH 6 . 8  o n  s ubstrates s uch as  
com pl ex protei ns s uc h  a s  C3a  i s  not  known . It  i s  co nce i va bl e  that the 
o pt ima l  pH for proteol ys i s  of C3a  i s  cl o s er to pH 7 . 4-7 . 8  than to pH 6 . 8 .  
T he C3a co ncentrati o ns requ i red t o  cause  greater than 15% rel ease of  
tota l  h i s tami ne from RMC are a ppro x i matel y 1 00 �g/ml whi ch i s  1 00 fol d 
more than  C5a - i nduced h i s tam i ne rel ease (personal  commun i ca t i o n  wi th  T .  
I s h i za ka ) . The reason for t he l ower a c ti v i ty o f  C3a  i n  R MC a c ti vati on as  
com pa red to C5a i s  no t known . One pos s i bl i l i ty i s  that  C3a  i s  be i ng 
degraded by RMC chym ase and that t he i n creased concentrati o ns of C 3a 
requ i r ed for RMC act i va t i o n  i s  d i rectl y a ffected by th i s  phenomena .  The 
e xperi ment s hown i n  Fi gure 16 i l l u s trates t he effect of pretreati n g  RMC 
125  wi th v ar ious  concentr a ti o ns of  SBT I  p ri or  to I -C3a  e xpos ure on both 
. 1 25  the degrada t i o n  o f  I -C3a  and  B- hexos am i n i da s e  rel ease . There i s  a 
dose-dependent i n h i bi t i o n  o f  1 2 5 I _C3a  proteo l ys i s by RMC u s i n g  SB TI . 
T here a ppea rs to be l i ttl e correl a ti on between the concentrati o ns o f  SBTI 
used  to i nh i b i t  proteol ys i s  of C3a  by RMC to the amount of 
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B - hexosami ni dase  rel eased . The concentrati o ns o f  SBTI between 0 . 1  ( . 0 1 5  
mM ) and  1 . 6  ( 0 . 2 4 mM ) �g/ml appe a r  t o  ha ve ve ry sl i ght en hancement ( 2 0% )  
on  t he percent B- hexosami ni dase  rel ease  fol l owi n g  s t imul a ti on w i t h  C3a  as  
com pa r ed to C3a  i nc u bated wi th un t reated RMC ( 15 % )  and  s po ntaneous RMC 
rel e a se ( 1 2 % ) . I t  has been s hown that pretreatment o f  RMC wi th 
i nh i bi tors that bl oc k seri ne es terase acti v i ty wi l l  comp l etel y a brogate 
I gE-medi ated rel ease  of  h i s tami ne from t hese cel l s  ( 1 54 ) . I n  a dd i ti on , 
i t  has been recentl y s hown by K i do et a l  ( 1 7 7 ) that s pec i f i c  i nh i b i t i on 
of c hym ase , u s i ng both F ( a b ' ) 2 fra gmen ts of a n t i - chymase a nti body and 
c hymos tati n ,  com pl etel y bl ocked h i s tami ne rel ease i nduced by rat 
ant i - I g E .  Both  F ( a b ' ) 2 fragments of  a n t i - c hymase anti body or  
c hymo s tat i n had  no a ffect on  h i s tami ne rel ease as  i nduced by com pound  
48 /80 ( 1 54 ) .  It  i s  evi dent from these e xperiments that chymase pl ays an  
essenti a l  rol e i n  the degranu l at i on process  of RMC . It  i s  co ncei va bl e 
that there i s  a concentra t ion  of SBTI that  i nh i b i ts t he proteol y s i s  of  
C3a  bu t not  the  chymase acti v i ty requ i red for  RMC degranu l at i on and that 
th i s  concentrati o n  may be between 0 . 01 5  mM and 0 . 2 4  mM . 
W i th t he u s e  o f  BS3 , t he bi nd i n g  components for 125 I _C3a  on RMC 
co u l d  be ana l yzed by e l ect ropho res i s  on S OS po l ya cryl ami de s l a b  ge l s .  
Fi gure 2 0 s hows t he a utorad i o gra phy of an SOS  PAGE anal y s i s fol l owi n g  t he 
c r o s s l  i n k i ng of 1 2 5 I _ C 3 a  to RMC ( l anes 1 and  3 )  and  C3a  to 
rad i o i od i n ated RMC ( l anes 2 and 4 ) . There are three d i s ti nct bands 
v i s ua l i zed i n  both the i ns o l ubl e pe l l et ( l ane 1) a nd the so l ub l e fracti on 
( l ane 3 )  fo l l owi n g  treatment o f  RMC wi th 1 2 5 I _ C3a • The mol ecul a r  
wei ghts of  these 3 com po nents , as  as certa i ned by the mo l ecu l ar wei ght 
s tandards s hown i n  Fi gure 2 1  and  Tabl e 6 ,  are 3 5 ,000 ,  45 , 000 , and 
5 5 , 000 .  The 3 5 , 000 mol ecul a r  wei ght s peci es i s  125 I _ C3a cross l i n ked to 
chymase as determi ned by i mmuno preci pi  ti on  �Ii th anti - chymase anti  body 
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( data not s hown ) . T he mol ecul ar wei ght o f  chymase  i s  between 2 6 , 000 and 
2 9 ,000 .  The d i fference between the mo l ecu l ar wei ght of C3a  ( 9 ,000 ) and 
3 5 , 000 i s  2 6 , 000 , mak i n g  th i s  band ( 3 5 , 000 ) i n  t he correct mol ecul ar 
wei ght range for chymase .  The other ba nds ha ve not been defi ned . The 
mol ecul a r  wei ght d i fferences between t he 3 bands are 1 0 , 000 .  I t  i s  
conce i va bl e  that the 2 bands at 45 , 000 and  5 5 , 000 mol ecu l ar wei ght co u l d 
be c hyma se cros s l i n ked to two and t hree 1 2 5 I _C3a  mol ecul es , 
res pecti ve l y .  There are  two a rguments that s u gges t  that th i s  i s  not the 
case ; 1 ) when t he sol u bl i zed RMC fra c ti o ns are i mm uno prec i p i tated wi th 
ant i - chymase anti body and  Staph A there i s  onl y o ne band at 35 , 000 
mol ecul a r  wei g ht detected on  SDS PAGE and a utorad i o graphy , 2 ) these two 
ba nds at 45 , 000 and  55 ,000 mo l ec u l ar wei ght are not detected when C3a  i s  
cross l i n ked to 1 2 5 I _RMC ( l anes 2 and  4 ) , bu t the 3 5 , 000 mo l ecu l a r  
wei ght band i s .  Another pos s i bl i l i ty i s  that the bands at 4 5 , 000 and 
5 5 , 000 mol ecu l ar wei ght represent two com po nents of the C3a  rece ptor . 
The band at t he bottom of t he gel i s  free 125 I _C3a , as a s s es sed by the 
el ectro phoreti c pattern obs erved wi th 125 I _C3a  a l one . The i ntense 
rad i oacti v i ty at the to p of t he gel may be 125 I _C3a c ro s s l i n ked to 
hepa r i n proteo g l yc a n  or  to chymase wh i ch i n  turn i s  cros s l i n ked to 
he pari n proteog l ycan . The fact that th i s  i ntense rad i oa c ti v i ty is not 
found  i n  the so l ub l e fract i ons ( l anes 3 and 4 ) where hepa r i n proteo g l ycan  
wou l d not  be  found , s u pports th i s  noti on . The on ly  band  that  i s  s i m i l ar 
between 
125 I _C3a _RMC and C3a_ 1 2 5 I _RMC i s  the 35 , 000 mo l ecu l ar wei ght 
s pec i es .  The ot her two bands at 4 5 , 000 and 55 , 000 mol ecul a r  wei ght are 
not foun d  i n  the C3a _ 125 I _RMC ( l anes 2 and 4 ) . The 45 ,000 and 5 5 , 000 
mol ecu l a r  wei g ht s peci es are not l a bel ed w i t h  125 1 because  t hey are 
e i ther i nacces s i bl e  to the 
125 1 or they l ac k  tyros i ne res i dues expo s ed 
on the s u rface of t he pl a sma membrane . 
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T he e ffect of  v a r i o u s  i n h i b i to rs a n d  i nc u ba t i on cond i ti o ns on  the 
a b i l i ty of BS3 to cro s s l i n k  1 25 I _C3a  to RMC was tes ted . As s hown i n  
Fi gure 2 2 , t here i s  a n  a bsol ute re qu i rement for t he pretreatment o f  RMC 
w i t h  a chymotryps i n- s pec i fi c  i nh i b i tor p ri or  to 125 I _C3a  e xpos ure for 
t he detecti o n  of the 35 ,000 ,  45 ,000 ,  and  55 , 000 mol ecu l ar wei ght s pec i es . 
Recentl y ,  a second type of mast cel l (mucosal  mast  cel l ) has been 
i den i fed that i s  d i s ti nct i ve l y  d i fferent i n  the i r  proteo g l yc a n  and 
neutral  protease . It has been s hown that t he mucosal mast cel l i s  
equ i va l ent t o  the cu l tured mouse  mas t cel l ( CMMC ) . Prel im i nary 
experiments u s i  n g  t he CMMC i ndi  cate that t hese cel l s may be u s eful i n  
determ i  n i  n g  the numbe r  o f  C3a  receptors o f  the s ur face o f  mas t cel l s .  As 
s hown  i n  F i gure 2 3 ,  when 1 2 5 I _C3a  i s  i nc u bated wi th  CMMC at OOC ,  
250 C and  370 there a ppears  to be an equ i l  i bri um es tabl i s hed wi t h i n  30 
m i n  at a l l  of  the tem peratures tested , with t he pos s i bl e  e xcepti on  of 
25 0C .  The numbe r  of  C3a  b i nd i ng s i tes per CMMC ( 3 0 , 000 ) i n  F i gure 23  
i s  much  l ower t han t hat observed for RMC ( Fi gures 3 , 4 , 8 , 9 , and 1 0 ) . I n  
add i t i o n , the b i nd i ng curves for RMC and CMMC are ent i rel y d i fferent . As 
s hown i n  Fi gure 3 ,  when RMC are i ncu bated wi th  1 25 I _C3a  at 37 0C ,  
there was a h i gh amount  
1 a bel from t hese cel l s .  
1 25 I _C3a  at  37 0 C .  there 
s teady i ncrease d u ri n g  
di fference o bserved i n  
of bi ndi ng fol l owed by a rap i d d i s soc i at i on 
I n  contrast , when CMMC a r e  i nc u bated wi th  
are  fewer mo l ecu l es bound  per cel l wi th  a 
t he ens u i ng 3 0  mi n .  One e x pl anat i o n  for th i s 
C3a bi ndi ng i s  that CMMC does not degrade C3a 
rapi dl y as does RMC , as  i l l us trated i n  Fi gure 24.  The type of 
of  
as  
proteo g l ycan  foun d  in  CMMC i s  not  as s u l fated as  RMC he pa r i n ,  therefore 
i t  may not b i nd a s  much C 3a . 
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C 3 a  h a s  been s hown to pos sess  several b i o l o g i ca l  a c ti v i ti es i n  
va ri ous  an ima l  s pe c i es both i n  v i t ro and i n  v i vo .  I t  ca uses smooth 
musc l e co ntra c ti o ns , i nduces i ncreased v ascul a r  permea bl i ty ( 1 2 , 1 3 ) , and 
tri gger s  mas t cel l s  and ba s o ph i l s  to degran u l ate and rel ease h i s tami ne 
( 1 2 , 1 3 , 3 1 , 1 7 6 ) . Other i n fl ammatory proces s ess  can be medi ated by C3a  
such  a s  throm bo xa ne rel ease from macroph a ges ( 36 ) , l ysosomal enzyme 
secreti on  from neutro ph i l s  ( 3 5 ) and s eroto n i n rel ease  from pl atel ets 
( 3 3 ) . The co ntrol of  these b i ol og i ca l  acti v i t i es i s  medi ated 
systemi ca l l y  by serum carbo xype p ti d a s e  N ,  whi c h  c l ea ves t he carbo xyl 
tenn i na l  arg i n i n e  chan g i ng C3a  to C3ad A ' renderi ng i t  b i ol o g i ca l l y  e s  rg 
i na cti ve ( 2 0 ) . T he i na c ti v a t i o n  of  human C 3a by carbo xypepti dase  N i s  
s i m i l ar i n  human , g u i nea pi g ,  rat , and  rabb i t sera (2 0 ) . The data from 
t he present st udy s u g ges ts a regul atory rol e for c hymase i n  res po nse to 
C3a  s t i m u l at i on of mas t cel l s .  Our i n g  an acute i nfl ammatory e p i sode , C3  
i s  converted to C 3 b  and C3a ( 2 0 ) . Th i s  n ewl y generated C3a  t hen a c ts on  
mas t  cel l s  caus i ng degranul at i on and h i s tami n e  rel ease ( 29 , 2 0 , 2 3 ) . 
Fo l l owi n g  degranul a ti on  of mast ce l l s ,  C3a  i s  rapi dl y degraded by 
rel eased c hymase  i n  the pres ence o f  hepa r i  n proteog l  yca n . Once C3a  
i nterac ts wi th  mast  cel l s  it  i s  i na c ti vated a nd can  not  degranul ate ot her 
mas t  cel l s  i n  the a rea . C3a that has not i nteracted wi th  mas t ce l l s  may 
be i na c ti vated by t he s erum carbo xy pepti dase  N .  W h i l e the 
c a r bo xypepti dase  N may co ntro l  sys ten i c  l evel s of C3a , the e ffect of 
c hyma se a nd he pari n proteogl ycan may be i m po rtant i n  t he mi croenv i ronment 
of  the i nfl ammat ory l es i o n . 
1 .  
1 1 7  
B I B L I OGRAPHY 
Mul l er- Eberha rd , H . J . . 197 5 .  
44 : 697 . 
Com pl ement .  Annu . Rev . B i ochem . 
2 .  Med i cus , R . G . ,  Schrei ber , R . D . , Gotze , 0 . ,  and  H . J .  
Mu l l  er- Eberhard . 1976 .  A mol ecul a r  concept of t he pro perd i n  
pathw ay . Proc . Natl . Acad . Sc i .  USA 7 3 :6 1 2 .  
3 .  F ri e d ber ger , E . , We i tere . 1 91 0 .  U nters uchunger u be r  E i nwe i ss 
a n a phyl ax i e .  I V . Mi tterl un g ,  2 .  Immun i tacts  forsch . Immuno b i  0 1  • 
4 : 6 3 6 .  
4 .  Bo rdet , J .  191 3 .  Le mecan i sme de l '  a l anaphyl ax i e ,  C .  R .  Soc . 
B i o l . ( Par i s ) , 74 : 22 5 .  
5 . Novy , F . G . ,  and  P . H .  de Kru i f .  I X .  1917 . Spec i f i c  
ana phyl a c ti c s hoc k .  J .  I nfect . D i s .  2 0  : 7 7 6 .  
6 .  Hahn , F .  a n d  A .  Oberdo rf . 195 0 Anti h i s tami n i ca and  
ana phyl a ktoi de rea hti oner , Z .  Ifllll un i taetsforsch . I mmuno b i o l . 
1 07 :528 . 
7 .  Lepow , I . H . . 195 7 .  Nons pec i f i c  factors i n  i mmun i ty and  
hypersen s i ti v i ty .  J .  Al l ergy 28 : 37 9 .  
8 .  Hahn , F • •  195 0 .  Ana phyl ato x i ns : format i on , act i ons and  rol e 
i n  ana phyl a x i s , i n  pol ypepti des wh i ch a ffect smooth muscl es and 
bl ood ves se l s .  Per gamo n Pres s , Bri s tol . P .  27 5 . 
9 .  O sl er , A . G . ,  H . E .  Randal l ,  B .M . ,  H i l l , and Z. Ovary .  1 95 9 . 
Stud i es on the mechan i sm of hypersens i t i v i ty phenomen a .  I I I .  
The pa rti c i pati on of compl ement i n  the fo rmati on of 
anaphyl atox i n .  J. Exp . Med . 1 1 0 : 3 1 1 . 
1 1 8  
1 0 . Jensen , J . A  . .  1 95 9 .  Ana phyl ato x i n  i n  i ts rel at ion  to the 
com pl ement system . Sc i ence 1 55 : 1 1 22 .  
1 1 . Cochrane , C . G .  and H . J .  Mul l er-Eberhard . 1 968 . The deri vat ion  
of  two d i st i nct anaphyl atox i n  act i v i t i es from the th i rd and  
f i fth component of  human com pl ement . J .  Exp . Med . 1 27 : 37 1 . 
1 2 . D i sa da S i l va ,  W . ,  J .W .  E i sel e ,  and  I . H .  Lepow . 1967 . 
C ompl ement as a med i ator of i n fl ammat ion  I I I .  Pur i fi cat ion  of 
the acti v i ty wi th  a naphyl ato x i n  pro pe rt i es generated by 
i ntera c t i on of  t he fi rst fo ur com ponents of compl ement and i ts 
i denti f i ca t i o n  as a c l eava ge product of C ' 3 .  J .  Exp . Med . 
1 26 : 1 027 . 
1 3 .  Bo k i sch , V . A . , H . J .  Mul l er- Eberha rd , and  C . G .  Cochrane . 1969 . 
I so l a t i on of a fragment ( C3a ) of the t h i rd component of human 
com pl ement co nta i n i ng a n a phyl atoxi n and chemotact i c  act i v i ty and 
des c ri p t i o n  of  an ana phyl ato x i n i nacti vator of human s erum . J .  
Exp .  Med . � : 1 1 09 .  
1 4 . Bo k i sch , V . A .  and  H . J .  Mul l er- Eberha rd . 197 0 .  Ana phyl atox i n 
i nact i vator of human pl a sma : i ts i sol a t i on and characteri z a t i o n  
a s  a carbo xypepti das e . J .  C l i n .  I nves t .  49 : 2427 . 
1 5 .  Va l l ota ,  E . H .  and H . J .  Mu l l er- E berhard . 1 97 3 . Fonnat ion  o f  C3a  
and  C5 a a n aphy l ato x i ns in  who l e human serum  a fter i nh i b i t i on of  
t he ana phyl ato x i n i nacti vator . J .  Exp . Med . 112 : 1 1 09 .  
1 6 . Hugl i ,  T . E . .  197 5 .  Human anaphyl atox i n  ( C3a ) from the th i rd 
com ponent of compl ement : pr imary structure . J .  B i ol . Chem .  
2 5 0 :8293 . 
1 1 9  
1 7 .  Jaco bs , J .W . ,  J . S .  Rub i n ,  T . H .  H u g l i , R . A .  Bo gardt , I . K .  Mari z ,  
J . S .  Dan i e l s ,  W . H .  Dau ghaday , and  R . A . Brads haw . 197 8 .  
P u r i fi c a t i on , c haracteri z a t i on a n d  ami no aci d sequence o f  rat 
a n a phyl atox i n  ( C3a ) .  B i ochem i stry .  1 7 : 503 1 . 
1 8 .  Cor b i n ,  N . E .  and T . H .  H u g l i .  1 976 . The pr i mary s tructure of 
proc i ne C3a  a n a phyl atox i n .  J.  Irrununol . 1 1 7  :990 . 
1 9 .  Fern ande z , H . N .  and T . H .  H u g i l . 1 9 7 6 .  Pa rti al characteri z a t i o n  
of human C5 a a n a phyl atox i n  a n d  po l ypepti de po rt i on of  human 
C5a .  J .  I mm u no l . 1 1 7 : 1 688 . 
2 0 .  Hug l i ,  T . E .  1981 . The s tructura l  ba s i s  for ana phyl atox i n and 
c hemotacti c func t ion  of  C3a , C4a , and C5a .  C ri t .  Rev . Irrununol . 
1 : 32 1  • 
2 1 .  Tac k ,  B . F . and  J . W .  Pra h l . 197 6 .  Th i rd com po nent of human 
compl ement : pu r i fi cat ion  from pl a sma and phy s i ochemi cal 
cha racteri zati on . B i ochemi stry . � : 45 1 3  • •  
2 2 . H u g l i ,  T . E .  and B .W .  Er i c kson . 1 977 . Syntheti c pepti des wi th 
the b i o l o g i ca l  acti v i t i es and  s pec i f i c i ty of  human C3a 
ana phyl ato x i n .  P roc . N a tl . Acad . Sci . USA 74 : 1 82 6 .  
2 3 .  Hug l i ,  T . E .  and  H . J .  Mul l er- Eberhard . 197 8 .  Anaphyl ato x i ns : 
C3a  and C5a .  Adv . Imm unol . 26 : 1 . 
2 4 .  Hugl i ,  T . E . , W . T .  Morga n , and  H . J .  Mu l l er- Eberhard . 197 5 . 
C i rcul ar di chro i sm o f  C3a  ana phyl ato x i n :  e ffec ts of pH , heat , 
guan i d i n i um ch l ori de and merca p toethanol on co n format i on and 
functi on . J .  B i ol . C hern . 2 50 : 1 47 9 .  
120  
2 5 .  Hu ber , R . ,  H .  S c hol ye ,  E . P .  Pa ques , and J .  Dei senho fer . 1 98 0 .  
C rysta l  s tructure ana l ys i s  a n d  mol ecu l ar model of human C3a 
ana phyl ato x i n .  Ho ppe-Seyl ers-Z-Phys i o l . C hem . 361 : 1 389 . 
26 . Sachey fi o , A . C . 1972 . Ana phyl atoxi n- i nduced rel ease o f  
s ub s tances wi th pros tagl and i n- l i ke a c ti v i ty i n  i sol ated perfused 
gu i nea p i g l un g s . Br . J .  Pharmaco l . 46 :544 P .  
27 . Mota , I .  1 957 . Ac t ion  o f  ana phyl a c ti c s hock  and ana phyl ato xi n  
o n  mas t cel l and h i s tami ne i n  rats . Br . J .  Pharmaco l . 1 2  :453 . 
2 8 .  Rocha e S i l va ,  M . ,  O .  B i er ,  and M .  Aronson . 1 9 5 1 . H i s tami ne 
rel ease by a n a phyl atoxi n ,  Nature ( Londo n ) � :465 . 
2 9 .  Johnson , A . R . ,  T . H .  Hug l i ,  and H . J .  Mu l l er-Eberhard . 1 9 7 5 .  
Rel ease o f  h i s tami ne from rat mas t cel l s  by the com pl ement 
pe p ti des C3a  and C5a . I mmunol o gy 28 : 1 067 . 
3 0 .  Ter Saan , B . , J . L  Mol eanaar , T . M .  Fel t kamp-Vroom , a n d  K .W .  
Pondm an . 1 974 . I ntera c ti on of human ana phyl ato x i n C3a wi th  rat 
mas t  cel l s  demo ns trated by i mmunofl uo rescence . Eur . J .  Immuno 1 . 
4 : 3 9 3 . 
3 1 . G l ov s ky ,  M .M . ,  T . H .  Hugl i ,  T .  I s h i z a ka , L . M .  L i chtenstei n ,  and  
B .W .  E ri c kson . 1 9 7 9 .  Ana phyl atox i n- i nduced h i s tami ne rel ease 
w i th human l eu kocytes : stud i es of C3a l eu kocyte b i nd i n g  and  
h i s tami ne rel ease . J .  Cl i n .  I n vest . 64 : 804 . 
32 . Bec ker , S . , U .  Hadd i ng , H . V .  Sc horl enamer , and  D .  
B i tter-Suermann . 1 9 7 8 .  Demonstrat ion  o f  h i gh a ffi n i ty bi n d i n g  
s i tes f o r  C 3 a  a n a phyl atox i n  on  gu i nea pi g pl atel ets . Sca nd . J .  
I rllTl u no l . 8 : 551 . 
1 2 1  
33 . Bec ker , S . ,  S .  Meuer , U .  Hadd i ng , D .  B i tter-Suermann . 1 97 8 .  
Pl atel et acti vat i on : a new b i ol o g i ca l  acti v i ty o f  gu i nea pi g 
C3a  ana phyl ato x i n .  Scand . J .  I TlIllunol . 7 : 1 7 3 .  
3 4 .  Meue r , S . , V .  Ecker , U .  Hadd i n g , a n d  D .  B i tter-Suermann . 198 0 .  
P1 ate1 et- seroti n i n rel ease by C3a  a n d  C5a : two i nde pendent 
pathways of act i vat i on 4 : 1 26 .  
3 5 .  S howe l l , H . J . ,  M .M .  G1 ovs ky ,  and P .  Ward . 1 982 . C3a- i nduced 
l ysosomal enzyme recreat i o n  from human neutroph i 1 s .  I nt .  Arch s . 
Al l ergy Appl . I TlIll un . 64 : 227 . 
3 6 .  Hartun g , H . P . , D .  B i tter- Suermann , a n d  U .  Hadd i ng .  1983 . 
I nd uc ti on o f  t hrombo xane rel ease  from ma cro pha ges by 
anaphy1 at ox i c pe pti de C3a  o f  com pl ement and syn thet i c  
hexa pepti de C3a  72-77 . J .  I TlIllu no 1 . 1 30 : 1 34 5 . 
37 . C ha rri aut , C . ,  A. Sen i k ,  J . P .  Ko1 b ,  M .  Barel , and  R .  Frade 
1 982 . I nh i b i ti on of in v i tro n atural  k i l l er a c ti v i ty by the 
th i rd com po nent of com pl ement : Rol e for the C3a fragmen t . 
Proc . N a t1 . Acad . Sc i . USA 7 1  : 6003 . 
38 . Morga n , L L . , W . O .  Wei gl e ,  a n d  T . H .  Hug1 i .  1982 . 
Ana phyl ato x i n-medi ated regul a t i on o f  the i Tllll une res po nse . I .  
C3a -med i ated s u ppres s i on o f  human and mur i ne humora l  immune 
r es ponses . J. Exp . Med . � : 1 41 2 .  
39 . Paya n , D . G . ,  D . E .  Trentham , and  E . J .  Goet zl . 1982 . Mod ul at i on 
o f  human l ym p hocyte f un c ti on by C3a  and C 3a ( 70-77 ) . J .  Exp . 
Med . 1 56 :7 5 6 .  
4 0 .  C henoweth , D . E . a n d  T . H .  Hugl i .  197 8 .  Demonstrat i on o f  
s pec i fi c  C5a receptors on  i ntact human pol ymor phonuc l ear 
l eu kocytes . I TlIllunol ogy � : 3943 . 
122  
4 1 .  C henoweth , D . E . , M . G .  Goodman , and W . O .  Wei gl e .  1 982 . 
Demo ns trat i o n  o f  s pec i f i c  rece ptor for human C5a anaphyl atoxi n 
on m u ri ne macro pha ges . J .  Exp . Med . 1 56 :68 . 
42 . McCarthy , K .  and  P . M .  Henson . 197 9 .  I nduct i on o f  1 ysosoma 1 
en zyme secretion  by a l veol a r  macro pha ges i n  res po nse to the 
puri  f i ed com pl ement fragment C5a and  C5a des J. Immunol . arg · 
1 23 : 2 5 1 1 • 
4 3 . Morga n , L L . , M . L .  Thoman , W . O .  Wei gl e ,  and  T . H .  Hugl i .  1983 . 
Ana phyl ato x i n-medi ated regul at ion  of the i mmune res po nse . I I .  
C5a  Med i ated enhancement of human humoral  and T cel l med i ated 
i mmune res po nses . J .  I mm unol . 1 30 : 1 25 7 . 
4 4 .  Enerba ck  L .  1966 . Mas t cel l s  i n  r a t  ga s t ro i ntes t i na l  muco s a . 
I .  Effects o f  fi xat ion . Acta . Pathol . Mi cro b i o l . Scand . 
66 : 289 . 
4 5 . Enerba ck  L .  1966 . Mas t cel l s  i n  rat ga s tro i ntes t i nal  muco s a . 
I I .  Dye bi ndi n g  and metachromat ic  pro perti es . Acta . Pat hol . 
M i c r o b i o l . Sca nd . 66 : 3 03 . 
46 . Y ur t  R . W . ,  R . W . Lei d ,  K . F .  Aus ten , and  J . E . S i l bert . 1977 . 
N a ti ve he pari n from rat peri toneal mast  ce l l s .  J .  B i ol . Chern .  
252 : 5 1 8 .  
47 . Kat z ,  H . R . , R . L .  Stevens , and  K . F .  Aus ten . 1985 . Leu kotri ene 
and prostagl and i n  pathway meta bol i sm .  Hetero gene i ty of 
mamma l i an mas t cel l s  d i fferenti ated i n  v i vo and i n  v i tro . J .  
Al l ergy Cl i n .  I mmunol . 76 : 2 5 0 .  
123 
48.  Befu s  A . D . ,  F . L .  Pearce , J.  Gaul d i e , P.  Horsewood , and J .  
B i en i ns toc k .  1982 . Mucosa l  mas t  ce l l s .  I .  I sol ati on and 
funct iona l  chara cteri zati on of rat i ntes ti nal  mast cel l s .  J .  
I nrnunol . 128 : 2 475 . 
49 . Sanya l R . K . , and  G . B .  Wes t .  195 8 .  Rel at i o ns h i p of h i s tami ne 
and 5 - HT to ana phyl a c ti c s hock  i nd i fferent s pec i es .  J .  Phys i ol . 
( Lond ) . 144 :525 . 
50 . Hol gate  S . T . , M . K .  C hurch , M . J .  Cush l ey ,  et a l . 1984 . 
Phanna col og i c modul at ion  of a i rway cal i bre and med i ator rel ease 
i n  human model s o f  bronc h i a l  as thma . p.  391 . I n  Kay A . B . , K . F . 
Au sten , L . M .  L i c htenstei n ( eds ) . Asthma . Phys i o l o gy , 
Inrnun o ph a rmaco l ogy , and  Treatmen t .  Academi c ,  New Yor k .  
5 1 .  W a s s e nnan M . A . , D .W .  Duchanne , R . L .  G r i ffi n ,  et a l : 1 977 . 
Broncho - pu l monary and card i ovascu l ar effects of pro s tag l and i n  
O2 i n  t he dog . Prosta gl and i ns 13 : 2 5 5 . 
52 . Borgeat P . ,  and  B .  Samue l s son . 197 9 .  Met a bol i sm of arach i don i c 
ac i d  i n  pol ymor phonucl ear  l eu kocytes : s tructure anal y s i s  o f  
n o v e l  hydroxy l ated com pounds . J .  B i o . C hem . 254 :7865 . 
5 3 .  D razen  J .M . ,  K . F . Aus ten , R . A .  L ewi s ,  et a l : 1 98 0 .  Com parat i ve 
a i rway and vas cu l ar  acti v i t i es of l eu kotri enes C- 1 and 0 i n  v i vo 
and i n  v i tro . Proc . N atl . Acad . Sci . USA.  77 :4354 . 
54 . Lew i s R . A . , N . A . Soter , E . J .  Corey , and  K . F . Aus ten . 1981 . 
Local  e ffects of synt heti c l eu kotri enes ( LTs ) on mon key (M ) and 
human ( H ) s ki n .  C l i n .  Res . 29 :492 A .  
124  
5 5 . McManus  L .M . ,  D . J .  Hana han , and R . N .  P i nc ka rd .  1 98 0 .  Human 
pl atel et s t i mul at i o n  by a cetyl gl yceryl et her pho s pho ryl chol i ne 
( AGEPC ) . J .  Cl i n .  I n ves t .  67 :903 . 
5 6 .  F i ndl ay S .  R . , L . M .  L i chtens tei n ,  D . J .  Hana ha n , a n d  R . N .  
P i nc kard . 1 98 1 . T he contra c ti on o f  gu i nea p i g i l eal  smooth 
musc l e by a cetyl g l yceryl ether pho s pho ryl cho l i ne .  Am . J .  
P hys i o l . 241 : C 1 3 0 .  
5 7 .  Humphrey D . M . , L . M .  McManus , K .  Satouc h i , et a l . 1982 . 
V a soacti ve pro perti es of acetyl gl yceryl ether phos phoryl c hol i ne 
( AGEP C ) and AGEP ana l o gues . Lab .  I nves t .  46 :422 . 
5 8 .  Ehrl i ch P .  1 9 7 8 .  Be i trage z u r  theori e und pra x i s  der 
h i s tol og i schen farbu n g . Doctoral  thes i s ,  U n i ve rs i ty of Lei pz i g .  
5 9 .  B l and  C . E . ,  H .  G i ns burg , J . E .  S i l bert , and D . O .  Metca l fe .  
1 982 . Mou se hepa r i n proteog l ycan . J .  B i o l . Chem . 257 :8886 1 .  
6 0 .  Ra z i n  E ,  R . L .  Stevens , F .  Aki yama , e t  a l . 1 982 . Cul ture from 
mou se bone marrow of a subc l as s  of mas t cel l s  pos s es s i ng a 
d i s ti nct c hondro i t i n  s u l fate proteogl ycan wi th gl ycos ami no­
gl ycans  ri ch i n  N - acetyl ga l actosam i ne-4 , 6  d i s u l fate . J .  B i o l . 
C hem . 257 : 7229 . 
61 . Y urt  R . W . ,  R . W . Lei d ,  K . F . Aus ten , and  J . E . S i l bert . 1977 . 
Nat i ve hepari n from rat peri toneal mast cel l s .  J .  B i o l . Chem .  
252 : 5 1 8 . 
62 . Hel ti ng T ,  and  U .  L i ndahl . 1972 . B iosynthes i s  of he pa r i n :  
tran sfer o f  N-acetyl gl ucosami ne and gl ucuron i c a c i d  to l ow 
mol ecu l ar wei ght hepa ri n fragments . Acta . C hem . Scand . 26 : 3 5 1 5 . 
1 2 5  
63 . Grebner E . E . ,  C .W .  Ha l l , and E . F . Newfel d .  1966 . Gl ycosyl a t i on 
o f  seri ne res i dues by a ur i  d i ne d i pho s phate  xyl ose :  prote i n  
xyl osyl transferase  from mouse  mastocytoma . Arch . B i ochem .  
B i o phys . 1 16 :391 . 
64 . Hel ti ng T ,  and  L .  Roden . 196 9 . B iosynthes i s  of chondro i t i n  
s u l f ate : ga l a ctyosyl tran sfer i n  the fo rmat ion  o f  t he 
carbohyd r ate- protei n l i nkage reg i o n . J .  B i o l . C hem . 244 :2790 . 
65 . Hel t i n g  T ,  and L .  Roden . 1 96 9 .  B i osynt hes i s  of chondro i ti n  
s u l fate : gl ucuronosyl trans fer i n  the format i on o f  the 
c ar bohydrate- protei n l i n ka ge reg i on . J .  B i o l . C hem . 244 : 2799 . 
66 . Rob i ns o n  H . C . ,  A. Tel ser , and A .  Dorfman . 1966 . Stud i es on the 
b i osynthes i s  o f  the l i n ka ge regi on  of chondroi ti n  s u l fate­
protei n com pl ex . Proc . Natl . Acad . Sc i .  USA .  56 : 1859 .  
67 . Metca l fe D . O . ,  J . A . Smi th , K . F .  Austen , and J . E .  S i l bert . 
1980 . Pol yd i s pe l'S i ty o f  rat mas t cel l hepa r i n :  impl i ca t i ons 
for proteogl ycan a s s embl y .  J.  B i o l . C hem . 255 : 1 1 7 5 3 . 
68 . Rob i ns o n  H . C . ,  A . A .  Horner , M .  Hoo k ,  et a l . 1978 . A 
proteogl yc an form of hepa ri n and i ts degradati on to s i ngl e cha i n 
mol ecu l es . J .  B i o l . Chem . 253 : 6687 . 
6 9 .  Metca l fe D . O . ,  R . A . Lewi s ,  J . E .  S i l bert , et a l . 1 97 9 .  
I so l at i o n  and  characteri zat i on o f  he pa r i n from human l un g . J .  
C l i n .  I n ves t .  64 : 1 537 . 
7 0 .  Rob i ns o n  H . C . ,  A . A  Horner , M .  Hoo k ,  S .  Ogren , and  U .  L i nda hl . 
1 9 7 8 .  A proteo gl ycan form of hepa r i n  and i ts degradat ion  to 
s i ng l e  cha i n  mo l ecu l es . J .  B i o l . Chem . 253 : 6687 . 
126 
7 1 .  I sernura M ,  and T .  I kena ka . 1 97 5 .  8-El i mi na ti on and s u l f i te 
a dd i t i o n  react i o n  o f  chondroi t i n s u l fate pe pt i do g l ycan  and  the 
pep ti de s tructure of t he l i n ka ge reg i on . B i ochern . B i o phys . 
Acta . 404 : 1 1 -2 1 .  
72 . Grebner E . E . , C .W .  Ha l l , and  E . F . Neu fel d .  1966 . G l ycosyl at i on 
of s e r i n e  res i d ues by a u ri d i ne di phos phate xyl ose : Prote i n  
xyl os yl - trans ferase from mouse  mas tocytoma . Arc h . B i oc hem . 
B i o phys . � : 3 9 1 . 
73 . Rob i ns o n  H . C . , A. Tel ser , and  A .  Dorfman . 1966 . Stud i es on 
b i os ynthes i s  o f  the l i n ka ge reg i o n  of c hondroi t i n  s u l fate­
protei n com pl ex . Proc . Natl . Acad . Sc i . U SA . 56 : 185 9 .  
7 4 .  Hel ti n g  T ,  a n d  L .  Roden . 1969 . B i osynthes i s  of c hondroi ti n 
s u l fate : Gl ucuronosyl transfer i n  the format i o n  o f  the 
carbo hydrate- protei n 1 i n ka ge reg ion . J .  B i ol . C h ern .  244 : 27 9 0 .  
75 . Hel ti ng T ,  and  L .  Roden . 196 9 . B i osyn thes i s  of chondro i t i n  
s u l fate : Gl uc uro nosyl transfer i n  the fo rm a t i o n  o f  the 
c a r bohyd rate- protei n l i n ka ge reg i o n . J .  B oi o l . Chem . 244 :2799 . 
7 6 .  Hel t i n g  T ,  and U .  L i ndahl . 1 97 2 . B i osynthes i s  of hepari n :  
Transfer o f  N -acetyl gl ucos am i ne and gl ucuron i c  a c i d  to l ow 
mol ecul ar  we i ght hepa r i n  fra gments . Acta . Chem .  S cand . 26 : 3 5 1 5 . 
77 . Roden L :  1 980 . Structure and met a bo l i sm of co nnect i ve t i s s ue 
proteogl ycans . I n  Lennarz WJ ( ed ) : " The B i oc hemi s try o f  
G l yco protei ns a n d  Proteo g l ycans . "  New York : Pl enum , pp . 267 . 
127 
7 8 .  Sc hwa rt z  L . B . ,  C .  R i edel , J . P .  Cau l fi el d , e t  a l . 1 98 1 . Cel l 
a s s oc i at i o n  o f  com pl exes o f  chymase , hepa ri n  proteogl yca n , and  
prote i n  a fter degranul  a t i on by rat mast cel l s .  J .  I mmunol . 
� : 2 07 1 . 
7 9 . Sc hwartz  L . B . , C .  R i edel , J . J .  Sc hrat z ,  and  K . F .  Aus ten . 1982 . 
Local i z a t ion  o f  carbo xypept idase  A to the macromol ecul ar hepari n 
proteo g l yc a n - prote i n  com pl ex i n  secretory granul es of rat 
s erosal  mast cel l s .  J.  I nvnunol . 128 : 1 1 28 .  
8 0 .  Y u r t  R . W . ,  and  K . F .  Aus ten . 197 7 .  Prepa rati ve pu r i f i ca t i o n  rat 
mast cel l chymase : c hara cteri zat i on and i ntera c t i o n  w i t h  
granu l e com po nents . J .  Ex p .  Med . 146 : 1 405 . 
8 1 .  Everi tt M . T . , a n d  H .  Neurath . 1 97 9 .  R a t  mast cel l 
c hymot ryps i n -l i ke en zyme : pu r i f i cat i on , s pe c i f i c i ty and 
i ntera c t i o n  with  mast cel l hepa ri n .  Fed . Proc . 38 : 83 4 .  
82 . Sc hwartz  L . B . , M . S .  Kaw a hara , T . E .  Hugl i ,  et a l . 1983 . 
Generat ion  o f  C3a ana phyl ato x i n from human C 3  by human mast cel l 
tryptas e . J .  Immun ol . 130  : 1891 . 
83 . U vn a s  B ,  C . H . Aborg , and  A. Bergendoff . 1 9 7 0 .  Stora ge o f  mast  
ce l l s :  ev i dence for  an i o n i c b i nd i ng o f  h i s tam i ne to protei n 
carbo xyl s i n  t he granul e hepa ri n protei n  com pl ex . Acta . 
Phy s i o l . Sca nd . ( Su p pl ) . 336 :3 . 
8 4 .  L a m  L . H . ,  J . E .  S i l bert , a n d  R . D .  Rosen berg . 1 9 7 6 .  The 
sepa ra t i o n  o f  act i ve and  i nacti ve forms of hepa r i n .  B i ochem . 
B i o phys . Res . Commun . 69 : 5 7 0 .  
85 . Ros en berg R . D  . .  1977 . B i o l og i c  acti ons o f  hepa r i n .  Semi n .  
Hemato l . 1 4 : 42 7 . 
1 28 
86 .  Stead N ,  A . P  Ka pl an , and R . D .  Rosen berg . 1 976 . I n h i b i t i on o f  
act i  va ted factor X I I  by anti throm b i n - he pa r i n co facto r .  J .  B i o l . 
C hem . 2 5 1  : 6481 . 
87 . Dam us P . S . , M .  H i c k s , and  R . D .  Rosen berg . 197 3 . Ant i co a gu l ant 
a c ti on of hepari n .  Nature . 246 : 3 5 5 . 
88 . Y i n  E . T . , S .  Wes s l er , and  P . J .  Sto l l .  197 1 . Ident i ty o f  pl asma 
acti vated factor X i n h i b i tor wi th anti thrombi n I I I  and he pa ri n 
cofacto r .  J .  B i o l . C hem . 246 : 37 1 2 . 
89 . Oterud B ,  M .  M i l l er-Anderson , U .  Ab i l d guard , and H .  Pryd z . 
1 97 6 .  The effect o f  anti throm b i n  I l I on the acti v i ty o f  the 
coa gul a ti on factors  V I I ,  I X ,  and X .  T hromb H aemost . 35 : 2 9 5 . 
90 . Ros en be r g  R . D . , and  L .  Lam . 197 9 .  Correl at ion  between 
s t r ucture and functi on of hepa ri n .  Proc . N atl . Acad . Sc i . USA .  
76  : 1 2 1 8 .  
9 1 . H i gh sm i th R . F . , and  R . D .  Rosenberg . 197 4 .  The i n h i b i t i on o f  
human pl a sm i n  by human a n t i t hrombi n - he pa r i n  cofacto r .  J .  B i ol . 
C hem . 249 :4335 . 
92 . Burrowes C . E . , F . M .  Haba l , and  H . Z .  Mova t . 1975 . The 
i nh i b i ti on of human pl a sma ka l l i kre i n  by ant i t hrombi n  I I I . 
Throm b .  Res . 7 : 1 75 . 
93 . Mar kwa rdt F ,  and  H . P .  Kl oc k i ng .  1977 . Hepa r i n - i nduced rel ease 
of pl a smi no gen acti vator . Haemos t a s i s .  6 : 3 7 0 .  
94 . Loos M ,  J . E .  Vol ana k i s ,  and  R . M .  Stroud . 197 6 .  Mode o f  
i ntera c t i o n  of d i fferent pol yan i o ns w i t h  t he fi rst ( C 1 ,  C 1 ) , 
seco nd ( 2 ) , and  the fourth  ( C4 ) com ponent of com pl ement .  I I .  
E ffect of po l yan i o ns on  t he bi nd i n g  on  t he b i nd i n g  o f  C 2  to 
EAC4b . I lTfll unochemi stry .  1 3  : 2 5 7 . 
129 
9 5 .  Loos M ,  J . E .  Vol ana k i s , and R . M .  Stroud . 1976 . Mode o f  
i nteract i o n  o f  d i fferent po l ya n i ons  wi th the f i rs t  ( C 1 , C 1 ) , 
second ( C2 ) , and the fou rth ( C4 )  component of compl ement . I I I . 
I nh i bi t i o n  o f  C4 and C2 b i n d i n g  s i te ( s )  o f  C I s  by po l ya n i ons . 
Immunochemi stry .  ll : 789 . 
9 6 .  Raep pl e E ,  H . U . H i l l , and M .  Loos . 197 6 .  Mode o f  i nteract i on 
o f  d i fferent pol yan i o ns w ith  the fi rst ( C 1 , C 1 ) , the second ( 2 ) , 
and the fou rth ( C 4 )  com ponent of com pl emen t . I .  Effect on 
fl u i d  phase C l  and on C 1  bo und to EA or to EAC4 .  Immuno­
chemi stry .  13 :25 1 .  
97 . Brai  M ,  and A . G .  Osl er . 1972 . Stud i es on the C3 s hunt 
a c ti vat ion  in co bra venom i nd uced l ys i s  of unsensi ti zed 
erythrocytes . Proc . Soc . Exp . B i o l . Med . 140 : 1 1 1 6 .  
98 . We i l er J .M . ,  R .W .  Yu rt , D . T . Fearon , and K . F . Austen . 1 97 8 .  
Mod u l at i on o f  the forma t i o n  o f  the ampl i f i ca t i o n  co nvertase o f  
compl ement , C3b , Bb , by nati ve and commerc i al he pa ri n .  J .  Exp . 
Med . 147 :409 . 
99 . Sc hwartz L . B . .  1983 . Mas t cel l neutral proteases . I n  Adva nces 
i n  I mm u no pha nnacol o gy 2. Edi ted by J .W .  Hadden et a l . Pergamon 
P res s , Oxford and New Yor k ,  p p .  637 -643 . 
1 00 .  Lon ky S . A . , J .  Marsh , and H .  Wohl . 1 978 . St imul a t i on of human 
granu l ocyte el astase by pl atel et factor 4 and he pa r i n .  B i ochem . 
B i o phys . Res . Commun . 85 : 1 1 1 3 .  
130 
1 0 1 .  E h n ho l m  C ,  W.  Shaw , H .  G reten , and W . V .  B rown . 1975 . 
Pur i f i ca t i o n  from human pl asma of a hepa r i n- rel eased l i pase  wi th 
acti v i ty a ga i nst tri gl yceri de and phos pho l i pi ds .  J. B i ol . 
C hern . 250 :6756 . 
102 . Wa i te M ,  and P .  S i s son . 197 3 .  So l ub i l i za t i o n  by hepa r i n o f  the 
phos pho l i pase Al from the pl a sma membranes of rat l i ver . J .  
B i o l . C hern . 248 : 7201 . 
103 . Az i zkhan R . G . , J . C .  Az i zkha n , B . R . Zetter , and J .  Fol kman . 
1 980 . Mast cel l he pari n s t imul ates mi grat ion  of ca p i l l a ry 
endothel i a l  cel l s  i n  v i tro .  J .  Exp .  Med . 152 :93 1 . 
104 .  Ki e rs z en baum F ,  S . J .  Ac kennan , and G . J .  Gl ei ch . 1982 . 
I nh i b i t i o n of an i t body-dependent eo s i no ph i l -med i ated 
cytoto x i c i ty by he pari n .  J .  I rrvn unol . 128 : 5 1 5 . 
105 . C h i u H ,  and  D .  Lagunoff . 1972 . H i stochem i ca l  com pa r i son o f  
vertebrate m a s t  ce l l s .  H i s tochem .  J .  4 : 1 3 5 .  
106 . Yos h i da N ,  M . T .  Ever i tt , H .  Neurath , R . G .  Woodbu ry , and J . e .  
Powers . 1980 .  Substrate s pec i fi c i ty o f  two chymotryps i n- l i ke 
proteases  from rat mas t ce l l s .  Stud i es wi th pe pti de 
4 - n i troa n i l i des and com par i son wi th catheps i n  G .  B i oc hemi stry 
19 :5799 . 
107 . Y urt R . W . ,  and K . F . Aus ten . 1977 . Preparat i ve pu r i f i ca t i on of 
rat mast ce l l  chymase . C haracteri zat i on and i nterac t i on w i t h  
granu l e  com po nents . J .  Exp . Med . 146 : 1405 . 
108 . La gunoff D ,  and P .  P ri t zl . 1 97 6 .  Characteri z a t i on of rat mast 
cel l granu l e prote i ns . Arch . B i oc hem . B i ophys . 173 :554 . 
131  
109 . Kawi a k  J ,  W . H .  Vensel , J .  Komender , and E . A . Barnard . 1 97 1 .  
Non- pa ncreat i c proteas es o f  the chymot ryps i n  fami l y .  I .  A 
c hymotryps i n- l i ke protease from rat mast cel l s .  B i ochem .  
B i o phys . Acta . 23 : 172 . 
1 1 0 .  O ku n o - Kaneda  S ,  T .  Sa i to , Y .  Kawas a k i , A .  I c h i kawa , and  K .  
Tomi ta . 1 980 .  P ro perti es o f  protease in  mast  cel l granu l  es • 
B i ochem .  Pharmaco l . 29 : 1 7 1 5 . 
1 1 1 .  S c hwartz L . B . ,  C .  R i edel , J . P .  C au l fi el d ,  S . l .  W a s sennan , and 
K . F .  Aus ten . 1981 . Cel l a s s oc i at i on of com pl exes of chymase , 
he pari n proteogl ycan , and prote i n  a fter degranul a t i on by rat 
mas t ce l l s .  J .  Immunol . 126 : 2 07 l . 
1 1 2 .  Kat unuma N ,  E .  Komi nami , K .  Ko baya s h i , Y .  Banno , K .  Suzuk i , K .  
Ch i ch i bu ,  Y .  Hamaguc h i , and T .  Kat s unuma . 197 5 . Stud i es o n  new 
i ntracel l ul ar proteases  i n  v a r i o us or gans of rat . 1 .  
Pur i f i cat i on  and  com pa r i son  o f  the i r  pro pe rti es . Eur . J .  
B i o c hem . 52 : 37 . 
1 1 3 .  Seppa H . E . J . , a n d  M .  Jarv i nen . 197 8 .  Rat s k i n  ma i n  neutral  
protea s e :  pur i fi cati on and pro perti es . J .  I n vest . Dermato l . 
70 : 8 4 .  
1 1 4 .  Woodbury R . G . ,  M .  Eve r i t t , Y .  Sanada , N .  Katun uma , D .  Laguno ff , 
and H .  Neurath . 1 97 8 .  A major  seri ne protease i n  s kel eta l 
mus c l e :  Ev i dence for i ts mas t cel l ori g i n . Proc . Natl . Aca d . 
S c i . 75 : 5 3 1 1 .  
1 32 
1 1 5 .  Ko bayash i  K ,  Y .  Sanada , and N .  Katunuma . 1 97 8 .  Sel ecti ve 
c l eava ge of pepti de bonds by a seri ne protease  from rat s kel eta l  
muscl e .  J .  B i ochem .  84 : 477 . 
1 1 6 .  Varti o T ,  H .  Sep pa , and A .  Vaheri . 1981 . Susce pti b i l  i ty of 
sol u bl e  and matri x fi bronecti ns to degradati on by t i s s ue 
prote i n ases , mas t cel l chymase , and  catheps i n  G .  J .  B i o l . 
C hem . 256  :47 1 .  
1 17 .  Sage H ,  R . G .  Woodbu ry , and  P .  Borns tei n .  197 9 .  Structural  
studi es on  human  type I V  col l a gen . J .  B i ol . C hem .  254 : 9893 . 
1 18 .  Eve r i tt M . T . , and H .  Neurath . 197 9 . Rat mas t  ce l l  
chymotryp s i n- l i ke enzyme : Pu r i fi cati on , s pec i fi c i ty and 
i nteracti on  wi th mas t  cel l hepa r i n .  Fed . Proc . 38 :83 4 .  
1 1 9 .  Schwartz L . B . ,  R . A . Lewi s ,  D .  Sel d i n ,  and K . F . Aus ten . 1 98 1 . 
Ac i d  hydrol ases and tryptase  from secretory granu l es of 
d i s pe rsed human l un g  mast cel l s .  J .  Imm unol . 126 : 1290 . 
1 2 0 .  Schwartz L . B . , J . J .  Sc hrat z ,  D .  V i k ,  D . T .  Fearon , and K . F . 
Au sten . 1 982 . Cl eava ge of human C3 by human mast cel l 
t ryptase . Fed . Proc . 41 : 487 . 
1 2 1 .  S c hw a rtz L . B  • •  1 985 . The mast ce l l . I n  Al l ergy . Ed i ted by 
A . P .  Kapl an . Churc h i l l  L i v i ngstone , New Yor k .  pp . 53-7 6 .  
1 2 2 .  Ma i er M ,  J .  Spragg , and L . B .  Schwartz . 1 983 . I na c ti vat ion  of 
h uman h i gh mo l ec u l ar wei ght k i n i nogen by human mast cel l 
tryptase . J .  Imunol . 130 : 2352 . 
1 23 . Bodwel l J . E . , and W . L .  Meye r . 1981 . Pur i f i ca t i o n  and 
c haracteri z a t i on of carbo xypepti dase A from rat s kel etal 
musc l e .  B i ochem i stry .  20 : 2767 . 
133  
124 .  S chwartz L . B . ,  and  K . F . Austen . 1981 . Ac i d  hydrol a s es and 
other enzymes of rat and human mas t cel l secretory granul es , i n  
Bec ker E L , S i mon  AS , Au sten KF  ( eds ) :  B i oc hemi stry of t he Acute 
Al l erg i c Reacti o ns . New Yor k , Al an R.  L i ss , I nc . ,  pp . 1 03- 12 1 .  
1 2 5 . C h i u H ,  and D .  Laguno ff . 1 9 7 2 . H i s to c hemi cal  compari son of 
vertebrate mas t ce l l s .  H i s tochem . J .  4 : 1 3 5 .  
1 26 .  Ro bi nson D ,  and J . L  S t i rl i ng .  1965 . 
N-Acetyl - S- gl ucosam i n i dases i n  human s pl een . B i ochem . J . 
.!.QZ. : 3 2 1 . 
1 27 . Gei ge r B ,  and  R .  Arnon . 197 6 .  Chem i ca l  cha racter i zat i on and 
s u b un i t  structure of  human N-acetyl hexos ami ni dases  A and B .  
B i oc hem i s try . 15 : 3 489 . 
1 28 .  Fi s hman W . H . , B .  Spri  n ger , and  R .  Brunett i . 1948 . The 
a ppl i cat i on of an i mpro ved gl ucuroni dase assay met hod to the 
s tudy o f  human bl ood S- g l ucuroni dase . J .  B i o l . C hern . 173 :449 . 
1 29 . Owens JW , a nd P . D .  Stahl . 1 97 6 .  Puri fi cat ion and 
characteri zat i on of rat l i ve r  m i crosomal  S-g l ucuroni dase . 
B i o c hem . B i o phys . Acta . 438 : 47 4 .  
1 3 0 .  Schwa rtz L . B . , a n d  K . F . Aus ten . 1981 . Pur i f i ca t i o n  and 
c ha ra c teri z a t i o n  o f  a l ysosomal form and a vari  ant  form of 
S - g l ucuroni dase from the rat bas o ph i l  l eu kaem i a  tumor . B i ochem . 
J .  1 93 : 663 . 
1 3 1 . Kuby S . A . , and  H . A .  Lardy . 195 3 . Pur i f i ca t i o n  and k i net i cs of 
S-D- gal a c tosi dase from E s cheri ch i a col i K- 1 2 .  J .  Am .  C hern . 
Soc . 75 :890 . 
134 
1 32 . N i c ho l s R . G . ,  and A . B .  Roy . 1 97 1 .  Aryl s u l fatases . p .  2 1 .  I n  
Boyer P O  ( ed ) : The Enzymes . Vol V .  Academ i c  Pres s , New Yor k .  
1 3 3 .  W a s s erman S . I . , and K . F .  Aus ten . 1 97 7 .  I dent i fi cation  and 
cha racteri zat i on of aryl s u l fatases A and 8 of the rat ba s o ph i l  
1 eukemi a tumor . J .  8 i ol . C hem . 252 : 707 4 .  
1 3 4 .  Lync h  S . M . , K . F .  Aus ten , a n d  S . I .  Wasserman . 1978 . Rel ease o f  
aryl s u l fatase A but not B from r a t  mast cel l s  by noncytol yti c 
s ecretory st imu l  i .  J .  Irrmunol . 1 2 1  : 1 394 .  
1 35 . Tas  J ,  and R . G .  Berndsen . 1 97 7 .  Does hepari n occur i n  mucosa l  
mas t cel l s  of  the  rat sma l l  i ntes t i ne .  J .  H i stochem . Cytochem . 
25 : 1 058 .  
1 36 .  Woodbu ry R . G . , M .  Eve ri  tt , Y .  San ada , et al . 1978 . A major 
seri ne protease i n  s kel eta l muscl e :  evi dence for i ts mast cel l 
ori gi n .  Proc . Nat l . Acad . Sc i .  USA .  75 : 53 1 l .  
1 37 .  Wood bury R .G . ,  N .  Katunuma , K .  Ko bayash i , et a l . 1 97 8 .  
Cova l en t s tructure o f  a grou p- s pec i f i c  protease  from rat sma l l  
i ntes ti ne . B i oc hemi stry .  17 :81 1 .  
1 38 .  Woodbu ry R . G . , and H .  Neurath . 197 8 .  Pur i f i ca t i o n  o f  an 
atypi cal mast  cel l protease and i ts l evel s i n  devel o pi n g  rats . 
B i ochem i stry .  17 :42 98 . 
139 . Woodbury R . G . ,  G . M .  Gruzens ki , and D .  Lagunoff . 1978 . 
I mm u no fl uores cent l oca l i z a tion  of a seri ne protease i n  rat sma l l  
i ntes t i ne .  Proc . Natl . Acad . Sc i .  USA . 75 : 2785 . 
1 4 0 .  Wood bury R . G . ,  and H .  Neurath . 1 980 .  Structure , s pec i fi c i ty 
and l oc a l i za t i o n  o f  the seri ne proteases of co nnecti ve ti s s ue . 
FEB S .  Lett . 1 14 : 189 . 
135  
1 4 1 . Y o s h i da N ,  M . T .  E veri tt , H .  Neurath , et  a l . 1 98 0 .  Substrate 
s pec i f i c i ty of two chymot ryps i n-l i ke proteases from rat mast 
cel l s :  stud i es wi th pe pti de 4 - n i troa n i l i des and com pari son wi th  
cathep s i n  G .  B i oc hemi stry .  19 : 5799 . 
1 42 . Foreman  J .C . ,  B . D .  Mon gar , and B . D .  Gom perts . 1 9 7 3 .  Cal c i um 
i o no pho res and movement of cal c i um i o ns fol l ow i n g  the 
phys i 01 ogi ca 1 s timul us  to a secretory process . Nature . 245 : 249 . 
1 43 . F i n d l ay S . R . , A .M . Dvo ra k ,  and L . M .  L i chens tei n .  1980 . 
Hyperosmo l ar  tri g geri n g  of baso ph i l  h i s tami ne rel ease . J .  
A l l ery C l i n .  Immuno l . 65 : 1 7 0 .  
1 44 .  Bach M . K . ,  a n d  J . R .  Brashl er . 1 9 7 5 .  I nh i b i ti on o f  I gE- and 
com pou n d  48/80- i nduced h i s tam i ne rel ease by l ecti ns . 
I mm uno l o gy .  2 9  : 3 7 1 . 
145 . Ohmo ri  H ,  1 .  Yamamoto , H .  Akag i ,  and  K .  Tas a ka . 1980 . 
P ro perti es of hydro gen perox i de- i nduced h i s tami ne rel ease form 
rat mast  ce l l  s .  B i ochem . Pharmaco l . 29 : 74 1 . 
146 . Cau l fi el d J . P . ,  R . A . Lewi s ,  A .  He i n ,  and K . F . Aus ten . 1 98 0 .  
Secret i o n  i n  d i s soc i ated human pu l monary mast  ce l l s :  ev i dence 
for sol u b i l i z ati on  o f  granul e contents before d i s charge .  J .  
Cel l . B i o l . 85 : 299 . 
1 47 . I sh i za ka K ,  a n d  T .  I s h i za ka . 196 9 .  Immune mech a n i sms of 
reversed type reag i ni c  hypersens i ti v i ty .  J .  Immunol . 1 03 : 5 88 .  
1 48 .  S i r a ga n i an R . P . , W . A Hoo k ,  and B . B .  Lev i n e .  1975 . Spec i f i c  i n  
v i tro h i s tami ne rel ease from baso ph i l s  by b i val ent ha ptens . 
E v i dence for acti vat i on by s i m pl e bri dg i ng o f  membrane- bound 
a nti body . I mm u nochemi stry .  1 2 : 149 . 
136  
149 . Perea B . A . V . ,  and  J . L .  Mon gar . 1 96 3 .  The  rol e of a 
c hymot ryps i n- l i ke enzyme i n  h i s tami ne rel ease from rat mas t 
ce l l s .  I mm u nol o gy .  6 :4 72 . 
1 5 0 .  I sh i z a ka T ,  D . H .  Conrad , E . S .  Sc h u l man , e t  a l : 1 983 . 
B i ochemi cal anal y s i s of i n i ti al tri ggeri n g  e vents of 
I gE-medi ated h i s tami ne rel ease from human l un g  mast  ce l l s .  J .  
I mm u nol . 130  : 23 5 7 . 
1 5 1 . Fredho l m  B . B . .  198 0 .  Theo phyl l i ne acti ons  on adeno s i ne 
recepto rs . Eur . J. Res p .  D i s . ,  s u ppl . 109 . 61 : 2 9 .  
152 . Hol ga te S . T . , R . A .  Lew i s ,  and  K . F . Aus ten . 1980 . Rat sero s a l  
mast  cel l 3 ' 5 '  - cyc l i c  adenos i ne mo no phos phatede pendent prote i n  
k i nase  and  i t s  immunol o g i c  acti va t i on . J .  Immuno l . 124 :2 093 . 
1 5 3 . We l l s  E ,  and J .  Mann . 1 983 . Phos phoryl at i on of a mast  cel l 
protei n i n  res ponse  to treatment wi th  anti - a l l ergi c com pounds : 
i m pl i c a ti o n  for t he mode of a c ti on of sodi um cromogl ycate . 
B i ochem . Pharmaco l . 32 :837 . 
1 5 4 .  I s h i z a ka T . ,  F .  H i rata , K .  I s h i za ka ,  and J .  Axel rod . 1981 . 
Transm i s s i o n  and  regu l at i on of tri gge r i n g  s i ga l s i nduced by 
b ri dg i n g  o f  I g E  receptors on  rat mast  ce l l s .  I n  B i o c hemi stry of 
t he Acute Al l er g i c  Reacti ons . Ed i ted by E . L .  Becker , A . S .  
S i mon , and K . F . Aus ten . Al an R .  L i ss , I nc . ,  New York , pp . 
2 1 3-2 27 .  
15 5 .  Lew i s R . A . , N . A . Soter , P . T .  D i amond , et a l : 1982 . 
Prostagl and i n  D2 genera ti on a fter a c ti v a t i on of rat and human 
mas t cel l s  wi th  anti - I g E .  J . Immuno l . 129 : 1627 .  
156 Fei nstei n ,  M . B . ,  and R.  Wal en ga .  1 981 . The ro l e  of  cal c i um i n  
pl atel et act i va t i on . I n  B i oc hemi s try of the Acute Al l er 9 i c  
1 37 
Rea c ti o ns . Ed i ted by E . L .  Bec ker , A . S .  S i mon , and F . K .  Austen . 
Al an R .  L i s s , I nc . ,  New Yor k ,  pp . 279-293 . 
1 57 . W h i te J . R . , T .  I s h i za ka ,  K .  I s h i za ka ,  and R .  I .  S ha ' Afi . 1 984 . 
D i rect demons trat i on o f  i ncreased i ntracel l ul ar co ncentrat i on o f  
free cal c i um as meas ured by qu i n- 2 i n  s t imul ated r a t  peri toneal 
mas t  ce l l . J. Inrnunol . 81 : 3 97 8 .  
158 . Ka bat , E . A . , and M .M .  Mayer . 1 961 . I n  Ka bat and Maye r ' s 
Expe r i mental  Inrnunochem i stry. Cha rl es C .  Thomas , Spri n g f i el d ,  
I I I .  P .  3 1 4 .  
1 5 9 .  W i ntro u b , B . U . ,  N . B .  Schechter , G . S .  Lazarus , C . E .  Kaem pfer , and  
L . B .  Schwartz . 1 98 4 .  Angi otens i n  I con vers i on by  human and rat 
chymot rypti c protei nases • J. I nves t .  Dermato l . 83 : 3 36 . 
1 6 0 .  Otan i , 1 . ,  D . H .  Conrad , J . R .  Carl o ,  M .  Segal , and S R uddy . 
1982 . Pha gocytos i s by rat per i toneal mas t  cel l s :  I ndependence 
of I gG Fc-med i ated and C3-med i ated si gnal s .  J. I nrnunol . 
129 : 2 1 09 .  
161 . Hug l i ,  T . E . , E . H .  Val l ota , and  H . J . Mul l er- Eberhard . 197 5 . 
Pu r i fi ca ti on and parti a l  characteri z ati on of human and porc i ne 
C3a a n a phyl ato x i n .  J .  B i o l . Chern . 250 : 1 472 . 
1 62 . Dav i d ,  G . S . ,  and R . A . Rei sfel d .  1 9 7 4 .  Protei n i od i n a ti on wi th 
so l i d  s tate l actoperox i da s e . B i ochemi stry .  1 3 : 1 0 1 4 .  
1 63 .  Conrad , D . H . ,  E .  Studer , J .  Gervaso ni , and T .  Mo hana kumar . 
1983 . Properti es of two monoc l ona l  anti bod i es d i rected a ga i ns t  
t h e  F c  a n d  Fa b '  reg i o ns o f  r a t  I g E .  I nt .  Archs . Al l ergy Appl . 
I nrn un . 70 : 3 52 . 
1 38 
1 64 .  Staros , J . V .  1 982 . N -Hydro xys u l fos ucc i n i mi de a c ti ve esters : 
B i s  ( N- hyd roxys u l fos ucc i n i mde ) es ter of two d i ca r bo xyl i c  ac i ds 
a re by hydro ph i l i c , membrane- i m pe rmeant , prote i n  cross-l i n kers . 
B i o c hem i stry .  21 : 3950  
165 . Kes s l er , S .W .  197 5 .  Rap i d  i so l at i on o f  anti gens from cel l s  
wi th a s ta phyl ococcal  protei n A-anti body a bsorben t :  parameters 
of  the i nteracti on of anti body- anti gen com pl exes wi th  prote i n  
A .  J .  I ITlTI unol . 1 1 5  : 1 61 7 . 
166 . Sc h i ck ,  B . ,  K . F .  Aus ten , and  L . B .  Schwartz . 1984 . Act i va t i on 
o f  rat serosal  mast cel l s  by c hyma se , an endo genous secretory 
granu l  e protease . J .  IlTlnunol . 132 : 257 1 .  
167 . Hummel , B . C .W .  1 95 9 .  A mod i fi ed s pect ro photometri c 
determ i nati o n  o f  chymot ryps i n ,  tryps i n ,  and  thromb i n .  Can . J .  
B i oc hem .  37 : 1 393 . 
1 6 8 .  Fol k ,  J . E . , and  E .W .  Sc h i rmer . 1963 . The po rc i ne pa ncreat i c 
carbo xype p ti dase A sys tem .  J .  B i ol . C hem . 2 38 : 3884 . 
169 .  Jacques , L .  B . , and  A .  Wol l i n .  1967 . A mod i f i ed method for the 
col o r i metri c determi n a t i o n  of hepari n . C an . J .  Phanna col . 
45 : 7 87 . 
1 7 0 .  Sc hwart z ,  L . E . , K . F .  Aus ten , and  S . l .  Wasserman . 197 9 .  
I lTln u nol og i c rel ease o f  B- hexosami n i dase and B- gl uc uroni dase from 
pur i f i ed rat serosal  mas t cel l s .  J .  IlTlnunol . 123 : 1 445 . 
1 7 1 . Co nrad , D . H . ,  A .  F roese , T .  I s h i za ka , and K .  I s h i z a ka . 1 97 8 .  
E v i dence for anti body act i v i ty a ga i ns t  the rece ptor for 1 9E i n  a 
r a bb i t  a n ti serum prepared a ga i nst I g E  receptor com pl exes . J .  
I lTln un o l . 120 :507 
139 
1 72 . Stryer , L .  1 975 . Zymo gen acti vat ion : D i ges ti on enzymes and 
c l otti ng factors . I n  B i ochemi s try. W . H .  Freeman and Co , San 
Franc i s co . P. 1 62 . 
173 . Se i d l , D . S .  and  I . E .  L i ener . 197 2 .  I sol at i on and Propert i es of 
com pl exes of the Bowman-B i r k  soybean i nh i  bi tor w ith  tryps i n  and 
chymot ryps i n .  J .  B i o I . C hem . 247 :3 533 . 
1 7 4 .  S c hwart z , L . B .  1 983 . En zyme med i ators of mast cel l s  and 
ba s o ph i 1  s .  Cl  i n .  Rev . Al l ergy . 1 : 397 . 
1 75 . Hug l i ,  T . E .  and D . E .  C henoweth . 1 978 .  Demo nstrati on of 
s pec i f i c  C5a rece pto r on i ntact human po l ymor phonuc l ear 
l eu kocytes . Proc . N atl . Acad . Sc i . USA. 75 : 3943 . 
17 6 .  Lepow , I . H . , K .  W i l l ms- Kretschmer , R . A .  Pat ri c k , and  F . S .  
Rosen . 1 9 7 0 .  Observati ons o n  l es i o ns prod uced by i ntradermal 
i nj ecti on  o f  human C3a in man . Am .  J .  Patho l . 61 : 1 3 .  
177 . Ki do , H . ,  N .  Fu kusen , and N .  Katunuma . 1 985 . Chymotryps i n- and 
t ryps i n - type ser i ne proteases i n  rat mas t cel l s ;  Properti es and 
funct i o ns . Archi ves of B i oc hemi stry and B i o physi cs . 2 39 : 43 6 . 
140 
Curri cul um V i tae 
141 
